Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_001605.3(AARS1):c.2174del (p.Gly725fs)	AARS1	G725fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694884	16	70291939	16	70258036	694884	683072	rs1597435167	NC_000016.10:70258035:CCCCC:CCCC
NM_000443.4(ABCB4):c.3077del (p.Lys1026fs)	ABCB4	K979fs, K1026fs	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635317	7	87038556	7	87409240	635317	623143	rs1584678508	NC_000007.14:87409239:TT:T
NM_000443.4(ABCB4):c.1712del (p.Val571fs)	ABCB4	V571fs	Cholestasis, intrahepatic, of pregnancy 3|Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Jan 16, 1999)	no assertion criteria provided	VCV000013688	7	87069002	7	87439686	13688	28727	rs387906527	NC_000007.14:87439685:A:
NM_000443.4(ABCB4):c.394_400del (p.Tyr132fs)	ABCB4	Y132fs	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000013686	7	87082396 - 87082402	7	87453080 - 87453086	13686	28725	rs387906526	NC_000007.14:87453079:GTATATAG:G
NC_000007.13:g.(?_5567359)_(5569308_?)del	ACTB		Baraitser-Winter syndrome 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001064060	7	5567359 - 5569308			1064060	1039109		
NM_001101.5(ACTB):c.7_8delinsTT (p.Asp3Phe)	ACTB	D3F	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000968546	7	5569281 - 5569282	7	5529650 - 5529651	968546	955181		NC_000007.14:5529649:TC:AA
NM_001101.5(ACTB):c.329del (p.Leu110fs)	ACTB	L110fs	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000495296	7	5568826	7	5529195	495296	486793	rs1554329523	NC_000007.14:5529194:A:
NM_001614.5(ACTG1):c.985-40del	ACTG1		Deafness, autosomal dominant 20|not provided|Baraitser-Winter Syndrome 2	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000561394	17	79477899	17	81510873	561394	553009	rs59886367	NC_000017.11:81510872:CCCCCC:CCCCC
NM_032119.4(ADGRV1):c.11772del (p.Ile3925fs)	ADGRV1	I3925fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932230	5	90052809	5	90756992	932230	906125		NC_000005.10:90756991:TT:T
NC_000005.10:g.(?_90614729)_(90784051_?)del	ADGRV1		Rare genetic deafness	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000666992	5	89910546 - 90079868			666992	654975		
NM_032119.4(ADGRV1):c.1180del (p.Ser394fs)	ADGRV1	S394fs	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000666991	5	89923533	5	90627716	666991	654389	rs1400695342	NC_000005.10:90627715:TTT:TT
NM_032119.4(ADGRV1):c.1701del (p.Leu568fs)	ADGRV1	L568fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000228352	5	89925215	5	90629398	228352	229323	rs876657695	NC_000005.10:90629397:CCCC:CCC
NM_032119.3(ADGRV1):c.(?_4379)_(4752_?)del (p.(?))	ADGRV1		Rare genetic deafness	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000179513	5	89953722 - 89954095	5	90657905 - 90658278	179513	173539		
NM_032119.4(ADGRV1):c.17303_17315del (p.Gly5768fs)	ADGRV1	G5768fs	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179121	5	90149199 - 90149211	5	90853381 - 90853393	179121	174471	rs727504644	NC_000005.10:90853380:GGAGATTACATTCG:G
NM_032119.4(ADGRV1):c.(?_18153)-15_*(15_?)del	ADGRV1		Rare genetic deafness	Pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000178693	5	90368249 - 90459732	5	91072432 - 91163915	178693	173677		
NM_032119.4(ADGRV1):c.5643del (p.Tyr1882fs)	ADGRV1	Y1882fs	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163578	5	89977248	5	90681431	163578	174303	rs727503076	NC_000005.10:90681430:GGG:GG
NM_032119.4(ADGRV1):c.8737del (p.Val2913fs)	ADGRV1	V2913fs	Rare genetic deafness	Pathogenic(Last reviewed: Mar 14, 2011)	criteria provided, single submitter	VCV000046399	5	90004639	5	90708822	46399	55564	rs397517441	NC_000005.10:90708821:G:
NM_032119.4(ADGRV1):c.7374_7375del (p.Glu2459fs)	ADGRV1	E2459fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 24, 2012)	criteria provided, single submitter	VCV000046370	5	89989947 - 89989948	5	90694130 - 90694131	46370	55535	rs397517435	NC_000005.10:90694129:TG:
NM_032119.4(ADGRV1):c.17662del (p.Ser5888fs)	ADGRV1	S5888fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 17, 2010)	criteria provided, single submitter	VCV000046292	5	90151624	5	90855807	46292	55457	rs397517426	NC_000005.10:90855806:TT:T
NC_000018.9:g.73376178_78077248del4701071	ADNP2|ATP9B|CTDP1|ZNF516|SLC66A2|TXNL4A|ZNF236|NFATC1|PARD6G|RBFA|SALL3|GALR1|HSBP1L1|KCNG2|LINC00683|LINC01879|MBP		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000242603	18	73376178 - 78077248			242603	188239		
NM_054027.6(ANKH):c.1124_1126del (p.Ser375del)	ANKH	S375del	Craniometaphyseal dysplasia, autosomal dominant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005194	5	14716830 - 14716832	5	14716721 - 14716723	5194	20233	rs121908406	NC_000005.10:14716720:AGGAG:AG
NM_001127.4(AP1B1):c.2335del (p.Leu779fs)	AP1B1	L752fs, L772fs, L779fs, L710fs, L715fs, L722fs	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805797	22	29727880	22	29331891	805797	794117	rs1602683532	NC_000022.11:29331890:GGGGGG:GGGGG
NC_000022.10:g.29758984_29815476del	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805794					805794	794114		
NM_001283.5(AP1S1):c.364del (p.Asp122fs)	AP1S1	D122fs	not provided|Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2019)	criteria provided, conflicting interpretations	VCV000804404	7	100802405	7	101159124	804404	792764	rs767358930	NC_000007.14:101159123:GGGGGGGG:GGGGGGG
NM_001004051.4(GPRASP2):c.1717_1718delinsAA (p.Ala573Asn)	ARMCX5-GPRASP2|GPRASP2	A573N	X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590781	X	101971514 - 101971515	X	102716586 - 102716587	590781	581718	rs1569491884	NC_000023.11:102716585:GC:AA
NM_015915.5(ATL1):c.976del (p.Val326fs)	ATL1	V326fs	Charcot-Marie-Tooth disease|Hereditary sensory neuropathy type 1D	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000637513	14	51087429	14	50620711	637513	625307	rs1595619553	NC_000014.9:50620710:GG:G
NM_001692.4(ATP6V1B1):c.825del (p.Ala276fs)	ATP6V1B1	A276fs	not provided	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001071557	2	71189946	2	70962816	1071557	1059448		NC_000002.12:70962815:T:
NM_001692.4(ATP6V1B1):c.1155del (p.Ile386fs)	ATP6V1B1	I386fs	not provided	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000953951	2	71191573	2	70964443	953951	943087		NC_000002.12:70964442:CCCCCCC:CCCCCC
NM_001692.4(ATP6V1B1):c.*211del	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000336932	2	71192461	2	70965331	336932	287137	rs886056276	NC_000002.12:70965330:GG:G
NM_001692.4(ATP6V1B1):c.1249-15_1249-11del	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000336924	2	71191848 - 71191852	2	70964718 - 70964722	336924	287121	rs886056273	NC_000002.12:70964717:GCCTTGCC:GCC
ATP6V1B1, 1-BP DEL	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012226					12226	27265		
NM_001374385.1(ATP8B1):c.*2015del	ATP8B1|LOC100505549		Progressive familial intrahepatic cholestasis	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000327438	18	55313705	18	57646473	327438	331904	rs35833803	NC_000018.10:57646472:TTTTTTT:TTTTTT
NC_000018.9:g.76854774_78077248del1222475	ATP9B|CTDP1|HSBP1L1|KCNG2|NFATC1|PARD6G|RBFA|SLC66A2|TXNL4A|ADNP2		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000242601	18	76854774 - 78077248			242601	188241		
NM_000489.6(ATRX):c.6504+5_6504+14del	ATRX		X-linked intellectual disability-hypotonic face syndrome	Uncertain significance(Last reviewed: Aug 25, 2020)	no assertion criteria provided	VCV000981648	X	76814126 - 76814135	X	77558655 - 77558664	981648	969733		NC_000023.11:77558654:AATTATAAAC:
NM_000489.6(ATRX):c.477del (p.Lys159fs)	ATRX	K159fs	Alpha thalassemia-X-linked intellectual disability syndrome|X-linked intellectual disability-hypotonic face syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689744	X	76949320	X	77693831	689744	677477	rs1603240572	NC_000023.11:77693830:TTTTTT:TTTTT
NM_001079866.2(BCS1L):c.1220del (p.Pro407fs)	BCS1L	P240fs, P287fs, P407fs	Mitochondrial complex III deficiency, nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210366	2	219528067	2	218663344	1210366	1200366		NC_000002.12:218663343:CCC:CC
NM_001374258.1(BRAF):c.2248-27_2248-16delinsTCT	BRAF		Noonan syndrome with multiple lentigines|Cardio-facio-cutaneous syndrome|Noonan syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359046	7	140434586 - 140434597	7	140734786 - 140734797	359046	301998	rs886062016	NC_000007.14:140734785:GAAAAAAAAAAG:AGA
NM_001374258.1(BRAF):c.2248-16_2248-15del	BRAF		Noonan syndrome with multiple lentigines|Noonan syndrome|Cardio-facio-cutaneous syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359045	7	140434585 - 140434586	7	140734785 - 140734786	359045	309875	rs886062015	NC_000007.14:140734784:AGA:A
NM_001374258.1(BRAF):c.2248-4del	BRAF		Noonan syndrome with multiple lentigines|Noonan syndrome|Cardio-facio-cutaneous syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359044	7	140434574	7	140734774	359044	310013	rs886062014	NC_000007.14:140734773:C:
NM_001374258.1(BRAF):c.2248-5del	BRAF		Noonan syndrome with multiple lentigines|Cardio-facio-cutaneous syndrome|Rasopathy|Noonan syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044821	7	140434575	7	140734775	44821	53988	rs373442098	NC_000007.14:140734774:AAAAAAAAAAA:AAAAAAAAAA
NC_000001.11:g.(?_55006987)_(55008638_?)del	BSND		not provided	Likely pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000830840	1	55472660 - 55474311			830840	818985		
NM_057176.3(BSND):c.402del (p.Glu135fs)	BSND	E135fs	Bartter disease type 4a	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000631609	1	55472799	1	55007126	631609	620006	rs1281690580	NC_000001.11:55007125:T:
BSND, EX3-EX4 DEL	BSND		Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004383					4383	19422		
BSND, IVS1, 41-BP DEL	BSND		Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004382					4382	19421		
NC_000015.10:g.(?_43638998)_(43639062_?)del	CATSPER2		Deafness-infertility syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Feb 24, 2018)	criteria provided, single submitter	VCV000667392	15	43931196 - 43931260			667392	654985		
NM_172095.3(CATSPER2):c.(?_718)-34_(843_?)-857del	CATSPER2		Rare genetic deafness	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	VCV000162825	15	43929274 - 43931260	15	43637076 - 43639062	162825	175912		
NM_004357.5(CD151):c.[19A>T;622_630del]	CD151	K7*	Nephropathy with pretibial epidermolysis bullosa and deafness	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000982373	11|11	836088	11|11	836088	982373	970501|970502		NC_000011.10:836087:A:T|NC_000011.10:837946:CTGCATCACC:C
NM_003672.4(CDC14A):c.1351_1352del (p.Ala451fs)	CDC14A	A158fs, A393fs, A451fs	Sensorineural hearing loss	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000691620	1	100963693 - 100963694	1	100498137 - 100498138	691620	679341	rs1571346132	NC_000001.11:100498136:GC:
NM_003672.4(CDC14A):c.376del (p.Tyr126fs)	CDC14A	Y126fs, Y68fs	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559437	1	100889844	1	100424288	559437	550161	rs759201338	NC_000001.11:100424287:T:
NM_022124.6(CDH23):c.9389_9390del (p.Pro3130fs)	CDH23	P27fs, P3130fs, P890fs	not provided|Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001071896	10	73572245 - 73572246	10	71812488 - 71812489	1071896	1061968		NC_000010.11:71812487:CT:
NM_022124.6(CDH23):c.9726del (p.Ser3243fs)	CDH23	S1003fs, S140fs, S3243fs	Inborn genetic diseases|Childhood onset hearing loss	Uncertain significance(Last reviewed: Jul 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000985511	10	73573092	10	71813335	985511	973753		NC_000010.11:71813334:CC:C
NM_022124.6(CDH23):c.6449del (p.Gly2150fs)	CDH23	G2150fs	Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000623740	10	73553131	10	71793374	623740	612882	rs1564796673	NC_000010.11:71793373:GGGG:GGG
NM_022124.6(CDH23):c.9176del (p.Pro3059fs)	CDH23	P3059fs, P819fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000517317	10	73571169	10	71811412	517317	496544	rs1554877806	NC_000010.11:71811411:CC:C
NM_022124.6(CDH23):c.9129del (p.Asn3044fs)	CDH23	N804fs, N3044fs	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446450	10	73571122	10	71811365	446450	439918	rs1554877797	NC_000010.11:71811364:GG:G
NM_022124.6(CDH23):c.6667del (p.Leu2223fs)	CDH23	L2223fs	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446447	10	73553351	10	71793594	446447	439915	rs1554874879	NC_000010.11:71793593:CC:C
NC_000010.11:g.(?_71731987)_(71734281_?)del	CDH23|C10orf105		Rare genetic deafness	Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	VCV000179348	10	73491744 - 73494038	10	71731987 - 71734281	179348	174699		
NM_022124.6(CDH23):c.7979_7986del (p.Asp2660fs)	CDH23|LOC111982869	D2660fs, D420fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	VCV000179282	10	73565668 - 73565675	10	71805911 - 71805918	179282	175277	rs727504761	NC_000010.11:71805910:GACTGGGAG:G
NM_022124.6(CDH23):c.9510+19_9510+25del	CDH23|PSAP		Combined saposin deficiency|Usher syndrome type 1D|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy|not provided|not specified|Usher syndrome type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000133306	10	73572382 - 73572388	10	71812625 - 71812631	133306	137043	rs149704197	NC_000010.11:71812624:TCAGGCATCA:TCA
NM_022124.6(CDH23):c.9629_9632del (p.Ile3210fs)	CDH23	I107fs, I3210fs, I970fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000046077	10	73572640 - 73572643	10	71812883 - 71812886	46077	55242	rs397517367	NC_000010.11:71812882:CAATCAA:CAA
NM_022124.6(CDH23):c.6968del (p.Pro2323fs)	CDH23	P2323fs, P83fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 26, 2012)	criteria provided, single submitter	VCV000046023	10	73558247	10	71798490	46023	55188	rs397517350	NC_000010.11:71798489:CCC:CC
NM_022124.6(CDH23):c.6412del (p.Glu2138fs)	CDH23	E2138fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Nov 4, 2009)	criteria provided, single submitter	VCV000046009	10	73553096	10	71793339	46009	55174	rs111033473	NC_000010.11:71793338:GG:G
NM_022124.6(CDH23):c.46del (p.Val16fs)	CDH23	V16fs	Rare genetic deafness	Pathogenic(Last reviewed: Nov 1, 2010)	criteria provided, single submitter	VCV000045954	10	73199633	10	71439876	45954	55119	rs397517331	NC_000010.11:71439875:GG:G
NM_022124.6(CDH23):c.2290-13del	CDH23		CDH23-Related Disorders|not specified|not provided|Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000045892	10	73455161	10	71695404	45892	55057	rs397517316	NC_000010.11:71695403:TT:T
NM_022124.6(CDH23):c.2012del (p.Phe671fs)	CDH23	F671fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 6, 2010)	criteria provided, single submitter	VCV000045886	10	73447428	10	71687671	45886	55051	rs397517313	NC_000010.11:71687670:TT:T
NM_022124.6(CDH23):c.1246_1266del (p.Ala416_Glu422del)	CDH23		Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 8, 2013)	criteria provided, single submitter	VCV000045865	10	73405693 - 73405713	10	71645935 - 71645955	45865	55030	rs397517305	NC_000010.11:71645934:GGCCATCCCACTGGACTACGAG:G
NM_022124.6(CDH23):c.193del (p.Leu65fs)	CDH23-AS1|CDH23	L65fs	USHER SYNDROME, TYPE ID/F, DIGENIC|Usher syndrome type 1D|Usher syndrome type 1|not provided	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004925	10	73269882	10	71510125	4925	19964	rs796051861	NC_000010.11:71510124:CCCCC:CCCC
NM_001330691.3(CEP78):c.534del (p.Lys179fs)	CEP78	K179fs	not provided|Sensorineural hearing loss|Cone-rod degeneration|Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000372270	9	80856645	9	78241729	372270	359178	rs1057517695	NC_000009.12:78241728:TT:T
NM_017780.4(CHD7):c.2881del (p.Glu961fs)	CHD7	E961fs	CHARGE association	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001301896	8	61734626	8	60822067	1301896	1292178		NC_000008.11:60822066:GGG:GG
NM_017780.4(CHD7):c.4888del (p.Tyr1630fs)	CHD7	Y1630fs	CHARGE association	Pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001076953	8	61757460	8	60844901	1076953	1061385		NC_000008.11:60844900:T:
NM_017780.4(CHD7):c.1977del (p.Lys660fs)	CHD7	K660fs	CHARGE association	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV001074287	8	61693868	8	60781309	1074287	1061377		NC_000008.11:60781308:CCC:CC
NM_017780.4(CHD7):c.2707_2710del (p.His903fs)	CHD7	H903fs	CHARGE association	Pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001072855	8	61734355 - 61734358	8	60821796 - 60821799	1072855	1061380		NC_000008.11:60821795:ACTCACT:ACT
NM_017780.4(CHD7):c.1871del (p.Val624fs)	CHD7	V624fs	CHARGE association	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001071795	8	61693764	8	60781205	1071795	1061373		NC_000008.11:60781204:T:
NM_017780.4(CHD7):c.7710del (p.Val2571fs)	CHD7	V2571fs	CHARGE association	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001070672	8	61773564	8	60861005	1070672	1061391		NC_000008.11:60861004:T:
NM_017780.4(CHD7):c.2195del (p.Pro732fs)	CHD7	P732fs	CHARGE association	Pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001068833	8	61707639	8	60795080	1068833	1061378		NC_000008.11:60795079:CCCCC:CCCC
NM_017780.4(CHD7):c.481_482delinsAG (p.Gln161Arg)	CHD7	Q161R	CHARGE association	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001051449	8	61654472 - 61654473	8	60741913 - 60741914	1051449	1045615		NC_000008.11:60741912:CA:AG
NM_017780.4(CHD7):c.395_400delinsCAA (p.Glu132_His134delinsAlaAsn)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000970874	8	61654386 - 61654391	8	60741827 - 60741832	970874	955469		NC_000008.11:60741826:AGAGGC:CAA
NM_017780.4(CHD7):c.5932del (p.Val1978fs)	CHD7	V1978fs	CHARGE association	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000970243	8	61765093	8	60852534	970243	955478		NC_000008.11:60852533:GG:G
NM_017780.4(CHD7):c.3372_3373delinsAT (p.Met1124_Asp1125delinsIleTyr)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000953632	8	61736569 - 61736570	8	60824010 - 60824011	953632	946147		NC_000008.11:60824009:GG:AT
NM_017780.4(CHD7):c.5211-2_5227del	CHD7		CHARGE association	Likely pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000953238	8	61761069 - 61761087	8	60848510 - 60848528	953238	959899		NC_000008.11:60848509:TCCAGGGTCCTGCTGCGTGTCC:TCC
NM_017780.4(CHD7):c.7977_8063delinsCTCA (p.Gly2660fs)	CHD7	G2660fs, G611fs	CHARGE association	Pathogenic(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV000950894	8	61775112 - 61775198	8	60862553 - 60862639	950894	925252		
NM_017780.4(CHD7):c.3470del (p.Pro1157fs)	CHD7	P1157fs	CHARGE association	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000948614	8	61741311	8	60828752	948614	925247		NC_000008.11:60828751:CCC:CC
NM_017780.4(CHD7):c.3094_3114del (p.Glu1032_Trp1038del)	CHD7		CHARGE association	Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000943918	8	61735194 - 61735214	8	60822635 - 60822655	943918	925245		NC_000008.11:60822634:CTGGGAAAGGGAATTCCGAACCTGG:CTGG
NM_017780.4(CHD7):c.4424del (p.Glu1475fs)	CHD7	E1475fs	CHARGE association	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000940959	8	61750705	8	60838146	940959	934383		NC_000008.11:60838145:A:
NM_017780.4(CHD7):c.6817_6818del (p.Asn2273fs)	CHD7	N2273fs	CHARGE association	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000938241	8	61766963 - 61766964	8	60854404 - 60854405	938241	934390		NC_000008.11:60854403:AA:
NM_017780.4(CHD7):c.7276del (p.Gln2426fs)	CHD7	Q2426fs	CHARGE association	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000930111	8	61769113	8	60856554	930111	918297		NC_000008.11:60856553:CCC:CC
NM_017780.4(CHD7):c.2919_2927del (p.Glu974_Val976del)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000862433	8	61734665 - 61734673	8	60822106 - 60822114	862433	834942		NC_000008.11:60822105:TGGAGGGAGT:T
NM_017780.4(CHD7):c.1496_1497delinsGC (p.Gln499Arg)	CHD7	Q499R	CHARGE association	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000860025	8	61655487 - 61655488	8	60742928 - 60742929	860025	834936		NC_000008.11:60742927:AA:GC
NM_017780.4(CHD7):c.3514_3515del (p.Glu1172fs)	CHD7	E1172fs	CHARGE association	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000854705	8	61741356 - 61741357	8	60828797 - 60828798	854705	834947		NC_000008.11:60828796:AGA:A
NM_017780.4(CHD7):c.5330del (p.Phe1777fs)	CHD7	F1777fs	CHARGE association	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000853417	8	61761637	8	60849078	853417	834958		NC_000008.11:60849077:TTT:TT
NM_017780.4(CHD7):c.1267del (p.Glu423fs)	CHD7	E423fs	CHARGE association	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000841990	8	61655257	8	60742698	841990	834934		NC_000008.11:60742697:GG:G
NM_017780.4(CHD7):c.281del (p.Pro94fs)	CHD7	P94fs	CHARGE association	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000841463	8	61654269	8	60741710	841463	834925		NC_000008.11:60741709:CCCC:CCC
NM_017780.4(CHD7):c.7240_7241delinsTT (p.Ala2414Phe)	CHD7	A2414F	CHARGE association	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV000840509	8	61769079 - 61769080	8	60856520 - 60856521	840509	834972		NC_000008.11:60856519:GC:TT
NM_017780.4(CHD7):c.5211-3del	CHD7		not provided|CHARGE association	Likely benign(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000704321	8	61761070	8	60848511	704321	695394	rs1586437092	NC_000008.11:60848510:CC:C
NM_017780.4(CHD7):c.807del (p.Ala270fs)	CHD7	A270fs	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000692075	8	61654797	8	60742238	692075	679761	rs1586249559	NC_000008.11:60742237:TT:T
NM_017780.4(CHD7):c.6401del (p.Asn2134fs)	CHD7	N2134fs	CHARGE association	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000659630	8	61765682	8	60853123	659630	637335	rs1586446101	NC_000008.11:60853122:AAAA:AAA
NM_017780.4(CHD7):c.4652del (p.Leu1551fs)	CHD7	L1551fs	CHARGE association	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000658937	8	61754413	8	60841854	658937	637330	rs1586426486	NC_000008.11:60841853:T:
NM_017780.4(CHD7):c.2295del (p.Phe765fs)	CHD7	F765fs	CHARGE association	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000654941	8	61713003	8	60800444	654941	637320	rs1586350854	NC_000008.11:60800443:C:
NM_017780.4(CHD7):c.3999del (p.Pro1332_Tyr1333insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654472	8	61749385	8	60836826	654472	637327	rs1586417729	NC_000008.11:60836825:T:
NM_017780.4(CHD7):c.2700del (p.Pro900_Val901insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651761	8	61734351	8	60821792	651761	637322	rs1586389286	NC_000008.11:60821791:T:
NM_017780.4(CHD7):c.3577_3583del (p.Asp1193fs)	CHD7	D1193fs	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000648507	8	61742933 - 61742939	8	60830374 - 60830380	648507	637325	rs1586405367	NC_000008.11:60830373:AGGATGTAG:AG
NM_017780.4(CHD7):c.4295_4296del (p.Leu1432fs)	CHD7	L1432fs	CHARGE association	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000645093	8	61750336 - 61750337	8	60837777 - 60837778	645093	637329	rs1586419497	NC_000008.11:60837776:TG:
NM_017780.4(CHD7):c.29_30del (p.Phe10fs)	CHD7	F10fs	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000644954	8	61654017 - 61654018	8	60741458 - 60741459	644954	637303	rs1586247124	NC_000008.11:60741457:TTTTT:TTT
NM_017780.4(CHD7):c.8618_8634del (p.Ser2873fs)	CHD7	S824fs, S2873fs	CHARGE association	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000640219	8	61778115 - 61778131	8	60865556 - 60865572	640219	637357	rs1586468521	NC_000008.11:60865555:TCTGTTGGTGCTGCTACT:T
NM_017780.4(CHD7):c.6734del (p.Leu2245fs)	CHD7	L2245fs	CHARGE association	Likely pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000592091	8	61766018	8	60853459	592091	583103	rs1563661595	NC_000008.11:60853458:T:
NM_017780.4(CHD7):c.4662del (p.Asp1554fs)	CHD7	D1554fs	CHARGE association	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000581472	8	61754423	8	60841864	581472	568037	rs1563648905	NC_000008.11:60841863:T:
NM_017780.4(CHD7):c.2147_2148delinsTT (p.Lys716Ile)	CHD7	K716I	not provided|CHARGE association	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000581127	8	61707595 - 61707596	8	60795036 - 60795037	581127	562478	rs1563606900	NC_000008.11:60795035:AG:TT
NM_017780.4(CHD7):c.6473del (p.Ser2158fs)	CHD7	S2158fs	CHARGE association	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000581030	8	61765757	8	60853198	581030	562481	rs1563660938	NC_000008.11:60853197:C:
NM_017780.4(CHD7):c.8549_8555del (p.Asn2850fs)	CHD7	N2850fs, N801fs	CHARGE association	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000578478	8	61778044 - 61778050	8	60865485 - 60865491	578478	563037	rs1563674316	NC_000008.11:60865484:AGAATGAAGA:AGA
NM_017780.4(CHD7):c.2090del (p.Lys697fs)	CHD7	K697fs	CHARGE association	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000576625	8	61693979	8	60781420	576625	568015	rs1563595385	NC_000008.11:60781419:AAAAA:AAAA
NM_017780.4(CHD7):c.2452_2462del (p.Gly818fs)	CHD7	G818fs	CHARGE association	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000575329	8	61720784 - 61720794	8	60808225 - 60808235	575329	568032	rs1563618176	NC_000008.11:60808224:TGGAGAGGAGGT:T
NM_017780.4(CHD7):c.1952_1955del (p.Lys651fs)	CHD7	K651fs	CHARGE association	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574634	8	61693844 - 61693847	8	60781285 - 60781288	574634	565191	rs1563595101	NC_000008.11:60781284:AAAGA:A
NM_017780.4(CHD7):c.718del (p.Gln240fs)	CHD7	Q240fs	CHARGE association	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000574274	8	61654706	8	60742147	574274	565185	rs1563560493	NC_000008.11:60742146:CCCC:CCC
NM_017780.4(CHD7):c.6888_6889del (p.Ala2297fs)	CHD7	A2297fs	CHARGE association	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000567248	8	61767034 - 61767035	8	60854475 - 60854476	567248	568045	rs1563662791	NC_000008.11:60854474:AG:
NM_017780.4(CHD7):c.282del (p.Asn96fs)	CHD7	N96fs	CHARGE association	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560976	8	61654273	8	60741714	560976	552125	rs1563559321	NC_000008.11:60741713:T:
NM_017780.4(CHD7):c.2910_2925del (p.Glu970_Tyr971insTer)	CHD7		CHARGE association	Likely pathogenic(Last reviewed: Jul 31, 2018)	no assertion criteria provided	VCV000559419	8	61734652 - 61734667	8	60822093 - 60822108	559419	550149	rs1554597507	NC_000008.11:60822092:AGGGAATACCAGTTGGAGGGA:AGGGA
NM_017780.4(CHD7):c.8087del (p.Pro2696fs)	CHD7	P2696fs, P647fs	CHARGE association	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547197	8	61777584	8	60865025	547197	537837	rs1554606910	NC_000008.11:60865024:CC:C
NM_017780.4(CHD7):c.1294del (p.His432fs)	CHD7	H432fs	CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547190	8	61655282	8	60742723	547190	537830	rs1554581646	NC_000008.11:60742722:CCCC:CCC
NC_000008.11:g.(?_60741413)_(60865953_?)del	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000529154	8	61653972 - 61778512	8	60741413 - 60865953	529154	523175		
NM_017780.4(CHD7):c.6989_6990delinsCT (p.Gly2330Ala)	CHD7	G2330A	CHARGE association|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000529148	8	61768586 - 61768587	8	60856027 - 60856028	529148	524262	rs1554604771	NC_000008.11:60856026:GC:CT
NM_017780.4(CHD7):c.2726_2728del (p.Cys909del)	CHD7	C909del	CHARGE association	Uncertain significance(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000529129	8	61734376 - 61734378	8	60821817 - 60821819	529129	524246	rs1554597381	NC_000008.11:60821816:TGTT:T
NM_017780.4(CHD7):c.478del (p.Tyr160fs)	CHD7	Y160fs	CHARGE association	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000529127	8	61654469	8	60741910	529127	523645	rs1554581198	NC_000008.11:60741909:T:
NM_017780.4(CHD7):c.1925del (p.Lys642fs)	CHD7	K642fs	CHARGE association	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000529122	8	61693812	8	60781253	529122	524239	rs1554588712	NC_000008.11:60781252:AAAAAAA:AAAAAA
NM_017780.4(CHD7):c.1803_1806del (p.Lys602fs)	CHD7	K602fs	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524142	8	61693693 - 61693696	8	60781134 - 60781137	524142	514575	rs1554588671	NC_000008.11:60781133:AAAGAAA:AAA
NM_017780.4(CHD7):c.8067del (p.Lys2690fs)	CHD7	K641fs, K2690fs	CHARGE association	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000459565	8	61775201	8	60862642	459565	458581	rs1554606375	NC_000008.11:60862641:TT:T
NM_017780.4(CHD7):c.5101del (p.Gln1701fs)	CHD7	Q1701fs	CHARGE association	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000459549	8	61757857	8	60845298	459549	458490	rs1554602557	NC_000008.11:60845297:CCC:CC
NM_017780.4(CHD7):c.3937del (p.Ser1313fs)	CHD7	S1313fs	CHARGE association	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000459547	8	61748787	8	60836228	459547	457929	rs1554600538	NC_000008.11:60836227:TTTT:TTT
NM_017780.4(CHD7):c.2990del (p.Leu997fs)	CHD7	L997fs	CHARGE association	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000441170	8	61735092	8	60822533	441170	434798	rs1554597677	NC_000008.11:60822532:TTT:TT
NM_017780.4(CHD7):c.6114_6120del (p.Leu2039fs)	CHD7	L2039fs	not provided|CHARGE association	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429504	8	61765398 - 61765404	8	60852839 - 60852845	429504	421685	rs1131691420	NC_000008.11:60852838:CCTCTCC:
NM_017780.4(CHD7):c.7297del (p.Val2433fs)	CHD7	V2433fs	CHARGE association|not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419586	8	61769135	8	60856576	419586	407433	rs1064793972	NC_000008.11:60856575:GG:G
NM_017780.4(CHD7):c.2613+1del	CHD7		CHARGE association	Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000411191	8	61729060	8	60816501	411191	396538	rs1060503189	NC_000008.11:60816500:GG:G
NM_017780.4(CHD7):c.1058del (p.Phe353fs)	CHD7	F353fs	CHARGE association	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000411185	8	61655048	8	60742489	411185	396250	rs1060503184	NC_000008.11:60742488:TT:T
NM_017780.4(CHD7):c.2568del (p.Lys857fs)	CHD7	K857fs	CHARGE association	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000411180	8	61729014	8	60816455	411180	396912	rs1060503181	NC_000008.11:60816454:TT:T
NM_017780.4(CHD7):c.4985del (p.Ser1662fs)	CHD7	S1662fs	CHARGE association	Likely pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000403702	8	61757557	8	60844998	403702	390672	rs1060499937	NC_000008.11:60844997:G:
NM_017780.4(CHD7):c.*338del	CHD7		CHARGE association|Hypogonadism with anosmia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363494	8	61778830	8	60866271	363494	305676	rs886063045	NC_000008.11:60866270:G:
NM_017780.4(CHD7):c.*127del	CHD7		CHARGE association|not provided|Hypogonadism with anosmia	Benign(Last reviewed: Apr 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000363491	8	61778610	8	60866051	363491	314978	rs11322994	NC_000008.11:60866050:AAAAAAAAAA:AAAAAAAAA
NM_017780.4(CHD7):c.8960_8962del (p.Gly2987del)	CHD7	G2987del, G938del	CHARGE association|Hypogonadism with anosmia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363488	8	61778454 - 61778456	8	60865895 - 60865897	363488	314924	rs771806027	NC_000008.11:60865894:GGGGGGG:GGGG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363431	8	61591350	8	60678791	363431	309564	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363430	8	61591350	8	60678791	363430	309551	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363429	8	61591350	8	60678791	363429	309550	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363428	8	61591350	8	60678791	363428	314860	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCAGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363427	8	61591350	8	60678791	363427	314912	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCAGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363426	8	61591350	8	60678791	363426	314911	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCAGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363425	8	61591350	8	60678791	363425	314854	rs886063026	NC_000008.11:60678790:A:GGCGGCAGCG
NM_017780.4(CHD7):c.-466_-461del	CHD7		CHARGE association|Hypogonadism with anosmia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363422	8	61591345 - 61591350	8	60678786 - 60678791	363422	305618	rs886063025	NC_000008.11:60678785:GCGGCAGCGGC:GCGGC
NM_017780.4(CHD7):c.8730_8731del (p.Pro2911fs)	CHD7	P2911fs, P862fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267441	8	61778227 - 61778228	8	60865668 - 60865669	267441	262665	rs886041000	NC_000008.11:60865667:CTC:C
NM_017780.4(CHD7):c.4837_4838del (p.Leu1613fs)	CHD7	L1613fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267431	8	61754597 - 61754598	8	60842038 - 60842039	267431	262656	rs886040992	NC_000008.11:60842037:TCT:T
NM_017780.4(CHD7):c.3811_3814del (p.Glu1271fs)	CHD7	E1271fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267429	8	61748661 - 61748664	8	60836102 - 60836105	267429	262654	rs886040990	NC_000008.11:60836101:AAAGAAA:AAA
NM_017780.4(CHD7):c.3572_3573del (p.Lys1191fs)	CHD7	K1191fs	CHARGE association|not provided	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267426	8	61742929 - 61742930	8	60830370 - 60830371	267426	262651	rs886040987	NC_000008.11:60830369:AAA:A
NM_017780.4(CHD7):c.2504_2508del (p.Tyr835fs)	CHD7	Y835fs	not provided|CHARGE association	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267420	8	61728947 - 61728951	8	60816388 - 60816392	267420	262645	rs886040982	NC_000008.11:60816387:TCTTATCTT:TCTT
NM_017780.4(CHD7):c.1073del (p.Gly358fs)	CHD7	G358fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267417	8	61655063	8	60742504	267417	262642	rs886040980	NC_000008.11:60742503:GG:G
NM_017780.4(CHD7):c.6165_6166del (p.Tyr2056fs)	CHD7	Y2056fs	not provided|CHARGE association	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265405	8	61765448 - 61765449	8	60852889 - 60852890	265405	259903	rs886039528	NC_000008.11:60852888:TGT:T
NM_017780.4(CHD7):c.3964del (p.Leu1322fs)	CHD7	L1322fs	CHARGE association|not provided	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000252713	8	61748817	8	60836258	252713	247033	rs879255410	NC_000008.11:60836257:C:
NM_017780.4(CHD7):c.4915del (p.Asp1638_Val1639insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 19, 2015)	criteria provided, single submitter	VCV000220281	8	61757487	8	60844928	220281	221763	rs864622455	NC_000008.11:60844927:G:
NM_017780.4(CHD7):c.2442+2449_2498+259del	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 1, 2013)	criteria provided, single submitter	VCV000218417	8	61716600 - 61721089	8	60804041 - 60808530	218417	215174		
NM_017780.4(CHD7):c.7663del (p.Arg2555fs)	CHD7	R2555fs	CHARGE association	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000216875	8	61773516	8	60860957	216875	212636	rs863224843	NC_000008.11:60860956:AA:A
NM_017780.4(CHD7):c.3678del (p.Phe1226fs)	CHD7	F1226fs	CHARGE association	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000216116	8	61743036	8	60830477	216116	212635	rs863224518	NC_000008.11:60830476:C:
NM_017780.4(CHD7):c.1505del (p.Pro502fs)	CHD7	P502fs	CHARGE association	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000216115	8	61655495	8	60742936	216115	212634	rs863224517	NC_000008.11:60742935:CC:C
NM_017780.4(CHD7):c.6526del (p.Glu2176fs)	CHD7	E2176fs	CHARGE association	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000210723	8	61765809	8	60853250	210723	207561	rs797045471	NC_000008.11:60853249:GG:G
NM_017780.4(CHD7):c.6446del (p.Gly2149fs)	CHD7	G2149fs	CHARGE association	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000210722	8	61765729	8	60853170	210722	207560	rs797045470	NC_000008.11:60853169:GG:G
NM_017780.4(CHD7):c.4634del (p.Ala1544_Leu1545insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158298	8	61754302	8	60841743	158298	168614	rs587783443	NC_000008.11:60841742:TT:T
NM_017780.4(CHD7):c.2905_2906del (p.Arg969fs)	CHD7	R969fs	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158287	8	61734652 - 61734653	8	60822093 - 60822094	158287	168604	rs587783436	NC_000008.11:60822092:AG:
NM_017780.4(CHD7):c.4379_4380del (p.Ile1460fs)	CHD7	I1460fs	CHARGE association|not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095789	8	61750659 - 61750660	8	60838100 - 60838101	95789	101686	rs398124319	NC_000008.11:60838099:ATA:A
CHD7, DEL EXONS 8-12	CHD7		CHARGE association	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002031					2031	17070		
NC_000023.10:g.(?_84534427)_(85302634_?)del	CHM|POF1B		not provided	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001071374	X	84534427 - 85302634			1071374	1058350		
NC_000023.10:g.(?_83372068)_(86924394_?)del	CHM|ZNF711|RPS6KA6|KLHL4|POF1B|DACH2|APOOL|HDX|SATL1		not provided	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000833482	X	83372068 - 86924394			833482	821526		
NC_000023.10:g.(?_82763333)_(86924394_?)del	CHM|CYLC1|POU3F4|ZNF711|RPS6KA6|KLHL4|POF1B|DACH2|APOOL|HDX|SATL1		not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000833457	X	82763333 - 86924394			833457	821523		
NC_000023.10:g.(?_84634178)_(85404112_?)del	CHM|POF1B|DACH2		not provided	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000833170	X	84634178 - 85404112			833170	821528		
NC_000023.10:g.(?_83126460)_(86924394_?)del	CHM|CYLC1|ZNF711|RPS6KA6|KLHL4|POF1B|DACH2|APOOL|HDX|SATL1		not provided	Pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000831865	X	83126460 - 86924394			831865	821524		
NC_000023.10:g.(?_85090756)_(86924394_?)del	CHM|KLHL4|DACH2		not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000831838	X	85090756 - 86924394			831838	821529		
NC_000023.10:g.(?_85115185)_(85303566_?)del	CHM		not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000830989	X	85115185 - 85303566			830989	821530		
NC_000023.10:g.(?_85119615)_(85302556_?)del	CHM		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000651805	X	85119615 - 85302556			651805	653297		
NM_014918.5(CHSY1):c.96del (p.Glu33fs)	CHSY1	E33fs	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030715	15	101791566	15	101251361	30715	39672	rs1596459125	NC_000015.10:101251360:GG:G
NM_014918.5(CHSY1):c.14del (p.Gly5fs)	CHSY1	G5fs	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030711	15	101791648	15	101251443	30711	39668	rs1567112402	NC_000015.10:101251442:CC:C
CHSY1, 30-BP DEL, NT55	CHSY1		Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030710					30710	39667		
NM_006383.4(CIB2):c.300_309del (p.Glu100fs)	CIB2	E105fs, E100fs, E57fs, E51fs	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000505395	15	78401614 - 78401623	15	78109272 - 78109281	505395	497072	rs765741202	NC_000015.10:78109271:GGGAGCCGAC:
GRCh37/hg19 15q15.3(chr15:43890409-43939642)	CKMT1B|CATSPER2|STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625830	15	43890409 - 43939642			625830	614134		
GRCh37/hg19 15q15.3(chr15:43891364-43939659)	CKMT1B|CATSPER2|STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625827	15	43891364 - 43939659			625827	614131		
CLCNKB, DEL	CLCNKB		BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000007598					7598	22637		
NM_001146079.2(CLDN14):c.398del (p.Met133fs)	CLDN14	M133fs	Deafness, autosomal recessive 29	Pathogenic(Last reviewed: Jan 12, 2001)	no assertion criteria provided	VCV000004850	21	37833596	21	36461298	4850	19889	rs786200885	NC_000021.9:36461297:A:
NM_020982.4(CLDN9):c.86del (p.Leu29fs)	CLDN9	L29fs	Deafness, autosomal recessive 116	Pathogenic(Last reviewed: Nov 12, 2020)	no assertion criteria provided	VCV000984737	16	3063449	16	3013448	984737	972822		NC_000016.10:3013447:T:
NM_174878.3(CLRN1):c.149_152delinsTGTCCAAT (p.Ser50fs)	CLRN1	S50fs	Rare genetic deafness|Retinal dystrophy|not provided|Usher Syndrome, Type III	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188726	3	150690344 - 150690347	3	150972557 - 150972560	188726	186676	rs786204428	NC_000003.12:150972556:CCTG:ATTGGACA
NM_174878.3(CLRN1):c.301_305del (p.Val101fs)	CLRN1	C158fs, V25fs, V101fs	Rare genetic deafness|Usher Syndrome, Type III	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, multiple submitters, no conflicts	VCV000048145	3	150659497 - 150659501	3	150941710 - 150941714	48145	57309	rs397517932	NC_000003.12:150941709:ATGACAT:AT
NM_080629.2(COL11A1):c.2796_2813delTCAAGGACCTCAGGGTCC	COL11A1		not provided|Marshall syndrome	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000930420	1	103440417 - 103440434	1	102974861 - 102974878	930420	918539		NC_000001.11:102974860:GGACCCTGAGGTCCTTGAGGACCCTG:GGACCCTG
NM_001854.4(COL11A1):c.-198_-195del	COL11A1		Stickler Syndrome, Dominant|Fibrochondrogenesis 1|Marshall syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291558	1	103573929 - 103573932	1	103108373 - 103108376	291558	275727	rs886044981	NC_000001.11:103108372:CTCT:
NM_001854.4(COL11A1):c.3817-13del	COL11A1		Marshall syndrome|Stickler Syndrome, Dominant|not specified|Fibrochondrogenesis 1|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291509	1	103380380	1	102914824	291509	275684	rs34228277	NC_000001.11:102914823:AAAAAAAAAAAAA:AAAAAAAAAAAA
NM_001854.4(COL11A1):c.4140+13del	COL11A1		Stickler Syndrome, Dominant|not provided|Marshall syndrome|Fibrochondrogenesis 1	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291506	1	103364484	1	102898928	291506	275718	rs781736900	NC_000001.11:102898927:A:
NM_001854.4(COL11A1):c.4303-13del	COL11A1		Stickler Syndrome, Dominant|Fibrochondrogenesis 1|Marshall syndrome|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291504	1	103356073	1	102890517	291504	275704	rs35232764	NC_000001.11:102890516:AAAAAAAAAA:AAAAAAAAA
NM_001854.4(COL11A1):c.652-6del	COL11A1		Stickler syndrome type 2|Marshall syndrome|Fibrochondrogenesis 1|Deafness, autosomal dominant 37|not provided|not specified	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000218828	1	103496806	1	103031250	218828	215177	rs36076089	NC_000001.11:103031249:AAAAAAAAAAAAA:AAAAAAAAAAAA
NM_001854.4(COL11A1):c.652-7_652-6del	COL11A1		Stickler Syndrome, Dominant|not specified|Fibrochondrogenesis 1|Marshall syndrome|not provided	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197735	1	103496806 - 103496807	1	103031250 - 103031251	197735	194896	rs36076089	NC_000001.11:103031249:AAAAAAAAAAAAA:AAAAAAAAAAA
COL11A1, 4-BP DEL, EX50/IVS50	COL11A1		Marshall syndrome	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000017134					17134	32173		
NM_080680.3(COL11A2):c.2484+13del	COL11A2		not provided|Fibrochondrogenesis 1|Otospondylomegaepiphyseal dysplasia, autosomal recessive|Otospondylomegaepiphyseal dysplasia, autosomal dominant|not specified|Stickler Syndrome, Dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262308	6	33141929	6	33174152	262308	252334	rs55730247	NC_000006.12:33174151:CCCCCC:CCCCC
NM_080680.3(COL11A2):c.2584-5del	COL11A2		Stickler Syndrome, Dominant|Otospondylomegaepiphyseal dysplasia, autosomal recessive|not specified|not provided|Otospondylomegaepiphyseal dysplasia, autosomal dominant|Fibrochondrogenesis 1	Likely benign(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000227266	6	33141527	6	33173750	227266	229456	rs555657704	NC_000006.12:33173749:GGGGGG:GGGGG
NM_080680.2(COL11A2):c.3962delG (p.Gly1321Valfs)	COL11A2		Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000017130	6	33135628	6	33167851	17130	32169	rs1562315748	NC_000006.12:33167850:CCC:CC
NM_000091.5(COL4A3):c.3419-4del	COL4A3|MFF-DT		Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant|not provided	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV001246467	2	228159661	2	227294945	1246467	1236418		NC_000002.12:227294944:TTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_000091.5(COL4A3):c.2636del (p.Pro879fs)	COL4A3|MFF-DT	P879fs	Alport syndrome, autosomal recessive	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210382	2	228147227	2	227282511	1210382	1200382		NC_000002.12:227282510:CC:C
NM_000091.5(COL4A3):c.305del (p.Ser102fs)	COL4A3|MFF-DT	S102fs	Alport syndrome, autosomal recessive	Likely pathogenic	criteria provided, single submitter	VCV000974869	2	228109692	2	227244976	974869	963124		NC_000002.12:227244975:C:
NM_000091.5(COL4A3):c.2488_2488+2del	COL4A3|MFF-DT		Alport syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000870354	2	228145722 - 228145724	2	227281006 - 227281008	870354	858540		NC_000002.12:227281005:GGT:
NM_000091.5(COL4A3):c.4337_4338del (p.Phe1446fs)	COL4A3|MFF-DT	F1446fs	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000856468	2	228172509 - 228172510	2	227307793 - 227307794	856468	825809		NC_000002.12:227307792:TTT:T
NM_000091.5(COL4A3):c.949_950del (p.Arg317fs)	COL4A3|MFF-DT	R317fs	Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553304	2	228121074 - 228121075	2	227256358 - 227256359	553304	542126	rs756133651	NC_000002.12:227256357:AG:
NM_000091.5(COL4A3):c.2535del (p.Leu846fs)	COL4A3|MFF-DT	L846fs	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553278	2	228147127	2	227282411	553278	541922	rs993103826	NC_000002.12:227282410:C:
NM_000091.5(COL4A3):c.2621_2622delinsT (p.Gly874fs)	COL4A3|MFF-DT	G874fs	Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551951	2	228147213 - 228147214	2	227282497 - 227282498	551951	542030	rs1553760257	NC_000002.12:227282496:GA:T
NM_000091.5(COL4A3):c.2768_2778del (p.Val923fs)	COL4A3|MFF-DT	V923fs	Alport syndrome, autosomal recessive|not provided|Alport syndrome	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551819	2	228148946 - 228148956	2	227284230 - 227284240	551819	542034	rs766306957	NC_000002.12:227284229:AGTAAAGGGCCAG:AG
NM_000091.5(COL4A3):c.4803del (p.Gly1602fs)	COL4A3|MFF-DT		Alport syndrome 3, autosomal dominant|not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550931	2	228175539	2	227310823	550931	542065	rs760846085	NC_000002.12:227310822:T:
NM_000091.5(COL4A3):c.4347_4353del (p.Arg1450fs)	COL4A3|MFF-DT	R1450fs	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550302	2	228172517 - 228172523	2	227307801 - 227307807	550302	542022	rs748026887	NC_000002.12:227307800:CACCCGACAC:CAC
NM_000091.5(COL4A3):c.5010_*14del (p.His1670_Ter1671delinsXaa)	COL4A3|MFF-DT		not provided|Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000397585	2	228176575 - 228176592	2	227311859 - 227311876	397585	384476	rs765655100	NC_000002.12:227311858:AAAAGACACTGAAGCTAAAAAAGACA:AAAAGACA
NM_000091.5(COL4A3):c.40_63del (p.Leu14_Leu21del)	COL4A3		not provided|Alport syndrome|Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|Benign familial hematuria	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000192299	2	228029472 - 228029495	2	227164756 - 227164779	192299	190092	rs876657397	NC_000002.12:227164755:GGTGCTCCTGCTGCCGCTCCTGCTGGTGCTCCTG:GGTGCTCCTG
COL4A3, 5-BP DEL, NT4414	COL4A3		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017483					17483	32522		
NM_000092.5(COL4A4):c.2594del (p.Pro865fs)	COL4A4	P865fs	Alport syndrome, autosomal recessive	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210383	2	227920783	2	227056067	1210383	1200383		NC_000002.12:227056066:GG:G
NM_000092.5(COL4A4):c.4684del (p.Tyr1562fs)	COL4A4	Y1562fs	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 7, 2020)	no assertion criteria provided	VCV000992428	2	227872859	2	227008143	992428	980308		NC_000002.12:227008142:A:
GRCh37/hg19 2q36.3(chr2:227942610-227945265)	COL4A4		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000813305	2	227942610 - 227945265			813305	801557		
NM_000092.4(COL4A4):c.3861delinsCTC (p.Arg1288fs)	COL4A4		Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000634651	2	227895271	2	227030555	634651	622522	rs1575895541	NC_000002.12:227030554:C:GAG
NM_000092.5(COL4A4):c.1327_1344del (p.Pro444_Leu449del)	COL4A4		Alport syndrome, autosomal recessive|not provided	Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555889	2	227958866 - 227958883	2	227094150 - 227094167	555889	541964	rs1203564054	NC_000002.12:227094149:GCCTGGTGCTCCAGGCAAGCC:GCC
NM_000092.5(COL4A4):c.1323_1340del	COL4A4		not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552183	2	227958870 - 227958887	2	227094154 - 227094171	552183	541966	rs773081522	NC_000002.12:227094153:GGTGCTCCAGGCAAGCCAGGTG:GGTG
NM_000092.5(COL4A4):c.4760del (p.Pro1587fs)	COL4A4	P1587fs	Alport syndrome, autosomal recessive|not provided	Likely pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000551963	2	227872783	2	227008067	551963	541804	rs1206142672	NC_000002.12:227008066:GGGGGG:GGGGG
NM_000092.5(COL4A4):c.1935_1952del (p.Pro647_Val652del)	COL4A4		Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000551238	2	227942645 - 227942662	2	227077929 - 227077946	551238	541850	rs1553658892	NC_000002.12:227077928:CCTGGGTGGCCTGGAACTCCTGGGTGGCCT:CCTGGGTGGCCT
NM_000092.5(COL4A4):c.2638del (p.Ala880fs)	COL4A4	A880fs	Glomerulonephritis|Benign familial hematuria|not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550471	2	227920739	2	227056023	550471	541837	rs778043831	NC_000002.12:227056022:CCCC:CCC
NM_000092.5(COL4A4):c.4694_4713del (p.Arg1565fs)	COL4A4	R1565fs	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522488	2	227872830 - 227872849	2	227008114 - 227008133	522488	513026	rs1553612433	NC_000002.12:227008113:GGCCTCGCATACCGCACAGCGGC:GGC
NM_000092.5(COL4A4):c.3574_3577+8del	COL4A4		Alport syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438673	2	227898118 - 227898129	2	227033402 - 227033413	438673	432283	rs1553627655	NC_000002.12:227033401:GTGCTTACCTGA:
NM_000092.4(COL4A4):c.1320_1369+2del	COL4A4		not provided|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242441	2	227958838 - 227958889	2	227094122 - 227094173	242441	223748	rs1553676221	
NM_033380.3(COL4A5):c.3940del (p.Gln1314fs)	COL4A5	Q1308fs, Q1314fs	Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210384	X	107920860	X	108677630	1210384	1200384		NC_000023.11:108677629:CC:C
NM_033380.3(COL4A5):c.917del (p.Asn306fs)	COL4A5	N306fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974473	X	107824235	X	108581005	974473	962806		NC_000023.11:108581004:AAAA:AAA
NM_033380.3(COL4A5):c.2039del (p.Pro680fs)	COL4A5	P680fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974425	X	107844712	X	108601482	974425	962811		NC_000023.11:108601481:CC:C
NM_033380.3(COL4A5):c.4222del (p.Thr1408fs)	COL4A5	T1402fs, T1408fs	Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000870367	X	107929265	X	108686035	870367	858537		NC_000023.11:108686034:AA:A
NM_033380.3(COL4A5):c.1902del (p.Gly635fs)	COL4A5	G635fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000830035	X	107842050	X	108598820	830035	818352	rs1603290763	NC_000023.11:108598819:AAAAA:AAAA
NM_033380.3(COL4A5):c.3295del (p.Ser1099fs)	COL4A5	S1099fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000829918	X	107898608	X	108655378	829918	818361	rs1603306718	NC_000023.11:108655377:TT:T
NM_033380.3(COL4A5):c.4197_4200delinsGGG (p.Pro1401fs)	COL4A5	P1401fs, P1395fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000829907	X	107925099 - 107925102	X	108681869 - 108681872	829907	818364	rs1603318154	NC_000023.11:108681868:AGGA:GGG
NM_033380.3(COL4A5):c.4197del (p.Gly1400fs)	COL4A5	G1394fs, G1400fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000829905	X	107925098	X	108681868	829905	818363	rs1603318143	NC_000023.11:108681867:AA:A
GRCh37/hg19 Xq22.3(chrX:107683356-107683436)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000813306	X	107683356 - 107683436			813306	801558		
NM_033380.3(COL4A5):c.4618del (p.Asp1540fs)	COL4A5	D1534fs, D1540fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811258	X	107936067	X	108692837	811258	800209	rs1603326561	NC_000023.11:108692836:G:
NM_033380.3(COL4A5):c.1751_1756del (p.Pro584_Gly585del)	COL4A5		Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000807572	X	107840768 - 107840773	X	108597538 - 108597543	807572	798786	rs1603290199	NC_000023.11:108597537:GCCAGGGC:GC
NM_033380.3(COL4A5):c.3304del (p.Asp1102fs)	COL4A5	D1102fs	Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635053	X	107898618	X	108655388	635053	622927	rs1569504068	NC_000023.11:108655387:G:
NM_033380.3(COL4A5):c.3177del (p.Gly1060fs)	COL4A5	G1060fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000619957	X	107869510	X	108626280	619957	611357	rs1569499015	NC_000023.11:108626279:T:
NM_033380.3(COL4A5):c.1132_1138del (p.Ile378fs)	COL4A5	I378fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000599160	X	107829944 - 107829950	X	108586714 - 108586720	599160	590344	rs1569492147	NC_000023.11:108586713:ATACAGG:
NM_033380.3(COL4A5):c.446del (p.Pro149fs)	COL4A5	P149fs	Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000587321	X	107815044	X	108571814	587321	578063	rs104886054	NC_000023.11:108571813:CCCCC:CCCC
NM_033380.3(COL4A5):c.2846del (p.Pro949fs)	COL4A5	P949fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 18, 2020)	criteria provided, single submitter	VCV000587297	X	107865983	X	108622753	587297	578197	rs104886197	NC_000023.11:108622752:CC:C
NM_033380.3(COL4A5):c.4743del (p.Val1582fs)	COL4A5	V1576fs, V1582fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, single submitter	VCV000587238	X	107938073	X	108694843	587238	578280	rs1569509210	NC_000023.11:108694842:A:
NM_033380.3(COL4A5):c.687del (p.Gly230fs)	COL4A5	G230fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000522445	X	107821345	X	108578115	522445	513152	rs1556405926	NC_000023.11:108578114:AAAAA:AAAA
NM_033380.3(COL4A5):c.1032+17del	COL4A5		Alport syndrome 1, X-linked recessive|not specified|not provided	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439522	X	107827761	X	108584531	439522	433302	rs761615270	NC_000023.11:108584530:TTTTTTTTTTTT:TTTTTTTTTTT
NM_033380.3(COL4A5):c.3978del (p.Gly1327fs)	COL4A5	G1327fs, G1321fs	Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Oct 4, 2016)	no assertion criteria provided	VCV000430899	X	107923942	X	108680712	430899	424442	rs1131692246	NC_000023.11:108680711:AAA:AA
NM_033380.3(COL4A5):c.3819_3881del (p.Pro1274_Gly1294del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000397580	X	107920735 - 107920797	X	108677505 - 108677567	397580	384507	rs1556451235	
NM_033380.3(COL4A5):c.2048del (p.Pro683fs)	COL4A5	P683fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000397579	X	107845119	X	108601889	397579	384505	rs1060499694	NC_000023.11:108601888:CCC:CC
NM_033380.3(COL4A5):c.4763del (p.Gln1588fs)	COL4A5	Q1582fs, Q1588fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000369963	X	107938093	X	108694863	369963	354185	rs1057516203	NC_000023.11:108694862:A:
NM_033380.3(COL4A5):c.3487_3488delinsG (p.Pro1163fs)	COL4A5	P1163fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000369940	X	107909758 - 107909759	X	108666528 - 108666529	369940	354184	rs1057516187	NC_000023.11:108666527:CC:G
NM_033380.3(COL4A5):c.2766del (p.Gly923fs)	COL4A5	G923fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000266009	X	107865119	X	108621889	266009	260806	rs886039890	NC_000023.11:108621888:AAA:AA
NM_033380.3(COL4A5):c.4900_4903del (p.Pro1634fs)	COL4A5	P1628fs, P1634fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000266001	X	107938573 - 107938576	X	108695343 - 108695346	266001	260808	rs886039886	NC_000023.11:108695342:CTCCCT:CT
NM_033380.3(COL4A5):c.2965_2982del (p.Asp989_Gly994del)	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2019)	criteria provided, conflicting interpretations	VCV000024580	X	107867507 - 107867524	X	108624277 - 108624294	24580	35921	rs104886374	NC_000023.11:108624276:CCTGGAGACCCAGGGCAACCTGGA:CCTGGA
NM_033380.3(COL4A5):c.2057del (p.Pro686fs)	COL4A5	P686fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000024482	X	107845129	X	108601899	24482	35823	rs104886167	NC_000023.11:108601898:CC:C
NM_033380.3(COL4A5):c.1033-15del	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Benign/Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024358	X	107829821	X	108586591	24358	35699	rs104886089	NC_000023.11:108586590:TTTTTTTTTT:TTTTTTTTT
NM_033380.3(COL4A5):c.875del (p.Gly292fs)	COL4A5	G292fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024335	X	107823951	X	108580721	24335	35676	rs281874768	NC_000023.11:108580720:GG:G
NM_033380.3(COL4A5):c.635del (p.Pro212fs)	COL4A5	P212fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024303	X	107821206	X	108577976	24303	35644	rs104886065	NC_000023.11:108577975:CC:C
NM_033380.3(COL4A5):c.611_612del (p.Gly204fs)	COL4A5	G204fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024302	X	107821183 - 107821184	X	108577953 - 108577954	24302	35643	rs281874759	NC_000023.11:108577952:GC:
NM_033380.3(COL4A5):c.65_77del (p.Gln22fs)	COL4A5	Q22fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000024229	X	107683417 - 107683429	X	108440187 - 108440199	24229	35570	rs281874760	NC_000023.11:108440186:GGCAGCCTGCAGAGGC:GGC
NM_033380.3(COL4A5):c.49_50del (p.Leu17fs)	COL4A5	L17fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024228	X	107683404 - 107683405	X	108440174 - 108440175	24228	35569	rs104886427	NC_000023.11:108440173:CT:
COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000010460					10460	25499		
COL4A5, 38-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000010457					10457	25496		
COL4A5, 450-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000010456					10456	25495		
COL4A5, 10-15-KB INS, 40-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000010455					10455	25494		
COL4A5, EX5-10DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 8, 1990)	no assertion criteria provided	VCV000010453					10453	25492		
NM_001851.6(COL9A1):c.2644del (p.Val882fs)	COL9A1	V590fs, V639fs, V649fs, V882fs	Sensorineural hearing loss	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000984393	6	70926722	6	70217019	984393	972464		NC_000006.12:70217018:CCCC:CCC
NM_001853.4(COL9A3):c.543_551del (p.179PPG[2])	COL9A3		not provided	Uncertain significance(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001011975	20	61455815 - 61455823	20	62824463 - 62824471	1011975	999058		NC_000020.11:62824462:CCAGGTCCCCCAGG:CCAGG
Single allele	CRYL1|GJB6		Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000978790	13	20802727 - 21034768			978790	966868		
Single allele	CRYL1|GJB6		Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000978789	13	20797127 - 21105945			978789	966867		
NC_000018.9:g.77421290_77904990del483701	CTDP1|TXNL4A|HSBP1L1|KCNG2|SLC66A2|RBFA|ADNP2		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253193	18	77421290 - 77904990			253193	247606		
NC_000023.10:g.(?_83576897)_(86924394_?)del	DACH2|APOOL|CHM|ZNF711|KLHL4|POF1B|HDX|SATL1		not provided	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000832734	X	83576897 - 86924394			832734	821527		
NC_000023.10:g.(?_83372068)_(86890775_?)del	DACH2|APOOL|HDX|SATL1|CHM|ZNF711|RPS6KA6|KLHL4|POF1B		not provided	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000832217	X	83372068 - 86890775			832217	821525		
NM_025000.4(DCAF17):c.981+10del	DCAF17		not provided|Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000695583	2	172325550	2	171469040	695583	685118	rs760680285	NC_000002.12:171469039:T:
NM_025000.4(DCAF17):c.*1565del	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332289	2	172339179	2	171482669	332289	282841	rs560178345	NC_000002.12:171482668:TTTTTTTTTTT:TTTTTTTTTT
NM_025000.4(DCAF17):c.270del (p.Lys90fs)	DCAF17	K90fs	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Sep 22, 2015)	no assertion criteria provided	VCV000212711	2	172300069	2	171443559	212711	209327	rs879253799	NC_000002.12:171443558:AAAA:AAA
NM_025000.4(DCAF17):c.436del (p.Ala147fs)	DCAF17	A147fs	not provided|Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000209146	2	172305305	2	171448795	209146	205728	rs797045038	NC_000002.12:171448794:C:
NM_025000.4(DCAF17):c.127-3_127-1delinsAA	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031583	2	172291590 - 172291592	2	171435080 - 171435082	31583	40267	rs1574303761	NC_000002.12:171435079:TAG:AA
NM_025000.4(DCAF17):c.50del (p.Ala17fs)	DCAF17|METTL8	A17fs	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000531	2	172291137	2	171434627	531	15570	rs1559245286	NC_000002.12:171434626:C:
NM_005219.5(DIAPH1):c.1461+20_1461+21delinsAG	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001145038	5	140955776 - 140955777	5	141576209 - 141576210	1145038	1136592		NC_000005.10:141576208:TC:CT
NM_005219.5(DIAPH1):c.1137_1138delinsTT (p.Arg379_Leu380=)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Likely benign(Last reviewed: Jun 25, 2020)	criteria provided, single submitter	VCV001111728	5	140957817 - 140957818	5	141578250 - 141578251	1111728	1094059		NC_000005.10:141578249:GC:AA
NM_005219.5(DIAPH1):c.2067_2105del (p.Ser697_Gly709del)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001040334	5	140953312 - 140953350	5	141573745 - 141573783	1040334	1026423		NC_000005.10:141573744:GGGGGAATTCCAGCACTCCCAGGCAAAGGAGGTGGTGGTGGGGG:GGGGG
NM_005219.5(DIAPH1):c.2540_2541del (p.Lys847fs)	DIAPH1	K838fs, K847fs	Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000946228	5	140913942 - 140913943	5	141534375 - 141534376	946228	923907		NC_000005.10:141534374:TTTT:TT
NC_000005.10:g.(?_141516831)_(141618934_?)del	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831117	5	140896398 - 140998501			831117	819562		
NM_005219.5(DIAPH1):c.2779-6del	DIAPH1		not provided|Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1	Likely benign(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000752977	5	140908514	5	141528947	752977	775042	rs1431116673	NC_000005.10:141528946:AAA:AA
NM_005219.5(DIAPH1):c.685-8_685-6del	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1|not provided	Benign(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV000743431	5	140960456 - 140960458	5	141580889 - 141580891	743431	759451	rs773403319	NC_000005.10:141580888:AGGA:A
NM_005219.5(DIAPH1):c.2307del (p.Lys771fs)	DIAPH1	K762fs, K771fs	Deafness, autosomal dominant 1	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000632456	5	140953110	5	141573543	632456	620188	rs1562319896	NC_000005.10:141573542:GGGGG:GGGG
NM_005219.5(DIAPH1):c.1848_1862del (p.Pro618_Pro622del)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000566485	5	140953555 - 140953569	5	141573988 - 141574002	566485	564864	rs1562320961	NC_000005.10:141573987:AAAGGAGGTGGAGGA:
NM_005219.4(DIAPH1):c.3439-3del	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2018)	criteria provided, conflicting interpretations	VCV000475707	5	140905743	5	141526176	475707	455215	rs1335130331	NC_000005.10:141526175:GGGG:GGG
NM_005219.5(DIAPH1):c.3624_3625del (p.Ala1210fs)	DIAPH1	A1210fs, A1201fs	Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	VCV000424874	5	140903746 - 140903747	5	141524179 - 141524180	424874	413208	rs1064797096	NC_000005.10:141524178:CT:
NM_005219.5(DIAPH1):c.402+12del	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome|not specified|Nonsyndromic Hearing Loss, Mixed	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000163077	5	140963679	5	141584112	163077	174266	rs555848272	NC_000005.10:141584111:CCC:CC
NM_001378457.1(DMXL2):c.7520+35del	DMXL2		Polyendocrine-polyneuropathy syndrome|not provided|Developmental and epileptic encephalopathy, 81|Deafness, autosomal dominant 71	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV001255508	15	51758346	15	51466149	1255508	1245439		NC_000015.10:51466148:AAAAAAAAAA:AAAAAAAAA
NM_001378457.1(DMXL2):c.6833+11del	DMXL2		not provided|Polyendocrine-polyneuropathy syndrome|Deafness, autosomal dominant 71|Developmental and epileptic encephalopathy, 81	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV001234931	15	51770457	15	51478260	1234931	1222761		NC_000015.10:51478259:TTTTTTTTT:TTTTTTTT
NM_001005361.3(DNM2):c.1675_1677del (p.Lys559del)	DNM2	K559del, K555del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637071	19	10930659 - 10930661	19	10819983 - 10819985	637071	625413	rs1599620398	NC_000019.10:10819982:AAA:
NM_001005361.3(DNM2):c.1664_1671+1del	DNM2		Charcot-Marie-Tooth disease, dominant intermediate B|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000568603	19	10923043 - 10923051	19	10812367 - 10812375	568603	572748	rs1568314339	NC_000019.10:10812366:AGGATGAGGAGG:AGG
NM_001130823.3(DNMT1):c.4208_4210del (p.Ser1403del)	DNMT1	S1282del, S1387del, S1403del	Hereditary sensory neuropathy type IE	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001021617	19	10248591 - 10248593	19	10137915 - 10137917	1021617	1013444		NC_000019.10:10137914:AGGAG:AG
NM_001130823.3(DNMT1):c.637_639del (p.Asp213del)	DNMT1	D92del, D197del, D213del	Hereditary sensory neuropathy type IE	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV000960222	19	10286225 - 10286227	19	10175549 - 10175551	960222	950590		NC_000019.10:10175548:GTC:
NM_001130823.3(DNMT1):c.1400-4del	DNMT1		Hereditary sensory neuropathy type IE	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000954535	19	10266625	19	10155949	954535	960273		NC_000019.10:10155948:G:
NM_001130823.3(DNMT1):c.1044-3del	DNMT1		not provided|Hereditary sensory neuropathy type IE	Likely benign(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000796913	19	10270742	19	10160066	796913	788291	rs780538171	NC_000019.10:10160065:GGGGG:GGGG
NM_001130823.3(DNMT1):c.894_896del (p.Asp298del)	DNMT1	D298del, D282del, D177del	Hereditary sensory neuropathy type IE	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000565553	19	10274032 - 10274034	19	10163356 - 10163358	565553	572731	rs1568241116	NC_000019.10:10163355:TCATC:TC
NM_001130823.3(DNMT1):c.81-12del	DNMT1|LOC107080555		Dementia, Deafness, and Sensory Neuropathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000327928	19	10292765	19	10182089	327928	332344	rs886054130	NC_000019.10:10182088:AAA:AA
NM_001130823.3(DNMT1):c.1044-8del	DNMT1		Dementia, Deafness, and Sensory Neuropathy|Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant|not provided|not specified|Hereditary sensory neuropathy type IE	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000327915	19	10270747	19	10160071	327915	347891	rs59599980	NC_000019.10:10160070:AAAAAAAAAAA:AAAAAAAAAA
NM_001130823.3(DNMT1):c.1044-9_1044-8del	DNMT1		Dementia, Deafness, and Sensory Neuropathy|not provided|not specified|Hereditary sensory neuropathy type IE	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327914	19	10270747 - 10270748	19	10160071 - 10160072	327914	332327	rs59599980	NC_000019.10:10160070:AAAAAAAAAAA:AAAAAAAAA
NM_001130823.3(DNMT1):c.1518_1520delinsATA (p.Asp506_Pro507delinsGluTyr)	DNMT1		Hereditary sensory neuropathy type IE	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029683	19	10265705 - 10265707	19	10155029 - 10155031	29683	38638	rs199473691	NC_000019.10:10155028:GGA:TAT
NM_014208.3(DSPP):c.368_371delinsAACATATGTTCATCATGGGAAAGAAGAAA (p.Gly123fs)	DSPP	G123fs	not provided|Deafness, autosomal dominant 39, with dentinogenesis imperfecta 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2020)	criteria provided, conflicting interpretations	VCV000834048	4	88533706 - 88533709	4	87612554 - 87612557	834048	822295		NC_000004.12:87612553:GAAT:AACATATGTTCATCATGGGAAAGAAGAAA
NM_001376.5(DYNC1H1):c.5049+5del	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001063643	14	102471023	14	102004686	1063643	1048396		NC_000014.9:102004685:AAA:AA
NM_001376.5(DYNC1H1):c.7905del (p.Phe2635fs)	DYNC1H1	F2635fs	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, single submitter	VCV001001270	14	102483478	14	102017141	1001270	995668		NC_000014.9:102017140:TTTT:TTT
NM_001376.5(DYNC1H1):c.6405+4_6405+44del	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000863120	14	102476798 - 102476838	14	102010461 - 102010501	863120	852550		NC_000014.9:102010460:TTCGTTACAAACGTTTTGATCACTCAAACCTTATACGTTATTT:TT
NM_001376.5(DYNC1H1):c.5971_5973del (p.Asp1991del)	DYNC1H1	D1991del	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000859945	14	102474666 - 102474668	14	102008329 - 102008331	859945	841036		NC_000014.9:102008328:ACGAC:AC
NM_001376.5(DYNC1H1):c.13801_13802delinsGC (p.Lys4601Ala)	DYNC1H1	K4601A	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000843098	14	102516524 - 102516525	14	102050187 - 102050188	843098	841067		NC_000014.9:102050186:AA:GC
NM_001376.5(DYNC1H1):c.6857+9_6857+10delinsAA	DYNC1H1		not provided|Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000743451	14	102478459 - 102478460	14	102012122 - 102012123	743451	760243	rs1595615156	NC_000014.9:102012121:TC:AA
NM_001376.5(DYNC1H1):c.148del (p.Ala50fs)	DYNC1H1	A50fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694840	14	102431175	14	101964838	694840	683043	rs1595590195	NC_000014.9:101964837:GG:G
NM_001376.5(DYNC1H1):c.73_74delinsAA (p.Ala25Lys)	DYNC1H1	A25K	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000666149	14	102431101 - 102431102	14	101964764 - 101964765	666149	642067	rs1595590120	NC_000014.9:101964763:GC:AA
NM_001376.5(DYNC1H1):c.12109_12110delinsTT (p.Pro4037Phe)	DYNC1H1	P4037F	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000658365	14	102508356 - 102508357	14	102042019 - 102042020	658365	642103	rs1595631704	NC_000014.9:102042018:CC:TT
NC_000014.9:g.(?_101925141)_(101964947_?)del	DYNC1H1|PPP2R5C		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000584036	14	102391478 - 102431284	14	101925141 - 101964947	584036	568642		
NM_001376.5(DYNC1H1):c.5495del (p.Asn1832fs)	DYNC1H1	N1832fs	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000539788	14	102472285	14	102005948	539788	527897	rs1555409622	NC_000014.9:102005947:AA:A
NM_001376.5(DYNC1H1):c.624_625delinsAG (p.Ile209Val)	DYNC1H1	I209V	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	VCV000539762	14	102446161 - 102446162	14	101979824 - 101979825	539762	527842	rs1555407906	NC_000014.9:101979823:GA:AG
NM_001376.5(DYNC1H1):c.2719-9_2719-7del	DYNC1H1		not provided|Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: May 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000415324	14	102455029 - 102455031	14	101988692 - 101988694	415324	399507	rs566271356	NC_000014.9:101988691:GTTGT:GT
NM_000399.5(EGR2):c.1379del (p.Ser460fs)	EGR2	S410fs, S460fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001010400	10	64573019	10	62813259	1010400	993897		NC_000010.11:62813258:C:
NM_000399.5(EGR2):c.1314del (p.Ser439fs)	EGR2	S389fs, S439fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000944102	10	64573084	10	62813324	944102	925841		NC_000010.11:62813323:GGGGG:GGGG
NM_000399.5(EGR2):c.*814_*816del	EGR2		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300267	10	64572151 - 64572153	10	62812391 - 62812393	300267	310595	rs886047088	NC_000010.11:62812390:AGAA:A
NM_022772.4(EPS8L2):c.738del (p.Val247fs)	EPS8L2	V247fs	Deafness, autosomal recessive 106	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000433530	11	721321	11	721321	433530	427104	rs1554952193	NC_000011.10:721320:CC:C
NM_022772.4(EPS8L2):c.1014del (p.Ser339fs)	EPS8L2	S339fs	Deafness, autosomal recessive 106	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	VCV000433529	11	722117	11	722117	433529	427103	rs1554952443	NC_000011.10:722116:CCCC:CCC
NM_005236.3(ERCC4):c.1882_1885del (p.Glu628fs)	ERCC4	E628fs	Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000964961	16	14031690 - 14031693	16	13937833 - 13937836	964961	957627		NC_000016.10:13937832:AAGGAAG:AAG
NM_005236.3(ERCC4):c.580_584+1del	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|not provided	Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000840550	16	14020607 - 14020612	16	13926750 - 13926755	840550	851651		NC_000016.10:13926749:GGCCAAGG:GG
NC_000016.10:g.(?_13920156)_(13948357_?)del	ERCC4		Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000661743	16	14014013 - 14042214	16	13920156 - 13948357	661743	652453		
NC_000016.10:g.(?_13928022)_(13928241_?)del	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000541254	16	14021879 - 14022098	16	13928022 - 13928241	541254	529246		
NM_005236.3(ERCC4):c.1731del (p.Arg576_Tyr577insTer)	ERCC4		Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|Cockayne syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000541251	16	14029520	16	13935663	541251	529467	rs1555468482	NC_000016.10:13935662:C:
NM_000124.4(ERCC6):c.3481_3482delinsCC (p.Ser1161Pro)	ERCC6	S1161P	Cockayne syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000705820	10	50678524 - 50678525	10	49470478 - 49470479	705820	692846	rs1590405627	NC_000010.11:49470477:CT:GG
NM_000124.4(ERCC6):c.4438_4440del (p.Ser1480del)	ERCC6	S1480del	Macular degeneration|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|COFS syndrome|Cockayne syndrome	Uncertain significance(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000300033	10	50666903 - 50666905	10	49458857 - 49458859	300033	310413	rs886047032	NC_000010.11:49458856:AGAAG:AG
NM_000124.4(ERCC6):c.*1964_*1966del	ERCC6		Cockayne syndrome|Macular degeneration|COFS syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300005	10	50664895 - 50664897	10	49456849 - 49456851	300005	315483	rs147228327	NC_000010.11:49456848:AAT:
NM_031475.3(ESPN):c.2081_2082del (p.Ser694fs)	ESPN	S664fs, S673fs, S694fs	Deafness, autosomal recessive 36, with or without vestibular involvement	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001299307	1	6511911 - 6511912	1	6451851 - 6451852	1299307	1289166		NC_000001.11:6451850:TCT:T
NM_031475.3(ESPN):c.2496del (p.Gly831_Tyr832insTer)	ESPN		Deafness, autosomal recessive|Deafness, autosomal recessive 36, with or without vestibular involvement	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562076	1	6520137	1	6460077	562076	553249	rs754472294	NC_000001.11:6460076:C:
NM_031475.3(ESPN):c.2369_2386del (p.Arg790_Arg795del)	ESPN		Usher syndrome type 1|Usher syndrome, type 1M	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000560535	1	6517284 - 6517301	1	6457224 - 6457241	560535	551614	rs1557720377	NC_000001.11:6457223:GGAGGCGGGACCTCCTGCGGA:GGA
NM_031475.3(ESPN):c.1988_1991del (p.Lys663fs)	ESPN	K642fs, K663fs, K633fs	Deafness, autosomal recessive 36, with or without vestibular involvement	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000004419	1	6511735 - 6511738	1	6451675 - 6451678	4419	19458	rs1569726455	NC_000001.11:6451674:AGAG:
NM_031475.3(ESPN):c.2470_2473del (p.Ser824fs)	ESPN	S794fs, S824fs, S803fs	Deafness, autosomal recessive 36, with or without vestibular involvement	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000004418	1	6520108 - 6520111	1	6460048 - 6460051	4418	19457	rs1569770998	NC_000001.11:6460047:CAGTCAG:CAG
NM_017697.4(ESRP1):c.665_683del (p.Asp222fs)	ESRP1	D222fs	Deafness, autosomal recessive 109	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000545505	8	95676944 - 95676962	8	94664716 - 94664734	545505	536010	rs1554577339	NC_000008.11:94664715:GATGATAACACCGTAGTCAG:G
NM_004452.3(ESRRB):c.(?_1)_(1527_?)del	ESRRB		Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	VCV000179837	14	76905697 - 76967064	14	76439354 - 76500721	179837	175770		
NM_001379180.1(ESRRB):c.1268_1272del (p.Thr423fs)	ESRRB	T402fs, T423fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 2, 2013)	criteria provided, single submitter	VCV000178970	14	76964704 - 76964708	14	76498361 - 76498365	178970	175947	rs727504577	NC_000014.9:76498360:CGGCC:
NM_004452.3(ESRRB):c.(?_1501)_(1527_?)del (p.?)	ESRRB		Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 29, 2013)	criteria provided, single submitter	VCV000163415	14	76967038 - 76967064	14	76500695 - 76500721	163415	175407		
NM_000503.6(EYA1):c.396_406del (p.Gln132fs)	EYA1	Q131fs, Q160fs, Q161fs, Q132fs, Q15fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000228346	8	72233981 - 72233991	8	71321746 - 71321756	228346	229629	rs876657690	NC_000008.11:71321745:TGCCGTACGGCTG:TG
NM_172058.3(EYA1):c.(?_1598)-56_*(1968_?)del	EYA1		Rare genetic deafness	Pathogenic(Last reviewed: Feb 7, 2016)	criteria provided, single submitter	VCV000228344	8	72109607 - 72123547	8	71197372 - 71211312	228344	229615		
NM_172058.2(EYA1):c.(?_-66)_(*76_?)del	EYA1		Rare genetic deafness	Pathogenic(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	VCV000163426	8	72111499 - 72268758	8	71199264 - 71356523	163426	174260		
NM_000503.6(EYA1):c.1122del (p.Leu374fs)	EYA1	L252fs, L368fs, L374fs, L403fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 14, 2011)	criteria provided, single submitter	VCV000048099	8	72156856	8	71244621	48099	57263	rs397517916	NC_000008.11:71244620:T:
NM_004100.5(EYA4):c.1720_1722delTACinsAAA	EYA4|TARID	Y574K, Y526K, Y551K, Y580K, Y520K	Deafness, autosomal dominant 10	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813822	6	133844297 - 133844299	6	133523159 - 133523161	813822	905062		NC_000006.12:133523158:TAC:AAA
NC_000006.12:g.(?_133506020)_(133528840_?)del	EYA4		Rare genetic deafness	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000667003	6	133827158 - 133849978			667003	654976		
NM_004100.5(EYA4):c.441del (p.Tyr148fs)	EYA4	Y94fs, Y125fs, Y148fs	Deafness, autosomal dominant 10	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236032	6	133783474	6	133462336	236032	237601	rs878853223	NC_000006.12:133462335:CCC:CC
NC_000006.11:g.133783902_(133785996_?)del	EYA4		Rare genetic deafness|Primary dilated cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2014)	criteria provided, conflicting interpretations	VCV000163445	6	133783902 - 133785996	6	133462764 - 133464858	163445	174483		
NM_001370298.3(FGD4):c.1097_1101del (p.Asp366fs)	FGD4	D136fs, D229fs, D314fs, D366fs, D45fs	Charcot-Marie-Tooth disease, type 4H	Likely pathogenic	no assertion criteria provided	VCV001184559	12	32751514 - 32751518	12	32598580 - 32598584	1184559	1174320		NC_000012.12:32598579:AGATCAG:AG
NM_001370298.3(FGD4):c.1936_1938del (p.Lys646del)	FGD4	K165del, K261del, K325del, K416del, K509del, K594del, K646del	Charcot-Marie-Tooth disease, type 4H	Uncertain significance	criteria provided, single submitter	VCV000816535	12	32777369 - 32777371	12	32624435 - 32624437	816535	804743	rs1565920164	NC_000012.12:32624434:AAA:
NM_001370298.3(FGD4):c.2297_2300del (p.Arg766fs)	FGD4	R445fs, R536fs, R381fs, R285fs, R629fs, R714fs, R766fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637083	12	32786604 - 32786607	12	32633670 - 32633673	637083	625279	rs1592489096	NC_000012.12:32633669:AAAGAAA:AAA
NM_001370298.3(FGD4):c.2301_2305del (p.Lys767fs)	FGD4	K715fs, K382fs, K446fs, K630fs, K286fs, K537fs, K767fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637081	12	32786609 - 32786613	12	32633675 - 32633679	637081	625280	rs1592489165	NC_000012.12:32633674:AAAGGAA:AA
NM_001370298.3(FGD4):c.925del (p.Ala309fs)	FGD4	A257fs, A79fs, A172fs, A309fs	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 30, 2018)	no assertion criteria provided	VCV000598938	12	32735312	12	32582378	598938	590025	rs1565869918	NC_000012.12:32582377:GGGG:GGG
NM_005247.4(FGF3):c.255del (p.Ile85fs)	FGF3	I85fs	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013842	11	69631157	11	69816389	13842	28881	rs281860302	NC_000011.10:69816388:AA:A
NM_005247.4(FGF3):c.616del (p.Val206fs)	FGF3	V206fs	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013839	11	69625177	11	69810409	13839	28878	rs281860305	NC_000011.10:69810408:CCCCC:CCCC
NM_002010.3(FGF9):c.*2497del	FGF9		Symphalangism-brachydactyly syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311469	13	22278070	13	21703931	311469	319210	rs148832636	NC_000013.11:21703930:TT:T
NM_002010.3(FGF9):c.*2210del	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311465	13	22277775	13	21703636	311465	335621	rs577984328	NC_000013.11:21703635:TTTTTTTTTT:TTTTTTTTT
NM_002010.3(FGF9):c.*274_*275del	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311434	13	22275847 - 22275848	13	21701708 - 21701709	311434	333929	rs886050049	NC_000013.11:21701707:TAT:T
NM_002010.3(FGF9):c.*274_*277del	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311433	13	22275845 - 22275848	13	21701706 - 21701709	311433	333930	rs201279299	NC_000013.11:21701705:TGTATGT:TGT
NM_002010.3(FGF9):c.*274_*279del	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311432	13	22275843 - 22275848	13	21701704 - 21701709	311432	327662	rs886050047	NC_000013.11:21701703:TGTGTATGTGT:TGTGT
NM_002010.3(FGF9):c.-335del	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311411	13	22245710	13	21671571	311411	319166	rs886050042	NC_000013.11:21671570:TTTTTTTT:TTTTTTT
NM_014845.6(FIG4):c.447-16delinsTT	FIG4		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917077	6	110053824	6	109732621	917077	905584		NC_000006.12:109732620:G:TT
NM_014845.6(FIG4):c.1801del (p.Thr601fs)	FIG4	T601fs	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916867	6	110098175	6	109776972	916867	905185		NC_000006.12:109776971:A:
NM_014845.6(FIG4):c.2132del (p.Ser711fs)	FIG4	S711fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694986	6	110110832	6	109789629	694986	683000	rs1583738240	NC_000006.12:109789628:G:
NM_014845.6(FIG4):c.1147_1148delinsT (p.Glu382_Lys383insTer)	FIG4		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637526	6	110081462 - 110081463	6	109760259 - 109760260	637526	625131	rs1583695317	NC_000006.12:109760258:AA:T
NM_014845.6(FIG4):c.790_793delinsTTCCAAGAGCTGTT (p.Gly264fs)	FIG4	G264fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637525	6	110062661 - 110062664	6	109741458 - 109741461	637525	625130	rs1583669418	NC_000006.12:109741457:GGAC:TTCCAAGAGCTGTT
NM_014845.6(FIG4):c.1149_1150delinsT (p.Lys383fs)	FIG4	K383fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637085	6	110081464 - 110081465	6	109760261 - 109760262	637085	625132	rs1583695328	NC_000006.12:109760260:AA:T
NM_014845.6(FIG4):c.759del (p.Phe254fs)	FIG4		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11|not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254668	6	110059638	6	109738435	254668	249211	rs764717219	NC_000006.12:109738434:GGG:GG
NM_014845.6(FIG4):c.1043_1050del (p.Asp348fs)	FIG4	D348fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4J	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2007)	no assertion criteria provided	VCV000001724	6	110064881 - 110064888	6	109743678 - 109743685	1724	16763	rs1368013631	NC_000006.12:109743677:ATCAGGCA:
NM_014845.6(FIG4):c.294del (p.Phe98fs)	FIG4	F98fs	Charcot-Marie-Tooth disease|Yunis-Varon syndrome|Charcot-Marie-Tooth disease, type 4J	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000001722	6	110048313	6	109727110	1722	16761	rs1562648373	NC_000006.12:109727109:TTTT:TTT
NM_012188.5(FOXI1):c.965_967del (p.Phe322del)	FOXI1	F322del, F227del	Nonsyndromic Hearing Loss, Mixed|Pendred syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000352709	5	169535441 - 169535443	5	170108437 - 170108439	352709	302958	rs886060400	NC_000005.10:170108436:CTTCT:CT
NM_002047.4(GARS1):c.1904-19del	GARS1		not specified|Charcot-Marie-Tooth disease	Likely benign(Last reviewed: Apr 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000420733	7	30671844	7	30632228	420733	407128	rs745958570	NC_000007.14:30632227:C:
NM_001002295.2(GATA3):c.951del (p.Cys318fs)	GATA3	C317fs, C318fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jun 26, 2021)	no assertion criteria provided	VCV001174140	10	8111461	10	8069498	1174140	1163350		NC_000010.11:8069497:CC:C
NM_001002295.2(GATA3):c.389del (p.Leu130fs)	GATA3	L130fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Feb 4, 2021)	criteria provided, single submitter	VCV001065344	10	8100415	10	8058452	1065344	1053645		NC_000010.11:8058451:T:
NM_001002295.2(GATA3):c.1201_1202del (p.Met401fs)	GATA3	M400fs, M401fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000426472	10	8115852 - 8115853	10	8073889 - 8073890	426472	415235	rs1085307641	NC_000010.11:8073888:AT:
NM_001002295.2(GATA3):c.-370+28del	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000301103	10	8096870	10	8054907	301103	316777	rs397846644	NC_000010.11:8054906:TTTTTTTTTTTTT:TTTTTTTTTTTT
NM_001002295.2(GATA3):c.108_109del (p.Met36fs)	GATA3	M36fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000029692	10	8097726 - 8097727	10	8055763 - 8055764	29692	38647	rs1588374920	NC_000010.11:8055762:GG:
NM_001002295.2(GATA3):c.924+2delinsGCTTACTTCCC	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016629	10	8106103	10	8064140	16629	31668	rs387906551	NC_000010.11:8064139:T:GCTTACTTCCC
NM_001002295.2(GATA3):c.478del (p.Asp160fs)	GATA3	D160fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016628	10	8100503	10	8058540	16628	31667	rs1588378126	NC_000010.11:8058539:GG:G
NM_001002295.2(GATA3):c.431del (p.Gly144fs)	GATA3	G144fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000016627	10	8100452	10	8058489	16627	31666	rs1588377948	NC_000010.11:8058488:GGGGGG:GGGGG
GATA3, 12-BP DEL, NT946-957	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016622					16622	31661		
GATA3, 49-BP DEL, NT465-513	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016621					16621	31660		
GATA3, 250-KB DEL	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016620					16620	31659		
GATA3, 900-KB DEL	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016619					16619	31658		
NM_018972.4(GDAP1):c.272_274delinsTTT (p.Thr91_Gln92delinsIleTer)	GDAP1		Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000917000	8	75263663 - 75263665	8	74351428 - 74351430	917000	905243		NC_000008.11:74351427:CTC:TTT
NM_018972.4(GDAP1):c.928del (p.Arg310fs)	GDAP1	R201fs, R252fs, R242fs, R310fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637555	8	75276452	8	74364217	637555	625191	rs1586807541	NC_000008.11:74364216:CC:C
NM_018972.4(GDAP1):c.174_176delinsTGTG (p.Pro59fs)	GDAP1	P59fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637547	8	75263565 - 75263567	8	74351330 - 74351332	637547	625162	rs1586795216	NC_000008.11:74351329:GCC:TGTG
NM_018972.4(GDAP1):c.116del (p.Lys39fs)	GDAP1	K39fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000637504	8	75262809	8	74350574	637504	625159	rs778547659	NC_000008.11:74350573:AAAA:AAA
NM_018972.4(GDAP1):c.840del (p.Tyr279_Tyr280insTer)	GDAP1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637127	8	75276365	8	74364130	637127	625188	rs1586807387	NC_000008.11:74364129:C:
NM_018972.4(GDAP1):c.558del (p.Ile186fs)	GDAP1	I128fs, I186fs, I77fs, I118fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637126	8	75274191	8	74361956	637126	625177	rs770658701	NC_000008.11:74361955:TT:T
NM_018972.4(GDAP1):c.172_173delinsTTA (p.Pro59fs)	GDAP1	P59fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637123	8	75263563 - 75263564	8	74351328 - 74351329	637123	625161	rs1586795201	NC_000008.11:74351327:CT:TTA
NM_018972.4(GDAP1):c.433_437del (p.Glu145fs)	GDAP1	E145fs, E36fs, E77fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637115	8	75272493 - 75272497	8	74360258 - 74360262	637115	625173	rs1586803273	NC_000008.11:74360257:TGAGTT:T
NM_018972.4(GDAP1):c.439del (p.Thr147fs)	GDAP1	T38fs, T147fs, T79fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637109	8	75272499	8	74360264	637109	625174	rs1586803279	NC_000008.11:74360263:AA:A
NM_018972.4(GDAP1):c.579del (p.Lys193fs)	GDAP1	K193fs, K84fs, K125fs, K135fs	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV000406137	8	75274211	8	74361976	406137	396279	rs1060500979	NC_000008.11:74361975:AAA:AA
NM_018972.4(GDAP1):c.786del (p.Phe263fs)	GDAP1	F195fs, F263fs, F154fs, F205fs	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000406136	8	75276308	8	74364073	406136	396551	rs1060500978	NC_000008.11:74364072:GGGG:GGG
NM_018972.4(GDAP1):c.501del (p.Glu168fs)	GDAP1	E59fs, E100fs, E110fs, E168fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000280104	8	75274135	8	74361900	280104	264285	rs886041386	NC_000008.11:74361899:A:
NM_018972.4(GDAP1):c.310+6del	GDAP1		not provided|Charcot-Marie-Tooth with Vocal Cord Paresis|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth, Intermediate|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2021)	criteria provided, conflicting interpretations	VCV000245606	8	75263707	8	74351472	245606	244523	rs780828430	NC_000008.11:74351471:G:
NM_133261.3(GIPC3):c.279_295del (p.Gln95fs)	GIPC3	Q95fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	VCV000179296	19	3586546 - 3586562	19	3586546 - 3586562	179296	176587	rs727504771	NC_000019.10:3586545:GGGGGTCAGATAGGCCTGG:GG
NM_000166.6(GJB1):c.332_349del (p.His111_His116del)	GJB1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637922	X	70443887 - 70443904	X	71224037 - 71224054	637922	625580	rs1602349197	NC_000023.11:71224036:CCATGGGGACCCCCTACACC:CC
NM_000166.6(GJB1):c.793_821del (p.Arg264_Arg265insTer)	GJB1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637883	X	70444348 - 70444376	X	71224498 - 71224526	637883	625709	rs1602349984	NC_000023.11:71224497:GCCGCAGCCCTGGCACCGGGGCTGGGCTGGC:GC
NM_000166.6(GJB1):c.115del (p.Ala39fs)	GJB1	A39fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637877	X	70443671	X	71223821	637877	625493	rs1602348763	NC_000023.11:71223820:GG:G
NM_000166.6(GJB1):c.424del (p.Arg142fs)	GJB1	R142fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637681	X	70443980	X	71224130	637681	625603	rs1602349328	NC_000023.11:71224129:CC:C
NM_000166.6(GJB1):c.43del (p.Arg15fs)	GJB1	R15fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637680	X	70443599	X	71223749	637680	625459	rs1602348594	NC_000023.11:71223748:CC:C
NM_000166.6(GJB1):c.275_276del (p.Ala92fs)	GJB1	A92fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637677	X	70443832 - 70443833	X	71223982 - 71223983	637677	625562	rs1602349065	NC_000023.11:71223981:CC:
NM_000166.6(GJB1):c.273_274del (p.Ala92fs)	GJB1	A92fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637676	X	70443830 - 70443831	X	71223980 - 71223981	637676	625561	rs1602349061	NC_000023.11:71223979:GG:
NM_000166.6(GJB1):c.44_45delinsTT (p.Arg15Leu)	GJB1	R15L	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637673	X	70443601 - 70443602	X	71223751 - 71223752	637673	625461	rs1602348605	NC_000023.11:71223750:GG:TT
NM_000166.6(GJB1):c.436_437delinsAT (p.Glu146Met)	GJB1	E146M	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637659	X	70443993 - 70443994	X	71224143 - 71224144	637659	625607	rs1602349347	NC_000023.11:71224142:GA:AT
NM_000166.6(GJB1):c.775del (p.Ser258_Leu259insTer)	GJB1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637654	X	70444330	X	71224480	637654	625705	rs1602349948	NC_000023.11:71224479:CCC:CC
NM_000166.6(GJB1):c.358_360del (p.Val120del)	GJB1	V120del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637652	X	70443914 - 70443916	X	71224064 - 71224066	637652	625583	rs1602349233	NC_000023.11:71224063:GGTG:G
NM_000166.6(GJB1):c.474del (p.Gly159fs)	GJB1	G159fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637649	X	70444031	X	71224181	637649	625627	rs1602349441	NC_000023.11:71224180:T:
NM_000166.6(GJB1):c.155del (p.Ile52fs)	GJB1	I52fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637646	X	70443712	X	71223862	637646	625510	rs1602348856	NC_000023.11:71223861:T:
NM_000166.6(GJB1):c.439del (p.Ala147fs)	GJB1	A147fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637635	X	70443995	X	71224145	637635	625609	rs1602349352	NC_000023.11:71224144:GG:G
NM_000166.6(GJB1):c.84del (p.Phe29fs)	GJB1	F29fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637632	X	70443641	X	71223791	637632	625482	rs1602348695	NC_000023.11:71223790:C:
NM_000166.6(GJB1):c.641_642delinsAT (p.Ile214Asn)	GJB1	I214N	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637621	X	70444198 - 70444199	X	71224348 - 71224349	637621	625696	rs1602349807	NC_000023.11:71224347:TC:AT
NM_000166.6(GJB1):c.454del (p.Val152fs)	GJB1	V152fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637620	X	70444011	X	71224161	637620	625616	rs1602349383	NC_000023.11:71224160:G:
NM_000166.6(GJB1):c.77del (p.Ser26fs)	GJB1	S26fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637619	X	70443634	X	71223784	637619	625479	rs1602348679	NC_000023.11:71223783:C:
NM_000166.6(GJB1):c.208_209delinsTT (p.Pro70Phe)	GJB1	P70F	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637606	X	70443765 - 70443766	X	71223915 - 71223916	637606	625532	rs1602348930	NC_000023.11:71223914:CC:TT
NM_000166.6(GJB1):c.313del (p.Met105fs)	GJB1	M105fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637601	X	70443867	X	71224017	637601	625577	rs1602349163	NC_000023.11:71224016:AAAA:AAA
NM_000166.6(GJB1):c.338_345delinsTGGC (p.Asp113fs)	GJB1	D113fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637598	X	70443895 - 70443902	X	71224045 - 71224052	637598	625581	rs1602349208	NC_000023.11:71224044:ACCCCCTA:TGGC
NM_000166.6(GJB1):c.217del (p.His73fs)	GJB1	H73fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637593	X	70443772	X	71223922	637593	625534	rs1602348937	NC_000023.11:71223921:CCC:CC
NM_000166.6(GJB1):c.553_555del (p.Thr185del)	GJB1	T185del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637579	X	70444108 - 70444110	X	71224258 - 71224260	637579	625666	rs1602349648	NC_000023.11:71224257:CCACC:CC
NM_000166.6(GJB1):c.410del (p.Ile137fs)	GJB1	I137fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000637573	X	70443967	X	71224117	637573	625600	rs1602349316	NC_000023.11:71224116:T:
NM_000166.6(GJB1):c.277_278del (p.Met93fs)	GJB1	M93fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637561	X	70443834 - 70443835	X	71223984 - 71223985	637561	625564	rs1602349068	NC_000023.11:71223983:AT:
NM_000166.6(GJB1):c.248_257del (p.Leu83fs)	GJB1	L83fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637558	X	70443804 - 70443813	X	71223954 - 71223963	637558	625546	rs1602349000	NC_000023.11:71223953:CTAGTTTCCAC:C
NM_000166.6(GJB1):c.785_786del (p.Ile262fs)	GJB1	I262fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637234	X	70444341 - 70444342	X	71224491 - 71224492	637234	625707	rs1602349962	NC_000023.11:71224490:ATA:A
NM_000166.6(GJB1):c.606del (p.Ile203fs)	GJB1	I203fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637233	X	70444163	X	71224313	637233	625683	rs1602349746	NC_000023.11:71224312:C:
NM_000166.6(GJB1):c.62del (p.Gly21fs)	GJB1	G21fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637232	X	70443618	X	71223768	637232	625469	rs1602348638	NC_000023.11:71223767:GG:G
NM_000166.6(GJB1):c.397del (p.Trp133fs)	GJB1	W133fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637218	X	70443954	X	71224104	637218	625596	rs1602349299	NC_000023.11:71224103:T:
NM_000166.6(GJB1):c.196_198del (p.Asp66del)	GJB1	D66del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637213	X	70443753 - 70443755	X	71223903 - 71223905	637213	625528	rs1602348913	NC_000023.11:71223902:GAC:
NM_000166.6(GJB1):c.110del (p.Val37fs)	GJB1	V37fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637196	X	70443667	X	71223817	637196	625491	rs1602348754	NC_000023.11:71223816:T:
NM_000166.6(GJB1):c.822del (p.Glu275fs)	GJB1	E275fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637166	X	70444379	X	71224529	637166	625711	rs1602350029	NC_000023.11:71224528:T:
NM_000166.6(GJB1):c.800del (p.Pro267fs)	GJB1	P267fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637165	X	70444355	X	71224505	637165	625710	rs1602350003	NC_000023.11:71224504:CCC:CC
NM_000166.6(GJB1):c.772del (p.Ser258fs)	GJB1	S258fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000637164	X	70444329	X	71224479	637164	625704	rs1602349940	NC_000023.11:71224478:T:
NM_000166.6(GJB1):c.629_632del (p.Val210fs)	GJB1	V210fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637163	X	70444186 - 70444189	X	71224336 - 71224339	637163	625691	rs1602349779	NC_000023.11:71224335:TGTA:
NM_000166.6(GJB1):c.576del (p.Phe193fs)	GJB1	F193fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637162	X	70444133	X	71224283	637162	625672	rs1602349692	NC_000023.11:71224282:C:
NM_000166.6(GJB1):c.498_502del (p.Lys167fs)	GJB1	K167fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637161	X	70444053 - 70444057	X	71224203 - 71224207	637161	625635	rs1602349473	NC_000023.11:71224202:GTCAAGT:GT
NM_000166.6(GJB1):c.634del (p.Leu212fs)	GJB1	L212fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637155	X	70444190	X	71224340	637155	625693	rs1602349791	NC_000023.11:71224339:CC:C
NM_000166.6(GJB1):c.459_460del (p.Phe153fs)	GJB1	F153fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637154	X	70444014 - 70444015	X	71224164 - 71224165	637154	625618	rs1602349393	NC_000023.11:71224163:TTTT:TT
NM_000166.6(GJB1):c.116del (p.Ala39fs)	GJB1	A39fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637153	X	70443673	X	71223823	637153	625496	rs1602348779	NC_000023.11:71223822:C:
NM_000166.6(GJB1):c.371del (p.Lys124fs)	GJB1	K124fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637128	X	70443927	X	71224077	637128	625585	rs1602349248	NC_000023.11:71224076:AA:A
NM_000166.6(GJB1):c.304_306del (p.Glu102del)	GJB1	E102del	Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000477594	X	70443861 - 70443863	X	71224011 - 71224013	477594	470989	rs1555937135	NC_000023.11:71224010:GAG:
NM_000166.6(GJB1):c.225del (p.Leu76fs)	GJB1	L76fs	Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2010)	no assertion criteria provided	VCV000021083	X	70443781	X	71223931	21083	33935	rs116840820	NC_000023.11:71223930:GG:G
NM_004004.6(GJB2):c.247_249del (p.Phe83del)	GJB2	F83del	Deafness, autosomal recessive 1A	Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV001319975	13	20763472 - 20763474	13	20189333 - 20189335	1319975	1310223		NC_000013.11:20189332:GAAGA:GA
NM_004004.6(GJB2):c.79_82delinsAGA (p.Val27fs)	GJB2	V27fs	Deafness, autosomal recessive 1A	Pathogenic	criteria provided, single submitter	VCV001202621	13	20763639 - 20763642	13	20189500 - 20189503	1202621	1192629		NC_000013.11:20189499:GGAC:TCT
NM_004004.6(GJB2):c.298del (p.His100fs)	GJB2	H100fs	Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000496218	13	20763423	13	20189284	496218	487602	rs775828835	NC_000013.11:20189283:G:
NM_004004.6(GJB2):c.11del (p.Gly4fs)	GJB2	G4fs	Deafness, autosomal recessive 1A|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496214	13	20763710	13	20189571	496214	487388	rs1555342014	NC_000013.11:20189570:CCCC:CCC
NM_004004.6(GJB2):c.645del (p.Arg216fs)	GJB2	R216fs	Deafness, autosomal recessive 1A|Rare genetic deafness|not provided	Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449487	13	20763076	13	20188937	449487	445122	rs1555341794	NC_000013.11:20188936:AA:A
NM_004004.6(GJB2):c.564_565del (p.Lys188fs)	GJB2	K188fs	Rare genetic deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371691	13	20763156 - 20763157	13	20189017 - 20189018	371691	358129	rs770116143	NC_000013.11:20189016:TCT:T
NM_004004.6(GJB2):c.*1291_*1294del	GJB2		Keratitis ichthyosis and deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Hystrix-like ichthyosis with deafness|Mutilating keratoderma|Nonsyndromic Hearing Loss, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311352	13	20761746 - 20761749	13	20187607 - 20187610	311352	335541	rs886050025	NC_000013.11:20187606:TACTTAC:TAC
NM_004004.6(GJB2):c.176_191del (p.Gly59fs)	GJB2	G59fs	not provided|Deafness, autosomal recessive 1A|not specified	Pathogenic(Last reviewed: Dec 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000284906	13	20763530 - 20763545	13	20189391 - 20189406	284906	269143	rs750188782	NC_000013.11:20189390:CACACGTTCTTGCAGCC:C
NC_000013.11:g.20365207_20496559del	GJB2|CRYL1|MIR4499		Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000253028	13	20939346 - 21070698	13	20365207 - 20496559	253028	247435		
NM_004004.6(GJB2):c.523_533del (p.Pro175fs)	GJB2	P175fs	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Apr 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228350	13	20763188 - 20763198	13	20189049 - 20189059	228350	230433	rs876657693	NC_000013.11:20189048:ACAGTGTTGGGACA:ACA
NM_004004.6(GJB2):c.314_329del (p.Lys105fs)	GJB2	K105fs	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211079	13	20763392 - 20763407	13	20189253 - 20189268	211079	208014	rs797045596	NC_000013.11:20189252:TCCCCCTTGATGAACTTCC:TCC
NM_004004.6(GJB2):c.334_335del (p.Lys112fs)	GJB2	K112fs	Nonsyndromic hearing loss and deafness|Rare genetic deafness|Deafness, autosomal recessive 1A|not provided|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189051	13	20763386 - 20763387	13	20189247 - 20189248	189051	186857	rs756484720	NC_000013.11:20189246:TTT:T
NM_004004.6(GJB2):c.647_650del (p.Arg216fs)	GJB2	R216fs	Rare genetic deafness|Inborn genetic diseases|not specified|Hearing impairment|not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158609	13	20763071 - 20763074	13	20188932 - 20188935	158609	169009	rs587783647	NC_000013.11:20188931:TATCTA:TA
NM_004004.6(GJB2):c.592_600delinsCAGTGTTCATGACATTC (p.Val198_Gly200delinsGlnCysSerTer)	GJB2		Hearing loss|not provided|Rare genetic deafness|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044761	13	20763121 - 20763129	13	20188982 - 20188990	44761	53928	rs111033335	NC_000013.11:20188981:TCCAGACAC:GAATGTCATGAACACTG
NM_004004.6(GJB2):c.31_68del (p.Gly11fs)	GJB2	G11fs	Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044738	13	20763653 - 20763690	13	20189514 - 20189551	44738	53905	rs397516873	NC_000013.11:20189513:ATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC:
NM_004004.6(GJB2):c.313_326del (p.Lys105fs)	GJB2	K105fs	none provided|Nonsyndromic hearing loss and deafness|not provided|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Rare genetic deafness|Hearing loss|Deafness, autosomal recessive 1A|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044737	13	20763395 - 20763408	13	20189256 - 20189269	44737	53904	rs111033253	NC_000013.11:20189255:CCCTTGATGAACTTCC:CC
NM_004004.6(GJB2):c.299_300del (p.His100fs)	GJB2	H100fs	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|not specified|Rare genetic deafness|Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044736	13	20763421 - 20763422	13	20189282 - 20189283	44736	53903	rs111033204	NC_000013.11:20189281:AT:
NM_004004.6(GJB2):c.235del (p.Leu79fs)	GJB2	L79fs	Deafness, autosomal recessive 1A|Deafness, digenic, GJB2/GJB3|Rare genetic deafness|none provided|Hearing impairment|not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Hearing loss|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	VCV000017014	13	20763486	13	20189347	17014	32053	rs80338943	NC_000013.11:20189346:GGG:GG
NM_004004.6(GJB2):c.51_62delinsA (p.Thr18fs)	GJB2	T18fs	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000017013	13	20763659 - 20763670	13	20189520 - 20189531	17013	32052	rs886037624	NC_000013.11:20189519:CCAATGCTGGTG:T
NM_004004.6(GJB2):c.167del (p.Leu56fs)	GJB2	L56fs	not provided|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|GJB2-Related Disorders|Hystrix-like ichthyosis with deafness|Hystrix-like ichthyosis with deafness|Mutilating keratoderma|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Nonsyndromic hearing loss and deafness|Hearing impairment|Mutilating keratoderma|none provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness|Nonsyndromic Hearing Loss, Dominant|Keratitis ichthyosis and deafness syndrome|Hearing loss	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000017010	13	20763554	13	20189415	17010	32049	rs80338942	NC_000013.11:20189414:A:
NM_004004.6(GJB2):c.35del (p.Gly12fs)	GJB2	G12fs	Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Deafness, digenic, GJB2/GJB6|none provided|Deafness, autosomal recessive|Deafness, autosomal dominant 3a|Mutilating keratoderma|Deafness, autosomal recessive 1A|Rare genetic deafness|Hearing impairment|Bilateral sensorineural hearing impairment|Inborn genetic diseases|Hearing impairment|Bilateral sensorineural hearing impairment|Severe sensorineural hearing impairment|Bilateral conductive hearing impairment|Hearing impairment|Hearing loss|Deafness|Nonsyndromic Hearing Loss, Recessive|Knuckle pads, deafness AND leukonychia syndrome|not provided|Deafness, autosomal dominant 3a|Mutilating keratoderma|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Sep 20, 2018)	reviewed by expert panel	VCV000017004	13	20763686	13	20189547	17004	32043	rs80338939	NC_000013.11:20189546:CCCCCC:CCCCC
del(GJB6-D13S1830)	GJB2|GJB6		Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Deafness, digenic, GJB2/GJB6	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000005546					5546	20585		
NM_024009.3(GJB3):c.652_663del (p.Leu218_Asp221del)	GJB3		not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2021)	criteria provided, conflicting interpretations	VCV000163536	1	35251015 - 35251026	1	34785413 - 34785424	163536	172582	rs727503069	NC_000001.11:34785412:CCTGCACAAGGAC:C
NM_024009.3(GJB3):c.196_198del (p.Asp66del)	GJB3	D66del	not provided|Deafness, autosomal dominant, with peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2021)	criteria provided, conflicting interpretations	VCV000006490	1	35250557 - 35250559	1	34784956 - 34784958	6490	21529	rs786200895	NC_000001.11:34784955:ACGAC:AC
NM_024009.3(GJB3):c.421_423del (p.Ile141del)	GJB3	I141del	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006487	1	35250784 - 35250786	1	34785183 - 34785185	6487	21526	rs770247378	NC_000001.11:34785182:ATT:
NC_000013.10:g.(?_20797176_21105944del	GJB6		Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV001072828					1072828	1057603		
NM_001110219.3(GJB6):c.228del (p.Trp77fs)	GJB6	W77fs	Deafness, autosomal dominant 3b|Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|not provided	Uncertain significance(Last reviewed: Apr 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000837505	13	20797392	13	20223253	837505	840578		NC_000013.11:20223252:C:
NM_001110219.3(GJB6):c.63del (p.Lys22fs)	GJB6	K22fs	Hidrotic ectodermal dysplasia syndrome|not provided|Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1b|GJB6-related disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2019)	criteria provided, conflicting interpretations	VCV000311382	13	20797557	13	20223418	311382	333885	rs770612890	NC_000013.11:20223417:CCC:CC
NC_000013.10:g.(20802713_20802726)_(21034755_21034768)del	GJB6|CRYL1|MIR4499		Deafness, digenic, GJB2/GJB6	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000005548	13	20802713 - 21034768	13	20228574 - 20460629	5548	20587		
NM_000404.4(GLB1):c.1480-8del	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV001085585	3	33055810	3	33014318	1085585	1070689		NC_000003.12:33014317:G:
NM_000404.4(GLB1):c.964_965del (p.Ser322fs)	GLB1	S191fs, S292fs, S322fs, S370fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001075170	3	33087715 - 33087716	3	33046223 - 33046224	1075170	1059733		NC_000003.12:33046222:GAG:G
NM_000404.4(GLB1):c.473del (p.Val158fs)	GLB1	C87fs, V128fs, V158fs, V206fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV001069437	3	33107034	3	33065542	1069437	1059734		NC_000003.12:33065541:A:
NM_000404.4(GLB1):c.531_534del (p.Gly178fs)	GLB1	G178fs, R107fs, G148fs, G226fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000837229	3	33106973 - 33106976	3	33065481 - 33065484	837229	827906		NC_000003.12:33065480:CCCTCC:CC
NM_000404.4(GLB1):c.1468_1470del (p.Asn490del)	GLB1	N460del, N538del, N359del, N490del	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV000835718	3	33058210 - 33058212	3	33016718 - 33016720	835718	827901		NC_000003.12:33016717:GTTG:G
NC_000003.12:g.(?_33097001)_(33097095_?)del	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000832564	3	33138493 - 33138587			832564	819366		
NM_000404.4(GLB1):c.881_882del (p.Leu293_Tyr294insTer)	GLB1		GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: May 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817580	3	33093407 - 33093408	3	33051915 - 33051916	817580	805341	rs767704163	NC_000003.12:33051914:ATA:A
NM_000404.4(GLB1):c.495_497del (p.Leu166del)	GLB1	L136del, L166del, L214del, S95del	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2019)	criteria provided, conflicting interpretations	VCV000684406	3	33107010 - 33107012	3	33065518 - 33065520	684406	672002	rs754077128	NC_000003.12:33065517:AGAAG:AG
NM_000404.4(GLB1):c.163del (p.Ile55fs)	GLB1	I103fs, I25fs, I55fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000657106	3	33114118	3	33072626	657106	631178	rs1575475703	NC_000003.12:33072625:T:
NM_000404.4(GLB1):c.817_818delinsCT (p.Trp273Leu)	GLB1	W273L, W142L, W243L, W321L	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000568792	3	33093471 - 33093472	3	33051979 - 33051980	568792	559427	rs1559401428	NC_000003.12:33051978:CA:AG
NM_000404.4(GLB1):c.846del (p.Thr283fs)	GLB1	T152fs, T331fs, T253fs, T283fs	GM1 gangliosidosis|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557052	3	33093443	3	33051951	557052	543188	rs1553610382	NC_000003.12:33051950:GG:G
NM_000404.4(GLB1):c.769_792+13del	GLB1		GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556646	3	33094970 - 33095006	3	33053478 - 33053514	556646	543190	rs1282958432	NC_000003.12:33053477:CCTCGATTCTTACCAAGGGTCCTTTGGGCTCACACTTCCTC:CCTC
NM_000404.4(GLB1):c.1077del (p.Val360fs)	GLB1	V330fs, V408fs, V360fs, V229fs	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167146	3	33065809	3	33024317	167146	177750	rs727503952	NC_000003.12:33024316:TTTTT:TTTT
NM_000404.4(GLB1):c.1174_1175del (p.Leu392fs)	GLB1	L362fs, L392fs, L261fs, L440fs	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092893	3	33063116 - 33063117	3	33021624 - 33021625	92893	98800	rs398123348	NC_000003.12:33021623:AGA:A
NM_001042413.2(GLIS3):c.932del (p.Gly311fs)	GLIS3	G156fs, G311fs	Diabetes mellitus, neonatal, with congenital hypothyroidism	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253045	9	4118546	9	4118546	253045	247456	rs879255609	NC_000009.12:4118545:CC:C
NM_013296.5(GPSM2):c.858_859delinsGT (p.Tyr286_Ser287delinsTer)	GPSM2		Chudley-McCullough syndrome	Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV001064650	1	109444472 - 109444473	1	108901850 - 108901851	1064650	1052898		NC_000001.11:108901849:CA:GT
NM_013296.5(GPSM2):c.1473del (p.Phe492fs)	GPSM2	F492fs	GPSM2-Related Disorders|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000291707	1	109465069	1	108922447	291707	275828	rs772372530	NC_000001.11:108922446:GGG:GG
NM_013296.5(GPSM2):c.459_460del (p.Ala154fs)	GPSM2	A154fs	Rare genetic deafness	Likely pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000180034	1	109440625 - 109440626	1	108898003 - 108898004	180034	172467	rs727505300	NC_000001.11:108898002:TG:
NM_013296.5(GPSM2):c.742del (p.Gly249fs)	GPSM2	G249fs	not provided|Rare genetic deafness|GPSM2-Related Disorders|Chudley-McCullough syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035492	1	109441560	1	108898938	35492	44165	rs528069912	NC_000001.11:108898937:CC:C
GPSM2, 1-BP DEL, 1473G	GPSM2		Chudley-McCullough syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035491					35491	44164		
NM_004403.2(GSDME):c.(?_863)-60_(1257_?)+61del	GSDME		Rare genetic deafness	Likely pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000228250	7	24742318 - 24747933	7	24702699 - 24708314	228250	229531		
GSMDE, 3-BP DEL, IVS7, -17CTT	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000002091					2091	17130		
GSDME, INS/DEL, EX8DEL	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000002090					2090	17129		
NM_002109.6(HARS1):c.397-10_397-9del	HARS1		Retinitis pigmentosa-deafness syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000351238	5	140058721 - 140058722	5	140679136 - 140679137	351238	295655	rs886060020	NC_000005.10:140679135:AAA:A
NC_000023.10:g.(?_82763333)_(86890775_?)del	HDX|SATL1|KLHL4|POF1B|DACH2|CHM|CYLC1|POU3F4|ZNF711|RPS6KA6|APOOL		not provided	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000833505	X	82763333 - 86890775			833505	821522		
NM_000601.6(HGF):c.866-22del	HGF		Deafness, autosomal recessive 39|not provided	Benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001245186	7	81359117	7	81729801	1245186	1235139		NC_000007.14:81729800:AAAAAAAAA:AAAAAAAA
HGF, 10-BP DEL, NT482+1991	HGF		Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014951					14951	29990		
HGF, 3-BP DEL, 1986TGA	HGF		Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014950					14950	29989		
NM_004839.4(HOMER2):c.799_803del (p.Pro267fs)	HOMER2	P267fs, P278fs	Deafness, autosomal dominant 68	Pathogenic(Last reviewed: Mar 7, 2021)	no assertion criteria provided	VCV001013607	15	83519943 - 83519947	15	82851191 - 82851195	1013607	1001324		NC_000015.10:82851190:TGAGGT:T
NM_005522.5(HOXA1):c.185del (p.Gly62fs)	HOXA1	G62fs	Bosley-Salih-Alorainy syndrome	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000014901	7	27135347	7	27095728	14901	29940	rs1562700083	NC_000007.14:27095727:CC:C
NM_000414.4(HSD17B4):c.936_937del (p.His312_Thr313insTer)	HSD17B4		not provided|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000504023	5	118832304 - 118832305	5	119496609 - 119496610	504023	495228	rs758055753	NC_000005.10:119496608:ATA:A
NM_001540.5(HSPB1):c.510del (p.Lys171fs)	HSPB1	K171fs	Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000954704	7	75933380	7	76304063	954704	945761		NC_000007.14:76304062:CCC:CC
NM_001540.5(HSPB1):c.364+9_364+20del	HSPB1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916736	7	75932401 - 75932412	7	76303084 - 76303095	916736	905602		NC_000007.14:76303083:CCCCTGCTCCTGC:C
NM_001540.5(HSPB1):c.172del (p.Leu58fs)	HSPB1	L58fs	Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000844705	7	75932197	7	76302880	844705	833837		NC_000007.14:76302879:CCCCC:CCCC
NM_001540.5(HSPB1):c.233_234delinsTT (p.Ser78Ile)	HSPB1	S78I	Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000841120	7	75932262 - 75932263	7	76302945 - 76302946	841120	833840		NC_000007.14:76302944:GC:TT
NC_000007.14:g.(?_76303789)_(76304183_?)del	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831819	7	75933106 - 75933500			831819	819917		
NM_001540.5(HSPB1):c.365-5del	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV000700600	7	75933109	7	76303792	700600	689885	rs759570569	NC_000007.14:76303791:CCCCCC:CCCCC
NM_001540.5(HSPB1):c.476_477del (p.Pro159fs)	HSPB1	P159fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637688	7	75933348 - 75933349	7	76304031 - 76304032	637688	625150	rs1240900244	NC_000007.14:76304030:CT:
NM_001540.5(HSPB1):c.505del (p.Met169fs)	HSPB1	M169fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637259	7	75933377	7	76304060	637259	625152	rs1583966508	NC_000007.14:76304059:A:
NM_001540.5(HSPB1):c.248_249delinsAT (p.Ser83Asn)	HSPB1	S83N	Charcot-Marie-Tooth disease axonal type 2F|not provided	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618680	7	75932277 - 75932278	7	76302960 - 76302961	618680	609669	rs1563651975	NC_000007.14:76302959:GC:AT
NC_000007.14:g.(?_76303802)_(76304173_?)del	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000584236	7	75933119 - 75933490	7	76303802 - 76304173	584236	566153		
NC_000007.14:g.(?_76303782)_(76304193_?)del	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000533819	7	75933099 - 75933510	7	76303782 - 76304193	533819	522263		
NM_001540.5(HSPB1):c.572_584del (p.Leu191fs)	HSPB1	L191fs	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2020)	criteria provided, conflicting interpretations	VCV000503828	7	75933444 - 75933456	7	76304127 - 76304139	503828	495216	rs771457306	NC_000007.14:76304126:TTGGGGGCCCAGA:
NM_001540.5(HSPB1):c.512del (p.Lys171fs)	HSPB1	K171fs	Charcot-Marie-Tooth disease axonal type 2F|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439794	7	75933383	7	76304066	439794	433611	rs1554614680	NC_000007.14:76304065:AA:A
NM_001540.5(HSPB1):c.522_523delinsCT (p.Gln175Ter)	HSPB1	Q175*	Charcot-Marie-Tooth disease axonal type 2F	Likely pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000410713	7	75933394 - 75933395	7	76304077 - 76304078	410713	396422	rs1060503021	NC_000007.14:76304076:GC:CT
NM_014365.3(HSPB8):c.184_185del (p.Gly62fs)	HSPB8	G62fs	Charcot-Marie-Tooth disease, type 2L	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000971620	12	119617301 - 119617302	12	119179496 - 119179497	971620	956754		NC_000012.12:119179495:GG:
NM_014365.3(HSPB8):c.334del (p.Met111_Val112insTer)	HSPB8		Charcot-Marie-Tooth disease, type 2L	Uncertain significance(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV000968158	12	119617450	12	119179645	968158	956757		NC_000012.12:119179644:GG:G
NM_014365.3(HSPB8):c.515del (p.Pro172fs)	HSPB8	P172fs	Charcot-Marie-Tooth disease, type 2L	Uncertain significance(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000946382	12	119631585	12	119193780	946382	926476		NC_000012.12:119193779:CCC:CC
NM_000618.5(IGF1):c.*263_*265delinsAAA	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306904	12	102796020 - 102796022	12	102402242 - 102402244	306904	315826	rs886048889	NC_000012.12:102402241:ATA:TTT
NM_000618.5(IGF1):c.*753_*754del	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306899	12	102795531 - 102795532	12	102401753 - 102401754	306899	328986	rs5742700	NC_000012.12:102401752:TTTT:TT
NM_000618.5(IGF1):c.*2375del	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306885	12	102793910	12	102400132	306885	315812	rs35306040	NC_000012.12:102400131:TTTTTTTTTTTTTT:TTTTTTTTTTTTT
NM_000618.5(IGF1):c.*2376del	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306884	12	102793909	12	102400131	306884	322906	rs886048882	NC_000012.12:102400130:C:
NM_000618.5(IGF1):c.*4404_*4407del	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306857	12	102791878 - 102791881	12	102398100 - 102398103	306857	330159	rs886048872	NC_000012.12:102398099:AAACAAA:AAA
NM_000618.5(IGF1):c.*4484del	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306853	12	102791801	12	102398023	306853	328929	rs17881987	NC_000012.12:102398022:AAAAAAA:AAAAAA
NM_000618.5(IGF1):c.*6490_*6493delinsCTAAAATGTAACTAATTGAATA	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306829	12	102789792 - 102789795	12	102396014 - 102396017	306829	328883	rs886048856	NC_000012.12:102396013:AGTC:TATTCAATTAGTTACATTTTAG
IGF1, EX4-5DEL	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: Oct 31, 1996)	no assertion criteria provided	VCV000014787					14787	29826		
NM_002180.3(IGHMBP2):c.2773del (p.His925fs)	IGHMBP2	H925fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694861	11	68705810	11	68938342	694861	683034	rs1594458566	NC_000011.10:68938341:CC:C
NM_002180.3(IGHMBP2):c.2970_2982del (p.Glu990fs)	IGHMBP2	E990fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637949	11	68707185 - 68707197	11	68939717 - 68939729	637949	625260	rs1392401882	NC_000011.10:68939716:GAGAGGGGGACGTGA:GA
NM_002180.3(IGHMBP2):c.1714_1716del (p.Lys572del)	IGHMBP2	K572del	Charcot-Marie-Tooth disease|Autosomal dominant distal hereditary motor neuropathy	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000637699	11	68702846 - 68702848	11	68935378 - 68935380	637699	625243	rs775542203	NC_000011.10:68935377:AGAAG:AG
NM_002180.3(IGHMBP2):c.1463del (p.Leu488fs)	IGHMBP2	L488fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637273	11	68701307	11	68933839	637273	625236	rs1594451999	NC_000011.10:68933838:T:
NM_002180.3(IGHMBP2):c.983_984del (p.Lys328fs)	IGHMBP2	K328fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637272	11	68685272 - 68685273	11	68917804 - 68917805	637272	625225	rs1594431701	NC_000011.10:68917803:AAAA:AA
NM_001199799.2(ILDR1):c.294del (p.Val99fs)	ILDR1	V99fs	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001299310	3	121724176	3	122005329	1299310	1289169		NC_000003.12:122005328:TT:T
NM_001199799.2(ILDR1):c.1032del (p.Thr345fs)	ILDR1	T256fs, T345fs, T301fs	Deafness, autosomal recessive 42|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562090	3	121712564	3	121993717	562090	553255	rs1226171550	NC_000003.12:121993716:CC:C
NM_001199799.2(ILDR1):c.745del (p.Ser249fs)	ILDR1	S249fs, S160fs	Congenital sensorineural hearing impairment|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000523424	3	121713062	3	121994215	523424	513936	rs571007078	NC_000003.12:121994214:AAA:AA
NM_022489.4(INF2):c.205_216del (p.Leu69_Ser72del)	INF2		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637946	14	105167906 - 105167917	14	104701569 - 104701580	637946	625297	rs1595163808	NC_000014.9:104701568:CCTGGAGCAGAGC:C
NM_152558.5(IQCE):c.895_904del (p.Val301fs)	IQCE	V285fs, V236fs, V301fs	not provided|Brachydactyly|Retinal degeneration|Non-syndromic syndactyly|Postaxial polydactyly type A1|Polydactyly, postaxial, type a7|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000638149	7	2625907 - 2625916	7	2586273 - 2586282	638149	625969	rs773701437	NC_000007.14:2586272:TGTCCCGGAGTGTCC:TGTCC
NM_000214.3(JAG1):c.2916+27del	JAG1		Tetralogy of Fallot|Deafness, congenital heart defects, and posterior embryotoxon|not specified|Alagille syndrome 1|not provided	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000255555	20	10622081	20	10641433	255555	257308	rs3215563	NC_000020.11:10641432:AAAAAAAAAA:AAAAAAAAA
NM_005548.3(KARS1):c.1354del (p.Leu452fs)	KARS1	L452fs, L480fs, L296fs	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH DEAFNESS|Muscular hypotonia|Lactic acidosis|Global developmental delay|Sensorineural hearing loss	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000560389	16	75664391	16	75630493	560389	551445	rs1567498374	NC_000016.10:75630492:GG:G
NM_002241.5(KCNJ10):c.321_322del (p.Val109fs)	KCNJ10	V109fs	EAST syndrome	Pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000841424	1	160012001 - 160012002	1	160042211 - 160042212	841424	822885		NC_000001.11:160042210:AG:
NM_002241.5(KCNJ10):c.934_935delinsTT (p.Thr312Leu)	KCNJ10	T312L	EAST syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000663852	1	160011388 - 160011389	1	160041598 - 160041599	663852	626984	rs1571265205	NC_000001.11:160041597:GT:AA
NM_002241.5(KCNJ10):c.*2675_*2676del	KCNJ10		Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome|Nonsyndromic Hearing Loss, Mixed|Pendred syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293080	1	160008507 - 160008508	1	160038717 - 160038718	293080	277042	rs886045398	NC_000001.11:160038716:CC:
NM_002241.5(KCNJ10):c.775del (p.Val258_Val259insTer)	KCNJ10		EAST syndrome	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030253	1	160011548	1	160041758	30253	39209	rs1557967748	NC_000001.11:160041757:CC:C
NM_000218.3(KCNQ1):c.1667_1679del (p.Ile556fs)	KCNQ1	I429fs, I556fs	Jervell and Lange-Nielsen syndrome 1	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000976086	11	2797263 - 2797275	11	2776033 - 2776045	976086	964362		NC_000011.10:2776032:GCATCAAGGAGCTGCA:GCA
NM_181798.1(KCNQ1):c.352_353del (p.Gly118fs)	KCNQ1	G118fs, G245fs	Jervell and Lange-Nielsen syndrome 1	Pathogenic	no assertion criteria provided	VCV000438610	11	2593291 - 2593292	11	2572061 - 2572062	438610	432231	rs1554893092	NC_000011.10:2572060:GGG:G
NM_000218.3(KCNQ1):c.1534del (p.Ala512fs)	KCNQ1	A385fs, A512fs	Jervell and Lange-Nielsen syndrome 1	Pathogenic	criteria provided, single submitter	VCV000430941	11	2790091	11	2768861	430941	424482	rs1554919471	NC_000011.10:2768860:GGG:GG
NM_000218.3(KCNQ1):c.743_744delinsTC (p.Trp248Phe)	KCNQ1	W121F, W248F	Jervell and Lange-Nielsen syndrome 1	not provided	no assertion provided	VCV000053093	11	2593302 - 2593303	11	2572072 - 2572073	53093	67761	rs397508123	NC_000011.10:2572071:GG:TC
NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs)	KCNQ1	R192fs, R65fs	not provided|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Jervell and Lange-Nielsen syndrome|Congenital long QT syndrome|Long QT syndrome|Cardiovascular phenotype|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000053072	11	2591950 - 2591954	11	2570720 - 2570724	53072	67740	rs397508118	NC_000011.10:2570719:GCTGCGCT:GCT
NM_000218.3(KCNQ1):c.488del (p.Leu163fs)	KCNQ1	L36fs	not provided|Long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome|Rare genetic deafness|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053050	11	2591868	11	2570638	53050	67718	rs397508112	NC_000011.10:2570637:T:
NM_000218.3(KCNQ1):c.451_452del (p.Leu151fs)	KCNQ1	L151fs, L24fs	Jervell and Lange-Nielsen syndrome 1|not provided|Long QT syndrome	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053045	11	2549222 - 2549223	11	2527992 - 2527993	53045	67713	rs397508110	NC_000011.10:2527991:CT:
NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs)	KCNQ1|KCNQ1-AS1	P631fs, P504fs	Jervell and Lange-Nielsen syndrome 1|Long QT syndrome|not provided	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000053025	11	2869093 - 2869112	11	2847863 - 2847882	53025	67693	rs397508103	NC_000011.10:2847862:CCCAGAGAGGGCGGGGCCCAC:C
NM_000218.3(KCNQ1):c.1630_1635delinsGTTGAGA (p.Gln544fs)	KCNQ1	Q417fs, Q544fs	Jervell and Lange-Nielsen syndrome 1	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000052999	11	2797229 - 2797234	11	2775999 - 2776004	52999	67667	rs397515637	NC_000011.10:2775998:CAGTAC:GTTGAGA
NM_000218.3(KCNQ1):c.1189del (p.Arg397fs)	KCNQ1	R397fs, R270fs	Jervell and Lange-Nielsen syndrome 1	not provided	no assertion provided	VCV000052971	11	2608859	11	2587629	52971	67639	rs397508081	NC_000011.10:2587628:CC:C
NM_004700.4(KCNQ4):c.1044_1051del (p.Ala349Profs)	KCNQ4		Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208372	1	41287988 - 41287995	1	40822313 - 40822320	208372	204601	rs797044972	NC_000001.11:40822312:GGCTGCCTGGC:GGC
NM_004700.4(KCNQ4):c.459del (p.Ala154fs)	KCNQ4	A154fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	VCV000179111	1	41283888	1	40818216	179111	172583	rs727504635	NC_000001.11:40818215:CC:C
NM_004700.4(KCNQ4):c.211del (p.Gln71fs)	KCNQ4	Q71fs	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000006248	1	41249975	1	40784303	6248	21287	rs80358272	NC_000001.11:40784302:CC:C
NM_004700.4(KCNQ4):c.212_224del (p.Gln71fs)	KCNQ4	Q71fs	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV000006245	1	41249976 - 41249988	1	40784304 - 40784316	6245	21284	rs80358271	NC_000001.11:40784303:CAGCGCTCCTCGGC:C
NM_001365951.3(KIF1B):c.1945_1947del (p.Ser649del)	KIF1B	S603del, S649del	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917339	1	10357036 - 10357038	1	10296978 - 10296980	917339	905075		NC_000001.11:10296977:CTTCT:CT
NM_001365951.3(KIF1B):c.2043-9del	KIF1B		Charcot-Marie-Tooth disease	Benign	criteria provided, single submitter	VCV000917114	1	10357207	1	10297149	917114	905534		NC_000001.11:10297148:TTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT
NM_001365951.3(KIF1B):c.3423-15del	KIF1B		none provided|Charcot-Marie-Tooth disease|not provided|Neuroblastoma	Benign/Likely benign(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000291568	1	10399812	1	10339754	291568	275809	rs3215996	NC_000001.11:10339753:A:
NM_001365951.3(KIF1B):c.184-6_184-5del	KIF1B		not specified|not provided|Charcot-Marie-Tooth disease|Neuroblastoma|Charcot-Marie-Tooth disease, type 2|none provided	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260541	1	10318544 - 10318545	1	10258486 - 10258487	260541	249266	rs138324955	NC_000001.11:10258485:TTT:T
NM_001365951.3(KIF1B):c.2043-10_2043-9del	KIF1B		not provided|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2015)	criteria provided, conflicting interpretations	VCV000195513	1	10357207 - 10357208	1	10297149 - 10297150	195513	192674	rs58344165	NC_000001.11:10297148:TTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_000899.5(KITLG):c.200_202del (p.His67_Cys68delinsArg)	KITLG		Deafness, autosomal dominant 69	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218888	12	88912635 - 88912637	12	88518858 - 88518860	218888	215647	rs864309654	NC_000012.12:88518857:AAT:
NM_000899.5(KITLG):c.286_303delinsT (p.Leu95_Ser96insTer)	KITLG		Deafness, autosomal dominant 69	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218887	12	88912534 - 88912551	12	88518757 - 88518774	218887	215646	rs864309653	NC_000012.12:88518756:TATGATGGAATAATTACT:A
NM_024884.3(L2HGDH):c.1115del (p.Met372fs)	L2HGDH	M372fs	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001608	14	50732157	14	50265439	1608	16647	rs786200869	NC_000014.9:50265438:A:
NM_015340.3(LARS2):c.(?_2533)-70_*(70_?)del	LARS2		Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000517278	3	45588773 - 45589092	3	45547281 - 45547600	517278	496765		
NM_182548.4(LHFPL5):c.649+1del	LHFPL5		Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001696	6	35782559	6	35814782	1696	16735	rs1581972457	NC_000006.12:35814781:GG:G
NM_182548.4(LHFPL5):c.250del (p.Pro83_Leu84insTer)	LHFPL5		Deafness, autosomal recessive 67|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001694	6	35773693	6	35805916	1694	16733	rs779841884	NC_000006.12:35805915:CCCCC:CCCC
NM_178138.6(LHX3):c.80-530_776-454del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009028	9	139090043 - 139093129	9	136198197 - 136201283	9028	24067		
NC_000009.12:g.(?_136197325)_(136205012_?)del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009026			9	136197325 - 136205012	9026	24065		
NM_178138.6(LHX3):c.287_288delinsTCCT (p.Gly96fs)	LHX3	G101fs, G85fs, G96fs	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009025	9	139091690 - 139091691	9	136199844 - 136199845	9025	24064	rs137854504	NC_000009.12:136199843:GC:AGGA
NM_178138.6(LHX3):c.96del (p.Gly33fs)	LHX3	G38fs, G22fs, G33fs	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000009023	9	139092583	9	136200737	9023	24062	rs587776712	NC_000009.12:136200736:A:
NM_178138.6(LHX3):c.452_454+20del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000009022	9	139091504 - 139091526	9	136199658 - 136199680	9022	24061	rs587776711	NC_000009.12:136199657:GCGTCGTCCCCTCGGCTGACCTCGC:GC
NM_001136472.2(LITAF):c.302del (p.Lys101fs)	LITAF	K101fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694882	16	11647464	16	11553608	694882	683070	rs1597329350	NC_000016.10:11553607:TT:T
NM_170707.4(LMNA):c.864_867del (p.His289fs)	LMNA	H208fs, H289fs, H177fs	not provided|Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000066948	1	156105030 - 156105033	1	156135239 - 156135242	66948	77845	rs60168366	NC_000001.11:156135238:CCCAC:C
NM_000085.5(CLCNKB):c.866+47del	LOC106501713|CLCNKB		not provided|Bartter syndrome type 3|Bartter syndrome, type 4b	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV001209750	1	16376239	1	16049744	1209750	1199670		NC_000001.11:16049743:CCCCCC:CCCCC
NC_000008.11:g.(?_99384188)_(99721067_?)del	LOC110120801|MIR599|MIR875|VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000664445	8	100396416 - 100733295	8	99384188 - 99721067	664445	651878		
NC_000008.11:g.(?_99431517)_(99721067_?)del	LOC110120801|MIR599|MIR875|VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000584084	8	100443745 - 100733295	8	99431517 - 99721067	584084	564568		
NM_001384474.1(LOXHD1):c.1286del (p.Leu429fs)	LOXHD1	L429fs	Deafness, autosomal recessive 77	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210426	18	44173708	18	46593745	1210426	1200426		NC_000018.10:46593744:A:
NM_001384474.1(LOXHD1):c.46del (p.Leu16fs)	LOXHD1	L16fs	Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Dec 31, 2020)	criteria provided, single submitter	VCV000813824	18	44236951	18	46656988	813824	802079	rs1599083635	NC_000018.10:46656987:GG:G
NM_001384474.1(LOXHD1):c.3287_3295del (p.Thr1096_Asn1098del)	LOXHD1		Deafness, autosomal recessive 77|not provided	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000804993	18	44137374 - 44137382	18	46557411 - 46557419	804993	793714	rs1488153218	NC_000018.10:46557410:TGTTGCCTGTGTTG:TGTTG
NM_001384474.1(LOXHD1):c.2303del (p.Gly768fs)	LOXHD1	G768fs	Rare genetic deafness	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000163919	18	44146354	18	46566391	163919	176571	rs727503146	NC_000018.10:46566390:CCC:CC
NM_004525.3(LRP2):c.13568del (p.Asn4523fs)	LRP2	N4523fs	Donnai-Barrow syndrome	Likely pathogenic(Last reviewed: Jan 29, 2021)	criteria provided, single submitter	VCV000996083	2	169993954	2	169137444	996083	983790		NC_000002.12:169137443:TTTT:TTT
NM_004525.3(LRP2):c.428-10_428-8del	LRP2		Donnai-Barrow syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2019)	criteria provided, conflicting interpretations	VCV000332204	2	170151228 - 170151230	2	169294718 - 169294720	332204	283582	rs370823033	NC_000002.12:169294717:AAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.428-8del	LRP2		not provided|Donnai-Barrow syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2019)	criteria provided, conflicting interpretations	VCV000332203	2	170151228	2	169294718	332203	282759	rs370823033	NC_000002.12:169294717:AAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.428-9_428-8del	LRP2		Donnai-Barrow syndrome|not provided|not specified	Benign(Last reviewed: Dec 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000332202	2	170151228 - 170151229	2	169294718 - 169294719	332202	283580	rs370823033	NC_000002.12:169294717:AAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.428-6del	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332201	2	170151226	2	169294716	332201	283578	rs886055093	NC_000002.12:169294715:G:
NM_004525.3(LRP2):c.4691+7del	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332170	2	170093606	2	169237096	332170	285082	rs775018424	NC_000002.12:169237095:G:
NM_004525.3(LRP2):c.*910del	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332055	2	169984263	2	169127753	332055	282641	rs11411235	NC_000002.12:169127752:TTTTTTTTTTTT:TTTTTTTTTTT
NM_004525.3(LRP2):c.11498-13del	LRP2		Donnai-Barrow syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000259412	2	170025199	2	169168689	259412	250373	rs143342962	NC_000002.12:169168688:AAAAAAA:AAAAAA
NM_004525.3(LRP2):c.13139del (p.Pro4380fs)	LRP2	P4380fs	Donnai-Barrow syndrome|not provided	Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211391	2	169997025	2	169140515	211391	206891	rs80338754	NC_000002.12:169140514:GGGGGGGG:GGGGGGG
NM_004525.3(LRP2):c.12437del (p.Gly4146fs)	LRP2	G4146fs	Donnai-Barrow syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039973	2	170009333	2	169152823	39973	48493	rs786205122	NC_000002.12:169152822:CC:C
NM_004525.3(LRP2):c.8519_8522del (p.Tyr2840fs)	LRP2	Y2840fs	Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009453	2	170055352 - 170055355	2	169198842 - 169198845	9453	24492	rs80338749	NC_000002.12:169198841:AAATAAA:AAA
NM_004525.3(LRP2):c.9484_9485del (p.Val3162fs)	LRP2	V3162fs	Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009451	2	170042373 - 170042374	2	169185863 - 169185864	9451	24490	rs80338751	NC_000002.12:169185862:ACA:A
NC_000009.11:g.(?_130241724_130244069del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV001067568					1067568	1054457		
NM_001005373.4(LRSAM1):c.2046_2046+12del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001052525	9	130263422 - 130263434	9	127501143 - 127501155	1052525	1045851		NC_000009.12:127501142:GGTAAGTCCGGGG:
NM_001005373.4(LRSAM1):c.109del (p.Ser37fs)	LRSAM1	S37fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000969216	9	130217313	9	127455034	969216	955676		NC_000009.12:127455033:T:
NM_001005373.4(LRSAM1):c.1773_1774delinsAA (p.His592Asn)	LRSAM1	H592N, H565N, H329N, H559N	Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000959968	9	130258317 - 130258318	9	127496038 - 127496039	959968	946346		NC_000009.12:127496037:GC:AA
NM_001005373.4(LRSAM1):c.2029_2046+7del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000946095	9	130263402 - 130263426	9	127501123 - 127501147	946095	940922		NC_000009.12:127501122:GTCGTGTGCCTGGAACGGGAGGTAAGTC:GTC
NM_001005373.4(LRSAM1):c.1333del (p.Gln445fs)	LRSAM1	Q445fs, Q182fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000946022	9	130250027	9	127487748	946022	925355		NC_000009.12:127487747:CC:C
NM_001005373.4(LRSAM1):c.2161_2163del (p.His721del)	LRSAM1	H694del, H721del, H458del, H688del	Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000940588	9	130265165 - 130265167	9	127502886 - 127502888	940588	934533		NC_000009.12:127502885:ACCAC:AC
NM_001005373.4(LRSAM1):c.2008del (p.Val670fs)	LRSAM1	V643fs, V670fs, V407fs, V637fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000917118	9	130263383	9	127501104	917118	905262		NC_000009.12:127501103:GG:G
NM_001005373.4(LRSAM1):c.1815del (p.Asp607fs)	LRSAM1	D607fs, D580fs, D344fs, D574fs	Charcot-Marie-Tooth disease type 2P|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000859441	9	130258359	9	127496080	859441	835449		NC_000009.12:127496079:A:
NM_001005373.4(LRSAM1):c.1912+4_1912+5delinsTC	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000851234	9	130259617 - 130259618	9	127497338 - 127497339	851234	852475		NC_000009.12:127497337:CA:TC
NC_000009.12:g.(?_127502764)_(127502909_?)del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000831957	9	130265043 - 130265188			831957	820049		
NC_000009.12:g.(?_127461163)_(127473941_?)del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000830785	9	130223442 - 130236220			830785	820048		
NM_001005373.4(LRSAM1):c.1599+9_1599+10del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000751402	9	130255184 - 130255185	9	127492905 - 127492906	751402	775473	rs1588134360	NC_000009.12:127492904:TTT:T
NM_001005373.4(LRSAM1):c.2134_2145del (p.Asp712_Gln715del)	LRSAM1		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000695015	9	130265136 - 130265147	9	127502857 - 127502868	695015	683024	rs1588144737	NC_000009.12:127502856:CCAGGACATCGCCCAG:CCAG
NM_001005373.4(LRSAM1):c.119del (p.Glu40fs)	LRSAM1	E40fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000695011	9	130217323	9	127455044	695011	683021	rs1588090984	NC_000009.12:127455043:A:
NM_001005373.4(LRSAM1):c.849_1088+565del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000650288	9	130241728 - 130244069	9	127479449 - 127481790	650288	651893		
NC_000009.12:g.(?_127501000)_(127501153_?)del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000644828	9	130263279 - 130263432	9	127501000 - 127501153	644828	651817		
NM_001005373.4(LRSAM1):c.1694del (p.Leu565fs)	LRSAM1	L538fs, L565fs, L302fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000577820	9	130257693	9	127495414	577820	568465	rs749012928	NC_000009.12:127495413:T:
NM_001005373.4(LRSAM1):c.1026_1027delinsTT (p.Leu342_Leu343=)	LRSAM1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2P	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000540013	9	130242240 - 130242241	9	127479961 - 127479962	540013	524209	rs1554757292	NC_000009.12:127479960:GC:TT
NM_001005373.4(LRSAM1):c.2102del (p.Gln701fs)	LRSAM1	Q674fs, Q701fs, Q438fs, Q668fs	Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000540008	9	130265108	9	127502829	540008	524556	rs1554763035	NC_000009.12:127502828:A:
NM_001005373.4(LRSAM1):c.2093_2104del (p.Gln698_Gln701del)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000472799	9	130265089 - 130265100	9	127502810 - 127502821	472799	458760	rs1554763017	NC_000009.12:127502809:TGCTGCCAGCAGTGCTGCCAGC:TGCTGCCAGC
NM_001005373.4(LRSAM1):c.904-4del	LRSAM1		Charcot-Marie-Tooth disease|not provided	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432408	9	130242114	9	127479835	432408	425817	rs757987823	NC_000009.12:127479834:G:
NC_000009.12:g.(?_127502774)_(127503501_?)del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000417428	9	130265053 - 130265780	9	127502774 - 127503501	417428	396760		
NM_001005373.4(LRSAM1):c.2003_2015del (p.Leu668fs)	LRSAM1	L668fs, L641fs, L405fs, L635fs	not provided|Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234769	9	130263377 - 130263389	9	127501098 - 127501110	234769	231717	rs876661208	NC_000009.12:127501097:GCTGGAGGTGCAGGC:GC
NM_005461.5(MAFB):c.803del (p.Asn268fs)	MAFB	N268fs	Duane retraction syndrome 3 with or without deafness|Duane syndrome type 1|Duane retraction syndrome 2	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000224628	20	39316688	20	40688048	224628	226409	rs879255275	NC_000020.11:40688047:TT:T
NM_145331.3(MAP3K7):c.130_135del (p.Arg44_Gly45del)	MAP3K7		Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264702	6	91281512 - 91281517	6	90571793 - 90571798	264702	259294	rs886039234	NC_000006.12:90571792:TCCTCTTCC:TCC
NM_001038603.2(MARVELD2):c.1331+4_1331+7delAGTG	MARVELD2		Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001196					1196	16235		
NM_030973.4(MED25):c.1747-19_1747-18del	MED25		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916784	19	50338965 - 50338966	19	49835708 - 49835709	916784	905718		NC_000019.10:49835707:CT:
NM_030973.4(MED25):c.807_809del (p.Pro270del)	MED25	P270del	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000916780	19	50333460 - 50333462	19	49830203 - 49830205	916780	905504		NC_000019.10:49830202:CCCCCC:CCC
NM_000091.5(COL4A3):c.2621del (p.Gly874fs)	MFF-DT|COL4A3	G874fs	Alport syndrome, autosomal recessive|Nephrotic syndrome|Benign familial hematuria|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000870355	2	228147212	2	227282496	870355	858530		NC_000002.12:227282495:GG:G
NM_000091.5(COL4A3):c.4326_4328del (p.Thr1443del)	MFF-DT|COL4A3	T1443del	Alport syndrome, autosomal recessive|not provided	Uncertain significance(Last reviewed: Jun 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555238	2	228172497 - 228172499	2	227307781 - 227307783	555238	542056	rs941454321	NC_000002.12:227307780:ACAAC:AC
NM_000091.5(COL4A3):c.345del	MFF-DT|COL4A3	P116fs	Alport syndrome|not provided|Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554004	2	228110688	2	227245972	554004	542004	rs749390823	NC_000002.12:227245971:GGG:GG
NM_014874.4(MFN2):c.2120_2128del (p.Arg707_Asn709del)	MFN2		Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917375	1	12069697 - 12069705	1	12009640 - 12009648	917375	905103		NC_000001.11:12009639:CCGGGAGAACC:CC
NM_014874.4(MFN2):c.1495+10del	MFN2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Benign/Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000916792	1	12064992	1	12004935	916792	905551		NC_000001.11:12004934:CCC:CC
NM_014874.4(MFN2):c.136del (p.Leu46fs)	MFN2	L46fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694942	1	12049361	1	11989304	694942	682969	rs1569803014	NC_000001.11:11989303:C:
NM_014874.4(MFN2):c.677_688del (p.Val226_Ser229del)	MFN2		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637940	1	12058903 - 12058914	1	11998846 - 11998857	637940	624916	rs1569842627	NC_000001.11:11998845:GTGGCCAACTCAG:G
NM_014874.4(MFN2):c.1772_1773del (p.Gln591fs)	MFN2	Q591fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637734	1	12066650 - 12066651	1	12006593 - 12006594	637734	624951	rs1569868729	NC_000001.11:12006592:AG:
NM_014874.4(MFN2):c.1134_1142del (p.Leu379_Met381del)	MFN2		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637435	1	12062134 - 12062142	1	12002077 - 12002085	637435	624942	rs1569854405	NC_000001.11:12002076:CCTGCACAT:
NM_014874.4(MFN2):c.2230_2231delinsAT (p.Glu744Met)	MFN2	E744M	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637305	1	12071578 - 12071579	1	12011521 - 12011522	637305	624967	rs1569890153	NC_000001.11:12011520:GA:AT
NM_014874.4(MFN2):c.986_988del (p.Glu329del)	MFN2	E329del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637286	1	12061839 - 12061841	1	12001782 - 12001784	637286	624933	rs1569853108	NC_000001.11:12001781:AGAAG:AG
NC_000008.11:g.(?_99096292)_(99577653_?)del	MIR599|MIR875|VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000584321	8	100108520 - 100589881	8	99096292 - 99577653	584321	564561		
NC_000008.11:g.(?_99274178)_(99721067_?)del	MIR599|LOC110120801|MIR875|VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000528873	8	100286406 - 100733295	8	99274178 - 99721067	528873	523529		
NM_030973.4(MED25):c.1317-16del	MIR6800|MED25		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917045	19	50335340	19	49832083	917045	905715		NC_000019.10:49832082:CC:C
NC_000008.11:g.(?_99274178)_(99577653_?)del	MIR875|MIR599|VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 22, 2018)	criteria provided, single submitter	VCV000657371	8	100286406 - 100589881	8	99274178 - 99577653	657371	651768		
NM_001354604.2(MITF):c.*2160del	MITF		Waardenburg syndrome|Tietz syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346535	3	70016559	3	69967408	346535	292718	rs565618309	NC_000003.12:69967407:A:
NM_001354604.2(MITF):c.*413_*416del	MITF		Waardenburg syndrome|Tietz syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346510	3	70014805 - 70014808	3	69965654 - 69965657	346510	296046	rs886058810	NC_000003.12:69965653:AAAAAAAAAAA:AAAAAAA
NM_198159.2(MITF):c.(?_938)-102_*(78_?)del	MITF		Rare genetic deafness	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000228361	3	70005504 - 70014477	3	69956353 - 69965326	228361	228973		
NM_198159.2(MITF):c.(?_355)-1203_*(78_?)del	MITF|LOC107988030		Rare genetic deafness	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000228360	3	69985770 - 70014477	3	69936619 - 69965326	228360	228972		
NM_001303256.3(MORC2):c.2795del (p.Lys932fs)	MORC2	K932fs, K870fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694956	22	31328392	22	30932405	694956	683108	rs1602477282	NC_000022.11:30932404:TT:T
NM_000530.8(MPZ):c.638_639del (p.Gly213fs)	MPZ	G213fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001076512	1	161275904 - 161275905	1	161306114 - 161306115	1076512	1058459		NC_000001.11:161306113:CCC:C
NM_000530.8(MPZ):c.345del (p.His115fs)	MPZ	H115fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001070661	1	161276601	1	161306811	1070661	1058460		NC_000001.11:161306810:G:
NM_000530.8(MPZ):c.431_433del (p.Leu144_Tyr145delinsHis)	MPZ		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000949104	1	161276513 - 161276515	1	161306723 - 161306725	949104	921718		NC_000001.11:161306722:ACA:
NM_000530.8(MPZ):c.333_336del (p.Ile112fs)	MPZ	I112fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835791	1	161276610 - 161276613	1	161306820 - 161306823	835791	822937		NC_000001.11:161306819:AATG:
NC_000001.11:g.(?_161305674)_(161307434_?)del	MPZ		Charcot-Marie-Tooth disease, type I	Likely pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000830645	1	161275464 - 161277224			830645	818849		
NM_000530.8(MPZ):c.551del (p.Leu184fs)	MPZ	L184fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694954	1	161276152	1	161306362	694954	682980	rs1571818021	NC_000001.11:161306361:A:
NM_000530.8(MPZ):c.396_397del (p.Pro133fs)	MPZ	P133fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637795	1	161276549 - 161276550	1	161306759 - 161306760	637795	625031	rs1571818797	NC_000001.11:161306758:GAG:G
NM_000530.8(MPZ):c.223del (p.Asp75fs)	MPZ	D75fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637786	1	161277059	1	161307269	637786	625062	rs1571819824	NC_000001.11:161307268:C:
NM_000530.8(MPZ):c.560_566del (p.Gln187fs)	MPZ	Q187fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637779	1	161276137 - 161276143	1	161306347 - 161306353	637779	625008	rs1571817945	NC_000001.11:161306346:GCCGCCTGCC:GCC
NM_000530.8(MPZ):c.570del (p.Gln191fs)	MPZ	Q191fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637771	1	161276133	1	161306343	637771	625007	rs1571817919	NC_000001.11:161306342:C:
NM_000530.8(MPZ):c.560del (p.Gln187fs)	MPZ	Q187fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637770	1	161276143	1	161306353	637770	625009	rs1571817966	NC_000001.11:161306352:T:
NM_000530.8(MPZ):c.68-5_71del	MPZ		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637769	1	161277211 - 161277219	1	161307421 - 161307429	637769	625738	rs1571820401	NC_000001.11:161307420:AGCACTGCAAGCAC:AGCAC
NM_000530.8(MPZ):c.130_137del (p.Ser44fs)	MPZ	S44fs	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637764	1	161277145 - 161277152	1	161307355 - 161307362	637764	625084	rs1571820186	NC_000001.11:161307354:ACCCGGGA:
NM_000530.8(MPZ):c.290_293del (p.Glu97fs)	MPZ	E97fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637763	1	161276653 - 161276656	1	161306863 - 161306866	637763	625054	rs1571819196	NC_000001.11:161306862:CGCTC:C
NM_000530.8(MPZ):c.554del (p.Arg185fs)	MPZ	R185fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637756	1	161276149	1	161306359	637756	625010	rs1571817993	NC_000001.11:161306358:C:
NM_000530.8(MPZ):c.368_382del (p.Gly123_Cys127del)	MPZ		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637487	1	161276564 - 161276578	1	161306774 - 161306788	637487	625038	rs1571818858	NC_000001.11:161306773:CACAAGTGAACGTGCCA:CA
NM_000530.8(MPZ):c.550_552delinsG (p.Leu184fs)	MPZ	L184fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637357	1	161276151 - 161276153	1	161306361 - 161306363	637357	625012	rs1571818007	NC_000001.11:161306360:TAG:C
NM_000530.8(MPZ):c.149_151del (p.Cys50del)	MPZ	C50del	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637351	1	161277131 - 161277133	1	161307341 - 161307343	637351	625078	rs1553259792	NC_000001.11:161307340:AGCAG:AG
NM_000530.8(MPZ):c.553del (p.Arg185fs)	MPZ	R185fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637342	1	161276150	1	161306360	637342	625011	rs1571818002	NC_000001.11:161306359:G:
NM_000530.8(MPZ):c.626_630del (p.Ala209fs)	MPZ	A209fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637318	1	161275913 - 161275917	1	161306123 - 161306127	637318	625003	rs1571817499	NC_000001.11:161306122:CGACGCG:CG
NM_000530.8(MPZ):c.431del (p.Leu144fs)	MPZ	L144fs	Charcot-Marie-Tooth disease|MPZ-Related Disorders|Charcot-Marie-Tooth disease, type I	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2019)	criteria provided, conflicting interpretations	VCV000631569	1	161276515	1	161306725	631569	619958	rs1182353109	NC_000001.11:161306724:A:
NM_000530.8(MPZ):c.486del (p.Ile162fs)	MPZ	I162fs	Charcot-Marie-Tooth disease|Intellectual disability|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000625199	1	161276217	1	161306427	625199	613532	rs1571818248	NC_000001.11:161306426:G:
NM_000530.8(MPZ):c.77del (p.Pro26fs)	MPZ	P26fs	not provided|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000574580	1	161277205	1	161307415	574580	557014	rs1558154754	NC_000001.11:161307414:GGGG:GGG
NM_000530.8(MPZ):c.405_407del (p.Ile135_Val136delinsMet)	MPZ		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000531696	1	161276539 - 161276541	1	161306749 - 161306751	531696	515240	rs1553259646	NC_000001.11:161306748:ACTA:A
NM_000530.8(MPZ):c.434_437del (p.Tyr145fs)	MPZ	Y145fs	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000531677	1	161276509 - 161276512	1	161306719 - 161306722	531677	515228	rs1553259643	NC_000001.11:161306718:ACATACA:ACA
NM_000530.8(MPZ):c.305_310del (p.Val102_Gly103del)	MPZ		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000411667	1	161276636 - 161276641	1	161306846 - 161306851	411667	390862	rs1060503419	NC_000001.11:161306845:CCCCTACCC:CCC
NM_000530.8(MPZ):c.129_136del (p.Ser44fs)	MPZ	S44fs	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246122	1	161277146 - 161277153	1	161307356 - 161307363	246122	244256	rs760730366	NC_000001.11:161307355:CCCGGGAGCCC:CCC
NM_000530.8(MPZ):c.188_190del (p.Ser63del)	MPZ	S63del	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000246121	1	161277092 - 161277094	1	161307302 - 161307304	246121	244254	rs879254109	NC_000001.11:161307301:AGGAG:AG
NM_000530.8(MPZ):c.368_369delinsCT (p.Gly123Ala)	MPZ	G123A	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000237876	1	161276577 - 161276578	1	161306787 - 161306788	237876	238156	rs878854030	NC_000001.11:161306786:GC:AG
NM_000530.8(MPZ):c.646-10_650del	MPZ		Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000217234	1	161275763 - 161275777	1	161305973 - 161305987	217234	213792	rs863225026	NC_000001.11:161305972:GGCGTCTGGGGGAGGGGCG:GGCG
NM_000530.8(MPZ):c.306del (p.Asp104fs)	MPZ	D104fs	Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease	Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000041019	1	161276640	1	161306850	41019	49441	rs281865125	NC_000001.11:161306849:T:
NM_005797.4(MPZL2):c.463del (p.Ala155fs)	MPZL2	A155fs	Deafness, autosomal recessive 111	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV000689320	11	118130890	11	118260175	689320	676912	rs759432278	NC_000011.10:118260174:CC:C
NM_005797.4(MPZL2):c.72del (p.Ile24fs)	MPZL2	I24fs	Deafness, autosomal recessive 111|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000585268	11	118133799	11	118263084	585268	576318	rs752672077	NC_000011.10:118263083:T:
m.961delTinsC(2_7)	MT-RNR1		Aminoglycoside-induced deafness	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009629	MT	961	MT	961	9629	24668	rs1556422499	
NM_016156.6(MTMR2):c.1736_1745delinsCC (p.Tyr579fs)	MTMR2	Y507fs, Y579fs	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Sep 10, 2020)	no assertion criteria provided	VCV000993001	11	95569337 - 95569346	11	95836173 - 95836182	993001	980944		NC_000011.10:95836172:CTTATGTAAT:GG
NM_016156.6(MTMR2):c.358-42_358-18del	MTMR2		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916895	11	95595284 - 95595308	11	95862120 - 95862144	916895	905646		NC_000011.10:95862119:AAATAATTAAAACTGAGCAATTAATA:A
NM_016156.6(MTMR2):c.358-39_358-16del	MTMR2		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916894	11	95595282 - 95595305	11	95862118 - 95862141	916894	905645		NC_000011.10:95862117:AAAAATAATTAAAACTGAGCAATTAA:AA
NM_016156.6(MTMR2):c.766_767del (p.Lys256fs)	MTMR2	K184fs, K256fs	Charcot-Marie-Tooth disease, type 4B1	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804461	11	95583801 - 95583802	11	95850637 - 95850638	804461	792785	rs769429967	NC_000011.10:95850636:TTT:T
NM_016156.6(MTMR2):c.841_844del (p.Ile281fs)	MTMR2	I209fs, I281fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637809	11	95582987 - 95582990	11	95849823 - 95849826	637809	625265	rs1590983942	NC_000011.10:95849822:TGATTG:TG
NM_016156.6(MTMR2):c.1534del (p.Leu512fs)	MTMR2	L440fs, L512fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637807	11	95571317	11	95838153	637807	625262	rs1590970977	NC_000011.10:95838152:GG:G
NM_016156.6(MTMR2):c.324del (p.Asn109fs)	MTMR2	N37fs, N109fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637805	11	95595469	11	95862305	637805	625266	rs1590997478	NC_000011.10:95862304:C:
NM_016156.6(MTMR2):c.1770+7_1770+19delinsC	MTMR2		not specified|Charcot-Marie-Tooth disease	Likely benign(Last reviewed: Feb 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418333	11	95569293 - 95569305	11	95836129 - 95836141	418333	408497	rs1555056865	NC_000011.10:95836128:TATATTGTAAGGC:G
MTMR2, 10-BP DEL/2-BP INS	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006235					6235	21274		
MYH9, 18-BP DEL, NT228	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000014086					14086	29125		
NM_002473.6(MYH9):c.3195_3215del (p.Gln1068_Leu1074del)	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014084	22	36692946 - 36692966	22	36296900 - 36296920	14084	29123	rs876661302	NC_000022.11:36296899:GCGATCTGGGCCTGGAGCTCGGCGATCTGG:GCGATCTGG
NM_002473.6(MYH9):c.5821del (p.Asp1941fs)	MYH9	D1941fs	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 16, 2015)	no assertion criteria provided	VCV000014080	22	36678776	22	36282730	14080	29119	rs587776808	NC_000022.11:36282729:CCCC:CCC
NM_016239.4(MYO15A):c.10585del (p.Leu3529fs)	MYO15A	L3529fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000984793	17	18082174	17	18178860	984793	972891		NC_000017.11:18178859:CCC:CC
NM_016239.4(MYO15A):c.9612+9_10082del	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000930034	17	18066001 - 18071036	17	18162687 - 18167722	930034	918421		
NM_016239.4(MYO15A):c.3006del (p.Lys1003fs)	MYO15A	K1003fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV000929937	17	18025119	17	18121805	929937	918410		NC_000017.11:18121804:CC:C
NM_016239.4(MYO15A):c.7745_8224+177delinsCTCCCCGGAACGGCTGCTGGTAC	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813827	17	18054799 - 18058246	17	18151485 - 18154932	813827	802078		
NM_016239.4(MYO15A):c.346_376del (p.Gly116fs)	MYO15A	G116fs	Deafness, autosomal recessive 3	Likely pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800766	17	18022458 - 18022488	17	18119144 - 18119174	800766	788906	rs1597747826	NC_000017.11:18119143:GTGGCTACGGCCGCCTGCGGCCGCGCGCCCGGT:GT
NM_016239.4(MYO15A):c.5492del (p.Gly1831fs)	MYO15A	G1831fs	Deafness, autosomal recessive 3	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000632272	17	18044416	17	18141102	632272	620575	rs747371923	NC_000017.11:18141101:GGG:GG
NM_016239.4(MYO15A):c.3026del (p.Pro1009fs)	MYO15A	P1009fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000506256	17	18025137	17	18121823	506256	497269	rs1555539827	NC_000017.11:18121822:CCCC:CCC
NM_016239.4(MYO15A):c.2311del (p.Ser771fs)	MYO15A	S771fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000504879	17	18024425	17	18121111	504879	497699	rs754865266	NC_000017.11:18121110:T:
NM_016239.4(MYO15A):c.1137del (p.Tyr380fs)	MYO15A	Y380fs	Deafness, autosomal recessive 3|Hearing impairment|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000500061	17	18023248	17	18119934	500061	491485	rs769260536	NC_000017.11:18119933:CCCC:CCC
NM_016239.4(MYO15A):c.7184_7185del (p.Leu2394_Phe2395insTer)	MYO15A		not provided|Rare genetic deafness	Pathogenic(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451626	17	18052865 - 18052866	17	18149551 - 18149552	451626	445719	rs1415858976	NC_000017.11:18149550:TTT:T
NM_016239.4(MYO15A):c.7124_7127del (p.Asp2375fs)	MYO15A	D2375fs	Deafness, autosomal recessive 3|Congenital sensorineural hearing impairment|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jul 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000435919	17	18052803 - 18052806	17	18149489 - 18149492	435919	429949	rs780170125	NC_000017.11:18149488:CAGACAG:CAG
NM_016239.4(MYO15A):c.5335del (p.Leu1779fs)	MYO15A	L1779fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242332	17	18043953	17	18140639	242332	243886	rs878854413	NC_000017.11:18140638:CC:C
NM_016239.4(MYO15A):c.5851del (p.Ser1951fs)	MYO15A	S1951fs	Rare genetic deafness|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000179619	17	18046095	17	18142781	179619	176463	rs727504995	NC_000017.11:18142780:A:
NM_016239.4(MYO15A):c.7226del (p.Pro2409fs)	MYO15A	P2409fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Aug 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000164548	17	18053755	17	18150441	164548	176612	rs727503315	NC_000017.11:18150440:CC:C
NM_016239.4(MYO15A):c.8100del (p.Lys2701fs)	MYO15A	K2701fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000045765	17	18057453	17	18154139	45765	54930	rs397517287	NC_000017.11:18154138:CCCC:CCC
NM_016239.4(MYO15A):c.9958_9961del (p.Asp3320fs)	MYO15A	D3320fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006962	17	18070911 - 18070914	17	18167597 - 18167600	6962	22001	rs1567664131	NC_000017.11:18167596:CTGACT:CT
NM_016239.4(MYO15A):c.10573del (p.Ser3525fs)	MYO15A	S3525fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006961	17	18082164	17	18178850	6961	22000	rs1270302810	NC_000017.11:18178849:A:
NM_016239.4(MYO15A):c.3336del (p.Arg1113fs)	MYO15A	R1113fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000006958	17	18025448	17	18122134	6958	21997	rs769884586	NC_000017.11:18122133:GGG:GG
NM_017433.5(MYO3A):c.1370_1371del (p.Arg457fs)	MYO3A	R457fs	Deafness, autosomal recessive 30|Sensorineural hearing loss|not provided	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000655296	10	26377141 - 26377142	10	26088212 - 26088213	655296	638842	rs760866131	NC_000010.11:26088211:AGA:A
NM_017433.5(MYO3A):c.555del (p.Ser185_Val186insTer)	MYO3A		Deafness, autosomal recessive 30	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000631631	10	26305794	10	26016865	631631	620354	rs773432148	NC_000010.11:26016864:CC:C
NM_017433.5(MYO3A):c.3499del (p.Ser1167fs)	MYO3A	S1167fs	Deafness, autosomal recessive 30	Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000618746	10	26462691	10	26173762	618746	609748	rs752046945	NC_000010.11:26173761:TT:T
NM_004999.4(MYO6):c.78del (p.Asp27fs)	MYO6	D27fs	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000930134	6	76527339	6	75817622	930134	918287		NC_000006.12:75817621:CCCC:CCC
NM_004999.4(MYO6):c.3765del (p.Cys1256fs)	MYO6	C1243fs, C1228fs, C1233fs, C1265fs, C1224fs, C1256fs	Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813826	6	76624636	6	75914919	813826	802074	rs1582024232	NC_000006.12:75914918:C:
NM_004999.4(MYO6):c.258_259delinsCTTTACTAAA (p.Tyr87fs)	MYO6	Y87fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000667412	6	76538327 - 76538328	6	75828610 - 75828611	667412	654466	rs1583208411	NC_000006.12:75828609:TT:CTTTACTAAA
NM_004999.4(MYO6):c.1473_1473+2delinsC	MYO6		Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236034	6	76568710 - 76568712	6	75858993 - 75858995	236034	237602	rs878853225	NC_000006.12:75858992:GGT:C
NM_004999.4(MYO6):c.2814_2815del (p.Arg939fs)	MYO6	R934fs, R939fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228375	6	76599926 - 76599927	6	75890209 - 75890210	228375	229525	rs876657709	NC_000006.12:75890208:AAAAA:AAA
NM_004999.4(MYO6):c.3207_3212delinsATCCTACATACTTAAAATTTCTT (p.Ala1070fs)	MYO6	A1079fs, A1066fs, A1070fs, A1047fs, A1042fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	VCV000179643	6	76617352 - 76617357	6	75907635 - 75907640	179643	174151	rs727505015	NC_000006.12:75907634:TGCTGG:ATCCTACATACTTAAAATTTCTT
NM_000260.4(MYO7A):c.3886del (p.Arg1296fs)	MYO7A	R1285fs, R1296fs	Deafness, autosomal recessive 2	Likely pathogenic	no assertion criteria provided	VCV001184511	11	76901876	11	77190831	1184511	1174316		NC_000011.10:77190830:CC:C
NM_000260.4(MYO7A):c.1798-7_1800delinsATCGGCTGCT	MYO7A		not provided|Usher syndrome type 1|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000929939	11	76883787 - 76883796	11	77172741 - 77172750	929939	918364		NC_000011.10:77172740:CCCCCAGGGC:ATCGGCTGCT
NM_000260.4(MYO7A):c.2355del (p.Asn786fs)	MYO7A	N775fs, N786fs	Usher syndrome type 1	Likely pathogenic	criteria provided, single submitter	VCV000813429	11	76890163	11	77179117	813429	801713	rs1591369118	NC_000011.10:77179116:G:
NM_000260.4(MYO7A):c.1085_1086del (p.Asn362fs)	MYO7A	N351fs, N362fs	Usher syndrome type 1	Likely pathogenic	criteria provided, single submitter	VCV000813427	11	76871213 - 76871214	11	77160167 - 77160168	813427	801711	rs1591286221	NC_000011.10:77160166:AC:
NM_000260.4(MYO7A):c.4996_4997del (p.Ser1666fs)	MYO7A	S1617fs, S1628fs, S1666fs	Usher syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812101	11	76912636 - 76912637	11	77201591 - 77201592	812101	800360	rs1591467894	NC_000011.10:77201590:AG:
NC_000011.10:g.77147798del	MYO7A		Deafness, autosomal dominant 11	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800972	11	76858843	11	77147797	800972	788859	rs1591224147	NC_000011.10:77147796:GG:G
NM_000260.4(MYO7A):c.2339del (p.Gly780fs)	MYO7A	G769fs, G780fs	Deafness, autosomal recessive 2|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562093	11	76890144	11	77179098	562093	553266	rs1565402473	NC_000011.10:77179097:GGGG:GGG
NM_000260.4(MYO7A):c.4108_4111del (p.Gln1370fs)	MYO7A	Q1359fs, Q1370fs	Deafness, autosomal recessive 2|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557834	11	76903278 - 76903281	11	77192233 - 77192236	557834	546793	rs1480697910	NC_000011.10:77192232:GCAGG:G
NM_000260.4(MYO7A):c.5632del (p.Ala1877_Leu1878insTer)	MYO7A		not provided|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556569	11	76916656	11	77205611	556569	546838	rs1299898646	NC_000011.10:77205610:CCC:CC
NM_000260.4(MYO7A):c.4642del (p.Gly1547_Leu1548insTer)	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555107	11	76910653	11	77199608	555107	546814	rs1555100273	NC_000011.10:77199607:C:
NM_000260.4(MYO7A):c.4254del (p.Asp1419fs)	MYO7A	D1419fs, D1408fs	Deafness, autosomal recessive 2|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552398	11	76905497	11	77194452	552398	546469	rs1555096070	NC_000011.10:77194451:CCCC:CCC
NM_000260.4(MYO7A):c.4024del (p.Trp1342fs)	MYO7A	W1331fs, W1342fs	Deafness, autosomal recessive 2|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551642	11	76903195	11	77192150	551642	546790	rs1555093028	NC_000011.10:77192149:T:
NM_000260.4(MYO7A):c.4838del (p.Asp1613fs)	MYO7A	D1575fs, D1613fs, D1564fs	Usher syndrome|Deafness, autosomal recessive|not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000438178	11	76910849	11	77199804	438178	431767	rs1199012623	NC_000011.10:77199803:A:
NM_000260.4(MYO7A):c.2307del (p.Asn769fs)	MYO7A	N758fs, N769fs	Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000402264	11	76890115	11	77179069	402264	389240	rs1060499800	NC_000011.10:77179068:C:
NM_000260.4(MYO7A):c.5845_5855del (p.Ile1949fs)	MYO7A	I1911fs, I1949fs, I1900fs	Rare genetic deafness	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000228380	11	76918436 - 76918446	11	77207389 - 77207399	228380	230248	rs876657713	NC_000011.10:77207388:AAATTGCAGACAA:AA
NM_000260.4(MYO7A):c.4555del (p.Val1519fs)	MYO7A	V1508fs, V1519fs	Rare genetic deafness	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000228379	11	76909653	11	77198608	228379	230242	rs876657712	NC_000011.10:77198607:G:
NM_000260.4(MYO7A):c.223del (p.Asp75fs)	MYO7A	D64fs, D75fs	Usher syndrome type 1	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226431	11	76858930	11	77147884	226431	228233	rs876657415	NC_000011.10:77147883:GGGGG:GGGG
NC_000011.10:g.(?_77212952)_(77214696_?)del	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Sep 22, 2013)	criteria provided, single submitter	VCV000179327	11	76923997 - 76925741	11	77212952 - 77214696	179327	174722		
NM_000260.4(MYO7A):c.3564_3571delinsA (p.Tyr1188_Gly1191delinsTer)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000179061	11	76900449 - 76900456	11	77189404 - 77189411	179061	178260	rs797044513	NC_000011.10:77189403:TGCCCGGG:A
NM_000260.4(MYO7A):c.973_976del (p.Ile325fs)	MYO7A	I314fs, I325fs	Rare genetic deafness	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000164663	11	76869444 - 76869447	11	77158398 - 77158401	164663	176879	rs797044490	NC_000011.10:77158397:CCATCC:CC
NM_000260.4(MYO7A):c.6025del (p.Ala2009fs)	MYO7A	A1971fs, A1960fs, A2009fs	Rare genetic deafness|Retinal dystrophy|Usher syndrome type 1|not provided|Usher syndrome type 1B|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043313	11	76919821	11	77208776	43313	52483	rs397516326	NC_000011.10:77208775:GG:G
NM_000260.4(MYO7A):c.582del (p.Ile195fs)	MYO7A	I184fs, I195fs	Rare genetic deafness	Pathogenic(Last reviewed: Jan 16, 2012)	criteria provided, single submitter	VCV000043301	11	76867813	11	77156767	43301	52471	rs111033238	NC_000011.10:77156766:CCCCC:CCCC
NM_000260.4(MYO7A):c.496del (p.Glu166fs)	MYO7A	E166fs, E155fs	not provided|Deafness, autosomal recessive|Rare genetic deafness	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043266	11	76867730	11	77156684	43266	52436	rs111033448	NC_000011.10:77156683:GG:G
NM_000260.4(MYO7A):c.4544_4551delinsCA (p.Glu1515_Met1517delinsAla)	MYO7A		Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043245	11	76909642 - 76909649	11	77198597 - 77198604	43245	52415	rs111033259	NC_000011.10:77198596:AGATCATG:CA
NM_000260.4(MYO7A):c.4065del (p.His1355fs)	MYO7A	H1344fs, H1355fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	VCV000043232	11	76903236	11	77192191	43232	52402	rs111033202	NC_000011.10:77192190:C:
NM_000260.4(MYO7A):c.3764del (p.Lys1255fs)	MYO7A	K1244fs, K1255fs	Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000043223	11	76901754	11	77190709	43223	52393	rs111033347	NC_000011.10:77190708:AA:A
NM_000260.4(MYO7A):c.3696_3706del (p.Arg1232fs)	MYO7A	R1221fs, R1232fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 23, 2010)	criteria provided, single submitter	VCV000043217	11	76901130 - 76901140	11	77190084 - 77190094	43217	52387	rs397516303	NC_000011.10:77190083:GAAGGACCTTTG:G
NM_000260.4(MYO7A):c.3532del (p.Gln1178fs)	MYO7A	Q1167fs, Q1178fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	VCV000043209	11	76900417	11	77189372	43209	52379	rs111033239	NC_000011.10:77189371:C:
NM_000260.3(MYO7A):c.3503+12_3503+33delGAGGCGGGGACACCAGGGCCTG	MYO7A		Deafness, autosomal recessive 2|not specified|Nonsyndromic hearing loss and deafness|not provided	Benign(Last reviewed: Sep 28, 2018)	reviewed by expert panel	VCV000043207	11	76895772 - 76895793	11	77184726 - 77184747	43207	52377	rs111033223	NC_000011.10:77184725:GGAGGCGGGGACACCAGGGCCTG:G
NM_000260.4(MYO7A):c.3327del (p.His1109fs)	MYO7A	H1098fs, H1109fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 7, 2010)	criteria provided, single submitter	VCV000043202	11	76894154	11	77183109	43202	52372	rs111033433	NC_000011.10:77183108:C:
NM_000260.4(MYO7A):c.2172del (p.Lys725fs)	MYO7A	K714fs, K725fs	Rare genetic deafness	Pathogenic(Last reviewed: May 19, 2010)	criteria provided, single submitter	VCV000043174	11	76886494	11	77175448	43174	52344	rs397516294	NC_000011.10:77175447:CC:C
NM_000260.3(MYO7A):c.1556delG (p.Gly519Alafs)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Apr 8, 2010)	criteria provided, single submitter	VCV000043152	11	76873898	11	77162852	43152	52322	rs606231379	NC_000011.10:77162851:GGG:GG
MYO7A, 9-BP DEL, EX22	MYO7A		Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011857					11857	26896		
NM_006096.4(NDRG1):c.-18-2_-18-1del	NDRG1		Charcot-Marie-Tooth disease|not provided	Benign/Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000917391	8	134296573 - 134296574	8	133284330 - 133284331	917391	905612		NC_000008.11:133284329:CT:
NM_006096.4(NDRG1):c.756-5_756-4delinsTG	NDRG1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917156	8	134260173 - 134260174	8	133247930 - 133247931	917156	905606		NC_000008.11:133247929:GG:CA
NM_006096.4(NDRG1):c.1053_1082del (p.340TRSRSHTSEG[2])	NDRG1		Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4D|Charcot-Marie-Tooth disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2020)	criteria provided, conflicting interpretations	VCV000639524	8	134251224 - 134251253	8	133238981 - 133239010	639524	564664	rs751274009	NC_000008.11:133238980:CGGGTGCCCTCGCTGGTGTGGGAGCGGCTTCGGGTGCCCTCGCTGGTGTGGGAGCGGCT:CGGGTGCCCTCGCTGGTGTGGGAGCGGCT
NC_000008.10:g.(?_24810313)_(24811829_?)del	NEFL		Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001015497	8	24810313 - 24811829			1015497	1001578		
NM_006158.5(NEFL):c.999_1004delinsTGTCG (p.Gln334fs)	NEFL	Q334fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916804	8	24813026 - 24813031	8	24955512 - 24955517	916804	905226		NC_000008.11:24955511:TCCTGC:CGACA
NM_006158.5(NEFL):c.1039_1040del (p.Met347fs)	NEFL	M347fs	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916802	8	24812990 - 24812991	8	24955476 - 24955477	916802	905224		NC_000008.11:24955475:ATA:A
NM_006158.5(NEFL):c.1413del (p.Ser472fs)	NEFL	S472fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694999	8	24811065	8	24953552	694999	683010	rs11300136	NC_000008.11:24953551:GGGGGG:GGGGG
NM_006158.5(NEFL):c.1414del (p.Ser472fs)	NEFL	S472fs	Charcot-Marie-Tooth disease|Distal spinal muscular atrophy	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694998	8	24811064	8	24953551	694998	683009	rs780764641	NC_000008.11:24953550:A:
NM_006158.5(NEFL):c.1438_1440delinsAGA (p.Glu480Arg)	NEFL	E480R	Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000663136	8	24811038 - 24811040	8	24953525 - 24953527	663136	637025	rs1586126391	NC_000008.11:24953524:CTC:TCT
NM_006158.5(NEFL):c.338_339delinsCC (p.Gln113Pro)	NEFL	Q113P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000464926	8	24813691 - 24813692	8	24956177 - 24956178	464926	458664	rs1554497641	NC_000008.11:24956176:CT:GG
NM_006158.4(NEFL):c.78_81delinsTTCT (p.Ile26_Ser27=)	NEFL		Charcot-Marie-Tooth disease type 2E	Likely benign(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000417205	8	24813949 - 24813952	8	24956435 - 24956438	417205	396778	rs1060504999	NC_000008.11:24956434:GGAG:AGAA
NM_006158.5(NEFL):c.*407_*408del	NEFL		Charcot-Marie-Tooth disease, type I	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362638	8	24809915 - 24809916	8	24952402 - 24952403	362638	305003	rs144391096	NC_000008.11:24952401:TAT:T
NM_006158.5(NEFL):c.*565del	NEFL		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362634	8	24809758	8	24952245	362634	304992	rs886062833	NC_000008.11:24952244:AAAAAAAA:AAAAAAA
NM_006158.5(NEFL):c.*1340_*1342del	NEFL		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362622	8	24808981 - 24808983	8	24951468 - 24951470	362622	313936	rs886062829	NC_000008.11:24951467:TTCTT:TT
NM_006158.5(NEFL):c.*1609_*1612del	NEFL		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362618	8	24808711 - 24808714	8	24951198 - 24951201	362618	304958	rs886062826	NC_000008.11:24951197:TTCAT:T
NM_006158.5(NEFL):c.22_23delinsAG (p.Pro8Arg)	NEFL	P8R	Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|not provided	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000014030	8	24814007 - 24814008	8	24956493 - 24956494	14030	29069	rs60261494	NC_000008.11:24956492:GG:CT
NM_002506.3(NGF):c.681_682del (p.Ala228fs)	NGF|NGF-AS1	A228fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637471	1	115828735 - 115828736	1	115286114 - 115286115	637471	624882	rs1571069258	NC_000001.11:115286113:CC:
NM_004895.4(NLRP3):c.*328_*331del	NLRP3		Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome|Chronic infantile neurological, cutaneous and articular syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000296958	1	247612132 - 247612135	1	247448830 - 247448833	296958	282015	rs1057515460	NC_000001.11:247448829:CTAACT:CT
NM_004895.4(NLRP3):c.*324_*327del	NLRP3		Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome|Chronic infantile neurological, cutaneous and articular syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000296957	1	247612127 - 247612130	1	247448825 - 247448828	296957	281901	rs886506882	NC_000001.11:247448824:TCTGTCT:TCT
NM_001243133.2(NLRP3):c.*177del	NLRP3		Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000296955	1	247611982	1	247448680	296955	282014	rs796764638	NC_000001.11:247448679:CC:C
NOG, 1-BP DEL	NOG		Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006701					6701	21740		
NM_002529.4(NTRK1):c.924_930del (p.Gln308fs)	NTRK1	Q278fs, Q308fs	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000637912	1	156843494 - 156843500	1	156873702 - 156873708	637912	624976	rs1571695851	NC_000001.11:156873701:GGCAGCCGGCA:GGCA
NM_002529.4(NTRK1):c.543del (p.Leu183fs)	NTRK1	L153fs, L183fs	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000637814	1	156838008	1	156868216	637814	624974	rs1485714154	NC_000001.11:156868215:GGG:GG
NM_002529.4(NTRK1):c.1754del (p.Leu585fs)	NTRK1	L579fs, L549fs, L585fs	Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV000637429	1	156846313	1	156876521	637429	624983	rs1571699945	NC_000001.11:156876520:T:
NM_002529.4(NTRK1):c.354_359+3del	NTRK1		Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000637368	1	156834585 - 156834593	1	156864793 - 156864801	637368	625727	rs1571685736	NC_000001.11:156864792:GTCGCCTGTG:G
NM_130837.3(OPA1):c.1728_1734del (p.Glu576fs)	OPA1	E397fs, E398fs, E485fs, E503fs, E521fs, E522fs, E539fs, E540fs, E558fs, E576fs	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Likely pathogenic	no assertion criteria provided	VCV001184586	3	193363563 - 193363569	3	193645774 - 193645780	1184586	1174266		NC_000003.12:193645773:GTTTTTT:
NM_130837.3(OPA1):c.2287del (p.Ser763fs)	OPA1	S584fs, S585fs, S672fs, S690fs, S708fs, S709fs, S726fs, S727fs, S745fs, S763fs	not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Abortive cerebellar ataxia|Autosomal dominant optic atrophy classic form	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000973235	3	193374975	3	193657186	973235	961599		NC_000003.12:193657185:AAA:AA
NM_130837.3(OPA1):c.113_130del (p.Arg38_Ser43del)	OPA1		not provided|Abortive cerebellar ataxia|not specified|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|EMG: myotonic runs|Muscle weakness|Elevated serum creatine phosphokinase|Progressive proximal muscle weakness|Hypomimic face|Hepatic steatosis|EMG abnormality|EMG: myopathic abnormalities|Ptosis	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2021)	criteria provided, conflicting interpretations	VCV000214916	3	193332587 - 193332604	3	193614798 - 193614815	214916	210979	rs863224140	NC_000003.12:193614797:TTCACGAAGCATTTATCATTCAC:TTCAC
NM_130837.3(OPA1):c.3013_3014del (p.Asp1005fs)	OPA1	D827fs, D932fs, D969fs, D987fs, D1005fs, D826fs, D914fs, D950fs, D951fs, D968fs	Autosomal dominant optic atrophy classic form|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000005092	3	193409881 - 193409882	3	193692092 - 193692093	5092	20131	rs879255513	NC_000003.12:193692091:GA:
NM_015560.2(OPA1):c.2708_2711delTTAG	OPA1		Autosomal dominant optic atrophy classic form|Mitochondrial disease|Abortive cerebellar ataxia|Retinal dystrophy|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005082	3	193384957 - 193384960	3	193667168 - 193667171	5082	20121	rs80356530	NC_000003.12:193667167:AGTTAG:AG
NM_025136.4(OPA3):c.206_258del (p.Lys69fs)	OPA3	K69fs	Optic atrophy 3|3-Methylglutaconic aciduria type 3	Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001066277	19	46057054 - 46057106	19	45553796 - 45553848	1066277	1056585		
NM_025136.4(OPA3):c.143-2_143-1delinsCC	OPA3		Optic atrophy 3|3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000952107	19	46057170 - 46057171	19	45553912 - 45553913	952107	941234		NC_000019.10:45553911:CT:GG
NC_000019.10:g.(?_45584613)_(45584774_?)del	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy 3	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000831267	19	46087871 - 46088032			831267	821265		
NC_000019.10:g.(?_45553504)_(45553921_?)del	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy 3	Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830708	19	46056762 - 46057179			830708	821264		
NM_144498.4(OSBPL2):c.141_142del (p.Arg50fs)	OSBPL2	R50fs, R38fs	Deafness, autosomal dominant 67	Pathogenic(Last reviewed: Feb 10, 2015)	no assertion criteria provided	VCV000190111	20	60835140 - 60835141	20	62260084 - 62260085	190111	187946	rs786205881	NC_000020.11:62260083:TG:
NM_144672.4(OTOA):c.1765del (p.Gln589fs)	OTOA	Q265fs, Q589fs, Q510fs	Deafness, autosomal recessive 22|Rare genetic deafness	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000684616	16	21730783	16	21719462	684616	672206	rs775776282	NC_000016.10:21719461:CC:C
NM_144672.4(OTOA):c.2295del (p.Thr766fs)	OTOA	T687fs, T766fs, T442fs	Deafness, autosomal recessive 22	Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000623202	16	21742244	16	21730923	623202	612162	rs774366025	NC_000016.10:21730922:CC:C
NM_144672.3(OTOA):c.(?_-46)_(2431_?)+58del	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000505764	16	21689790 - 21747769	16	21678469 - 21736448	505764	497253		
NM_144672.4(OTOA):c.828del (p.Ser277fs)	OTOA	S198fs, S277fs	Deafness, autosomal recessive 22|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000402235	16	21709183	16	21697862	402235	389206	rs751447996	NC_000016.10:21697861:TT:T
NM_144672.4(OTOA):c.746_751delinsA (p.Ser249fs)	OTOA	S249fs, S170fs	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228383	16	21709102 - 21709107	16	21697781 - 21697786	228383	230618	rs876657716	NC_000016.10:21697780:CTGCTT:A
NC_000016.10:g.(?_21678515)_(21760540_?)del	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000178863	16	21689836 - 21771861	16	21678515 - 21760540	178863	176001		
NM_144672.3(OTOA):c.(?_2302)_(2431_?)del (p.(?))	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Feb 27, 2014)	criteria provided, single submitter	VCV000164814	16	21747582 - 21747711	16	21736261 - 21736390	164814	175913		
OTOA, 500-KB DEL	OTOA		Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000003561					3561	18600		
NM_194248.3(OTOF):c.1392+1del	OTOF		Bilateral sensorineural hearing impairment	Pathogenic	criteria provided, single submitter	VCV001185579	2	26706329	2	26483461	1185579	1175552		NC_000002.12:26483460:CC:C
NM_194248.3(OTOF):c.839del (p.Gly280fs)	OTOF	G280fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000929941	2	26717868	2	26495000	929941	918484		NC_000002.12:26494999:CCC:CC
NM_194248.3(OTOF):c.1946_1965del (p.Arg649fs)	OTOF	R649fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446439	2	26702469 - 26702488	2	26479601 - 26479620	446439	439896	rs1553353527	NC_000002.12:26479600:GGGCCGAGGCCGCTGGGGCCGGG:GGG
NM_194248.3(OTOF):c.*129del	OTOF	L1976fs, L1209fs	Nonsyndromic hearing loss and deafness|Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000180120	2	26680977	2	26458109	180120	173634	rs727505359	NC_000002.12:26458108:CCCC:CCC
NM_194248.3(OTOF):c.3178del (p.Ala1060fs)	OTOF	A313fs, A370fs, A1060fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 1, 2013)	criteria provided, single submitter	VCV000179115	2	26697491	2	26474623	179115	173509	rs727504639	NC_000002.12:26474622:CC:C
NM_194248.3(OTOF):c.5925del (p.Leu1976fs)	OTOF	L1976fs, L1209fs, L1286fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000177793	2	26682962	2	26460094	177793	173635	rs111033384	NC_000002.12:26460093:C:
NM_194248.3(OTOF):c.5203del (p.Arg1735fs)	OTOF	R968fs, R1735fs, R1045fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000164835	2	26685039	2	26462171	164835	173637	rs727503352	NC_000002.12:26462170:G:
NM_194248.3(OTOF):c.2905_2923delinsCTCCGAGCGCA (p.Ala969fs)	OTOF	A222fs, A279fs, A969fs	Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Likely pathogenic	criteria provided, single submitter	VCV000065794	2	26698850 - 26698868	2	26475982 - 26476000	65794	76702	rs397515596	NC_000002.12:26475981:CGGCAAAGAGGCTGCGGGC:TGCGCTCGGAG
NM_194248.3(OTOF):c.1966del (p.Arg656fs)	OTOF	R656fs	not provided|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV000065786	2	26702468	2	26479600	65786	76694	rs397515590	NC_000002.12:26479599:GGGG:GGG
NM_194248.3(OTOF):c.1552_1567del (p.Arg518fs)	OTOF	R518fs	Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Pathogenic	criteria provided, single submitter	VCV000065777	2	26705286 - 26705301	2	26482418 - 26482433	65777	76685	rs1443739332	NC_000002.12:26482417:CATTAGAAATCTTGCGCA:CA
NM_194248.3(OTOF):c.5575_5576del (p.Lys1859fs)	OTOF	K1092fs, K1169fs, K1859fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 3, 2009)	no assertion criteria provided	VCV000048264	2	26683856 - 26683857	2	26460988 - 26460989	48264	57428	rs111033446	NC_000002.12:26460987:TTT:T
NM_194248.3(OTOF):c.2348del (p.Gly783fs)	OTOF	G783fs, G93fs, G36fs	Rare genetic deafness|Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, multiple submitters, no conflicts	VCV000021834	2	26700342	2	26477474	21834	34686	rs80356591	NC_000002.12:26477473:CCC:CC
NM_001292063.2(OTOG):c.2561+1del	OTOG		Deafness, autosomal recessive 18b	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000977076	11	17598177	11	17576630	977076	965209		NC_000011.10:17576629:GG:G
NM_001277269.1(OTOG):c.(?_3914)-61_(6474_?)+67del	OTOG		Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000505208	11	17627343 - 17634379	11	17605796 - 17612832	505208	497153		
NM_001292063.2(OTOG):c.499del (p.Val167fs)	OTOG	V167fs	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228284	11	17575024	11	17553477	228284	230048	rs876657657	NC_000011.10:17553476:GG:G
NM_001292063.2(OTOG):c.5472del (p.Ala1826fs)	OTOG	A1826fs, A1838fs	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039817	11	17632316	11	17610769	39817	48416	rs1029389440	NC_000011.10:17610768:CCCC:CCC
NM_001378609.3(OTOGL):c.4341del (p.Met1447fs)	OTOGL	M1402fs, M1447fs	Rare genetic deafness|not provided	Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817774	12	80722892	12	80329112	817774	805757	rs766971906	NC_000012.12:80329111:G:
NM_173591.3:c.825_4834-43del	OTOGL		Rare genetic deafness	Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000667428	12	80632665 - 80732812			667428	654987		
NM_001378609.3(OTOGL):c.5020_5024del (p.Asn1674fs)	OTOGL	N1629fs, N1674fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000667384	12	80733012 - 80733016	12	80339232 - 80339236	667384	654731	rs1592726662	NC_000012.12:80339231:TTAACTT:TT
NM_173591.3(OTOGL):c.(?_6305)-71_*(79_?)del	OTOGL		Rare genetic deafness	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000517528	12	80761270 - 80771907	12	80367490 - 80378127	517528	497408		
NM_001378609.3(OTOGL):c.5341del (p.Ser1781fs)	OTOGL	S1736fs, S1781fs	Rare genetic deafness	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000505326	12	80746148	12	80352368	505326	497655	rs772723774	NC_000012.12:80352367:TTT:TT
NM_173591.3(OTOGL):c.(?_2657)_(4690_?)del	OTOGL		Rare genetic deafness	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000505207	12	80671950 - 80730309	12	80278170 - 80336529	505207	497628		
NM_001378609.3(OTOGL):c.975del (p.Leu325fs)	OTOGL	L325fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000228385	12	80633142	12	80239362	228385	230353	rs766753922	NC_000012.12:80239361:G:
NM_001378609.3(OTOGL):c.841_842del (p.Met281fs)	OTOGL	M272fs, M281fs	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228285	12	80632653 - 80632654	12	80238873 - 80238874	228285	230349	rs876657658	NC_000012.12:80238872:TAT:T
NM_001378609.3(OTOGL):c.1457del (p.Val486fs)	OTOGL	V486fs	Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039778	12	80648835	12	80255055	39778	48377	rs1233562246	NC_000012.12:80255054:T:
NC_000002.12:g.(?_222201051)_(222295679_?)del	PAX3		Rare genetic deafness	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000667019	2	223065770 - 223160398			667019	654974		
NM_001127366.2(PAX3):c.(?_-77)_(583_?)+547del	PAX3|CCDC140|LOC107980445		Rare genetic deafness|Waardenburg syndrome	Pathogenic(Last reviewed: Oct 7, 2015)	criteria provided, single submitter	VCV000228386	2	223158339 - 223163411	2	222293620 - 222298692	228386	228526		
NM_001384140.1(PCDH15):c.4368-3107del	PCDH15	Q1395fs, Q1424fs, Q1441fs, Q1442fs, Q1444fs, Q1461fs, Q1464fs, Q1466fs, Q1471fs	Deafness, autosomal recessive 23	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210450	10	55583097	10	53823337	1210450	1200450		NC_000010.11:53823336:AAAA:AAA
NM_001384140.1(PCDH15):c.3667_3668del (p.Ile1223fs)	PCDH15	I1152fs, I1186fs, I1201fs, I1223fs, I1228fs, I1230fs, I1235fs	Deafness, autosomal recessive 23|Usher syndrome type 1D|Usher syndrome type 1F	Pathogenic(Last reviewed: Oct 1, 2020)	no assertion criteria provided	VCV001027565	10	55626451 - 55626452	10	53866691 - 53866692	1027565	1015323		NC_000010.11:53866690:ATA:A
NC_000010.10:g.(55839185_55849743)_(55892768_55912859)del	PCDH15		Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619174	10	55839185 - 55912859	10	54079425 - 54153099	619174	610569		
NM_001384140.1(PCDH15):c.3502-10del	PCDH15		Retinitis pigmentosa-deafness syndrome|not provided|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000300180	10	55626627	10	53866867	300180	310529	rs750835578	NC_000010.11:53866866:GGGG:GGG
NM_001384140.1(PCDH15):c.4368-1360_4368-1359del	PCDH15		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300160	10	55581349 - 55581350	10	53821589 - 53821590	300160	315636	rs886047056	NC_000010.11:53821588:AAAAAA:AAAA
NM_033056.3(PCDH15):c.(?_3374)_(3501_?)del (p.(?))	PCDH15		Rare genetic deafness	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000228388	10	55663003 - 55663130	10	53903243 - 53903370	228388	229712		
NM_033056.3(PCDH15):c.(?_-15)_(876_?)del	PCDH15|MIR548F1|LOC105378311		Rare genetic deafness	Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000164883	10	56077031 - 56424037	10	54317271 - 54664277	164883	174581		
NM_001384140.1(PCDH15):c.16del (p.Tyr6fs)	PCDH15	Y6fs	USHER SYNDROME, TYPE ID/F, DIGENIC|not provided|Rare genetic deafness|Usher syndrome type 1F|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000046446	10	56424007	10	54664247	46446	55611	rs397517451	NC_000010.11:54664246:AAAA:AAA
NM_005391.5(PDK3):c.249-9del	PDK3		not provided|Charcot-Marie-Tooth disease	Benign(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000917223	X	24516926	X	24498809	917223	905725		NC_000023.11:24498808:TTTTTTTTTTTT:TTTTTTTTTTT
NM_005391.5(PDK3):c.1115_1116delinsAG (p.Phe372Ter)	PDK3	F372*	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917161	X	24552083 - 24552084	X	24533966 - 24533967	917161	905518		NC_000023.11:24533965:TT:AG
NM_001195263.2(PDZD7):c.2850del (p.Ser953fs)	PDZD7	S953fs	not provided|Deafness, autosomal recessive 57	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000955403	10	102768476	10	101008719	955403	946767		NC_000010.11:101008718:GGGG:GGG
NM_001195263.2(PDZD7):c.2089del (p.Ala697fs)	PDZD7	A697fs	Deafness, autosomal recessive 57|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000915843	10	102770557	10	101010800	915843	904068		NC_000010.11:101010799:CCCCC:CCCC
NM_001195263.2(PDZD7):c.1207del (p.His403fs)	PDZD7	H403fs	Deafness, autosomal recessive 57	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000545407	10	102778696	10	101018939	545407	535671	rs1554835103	NC_000010.11:101018938:GGGGG:GGGG
NM_001195263.2(PDZD7):c.2107del (p.Ser703fs)	PDZD7	S703fs	Rare genetic deafness|Deafness, autosomal recessive 57|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044121	10	102770539	10	101010782	44121	53289	rs397516633	NC_000010.11:101010781:TT:T
NM_000288.4(PEX7):c.364del (p.Thr122fs)	PEX7	T122fs	Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001074641	6	137166775	6	136845637	1074641	1060620		NC_000006.12:136845636:AAA:AA
NC_000006.11:g.(?_137187755)_(137193401_?)del	PEX7		Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001070609	6	137187755 - 137193401			1070609	1057196		
NC_000006.11:g.(?_137166776_137167549del	PEX7		Peroxisome biogenesis disorder 9B	Likely pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV001067456					1067456	1054390		
NM_000288.4(PEX7):c.346_348del (p.Ser116del)	PEX7	S116del	Peroxisome biogenesis disorder 9B	Uncertain significance(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV001004762	6	137166758 - 137166760	6	136845620 - 136845622	1004762	991363		NC_000006.12:136845619:TAGT:T
NM_000288.4(PEX7):c.363_526+230del	PEX7		Peroxisome biogenesis disorder 9B	Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000659636	6	137166776 - 137167549	6	136845638 - 136846411	659636	651639	rs1582744649	
NM_000288.4(PEX7):c.747+20_747+24del	PEX7		not provided|Peroxisome biogenesis disorder 9B	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000559080	6	137191160 - 137191164	6	136870022 - 136870026	559080	549600	rs199624608	NC_000006.12:136870021:TTTTAT:T
NM_000288.4(PEX7):c.429del (p.Val144fs)	PEX7	V144fs	Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554785	6	137167222	6	136846084	554785	543938	rs61753248	NC_000006.12:136846083:T:
NM_000288.4(PEX7):c.736_747+17del	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371420	6	137191128 - 137191156	6	136869990 - 136870018	371420	357432	rs1057517257	NC_000006.12:136869989:TTAGGAGGGTGAAAGTAAGTTTTCATCTTTT:TT
NM_000288.4(PEX7):c.*305_*310del	PEX7		Rhizomelic chondrodysplasia punctata|Phytanic acid storage disease	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355541	6	137234964 - 137234969	6	136913826 - 136913831	355541	301608	rs886061123	NC_000006.12:136913825:TTATACTTATA:TTATA
NM_000288.4(PEX7):c.183del (p.Phe61fs)	PEX7	F61fs	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225436	6	137146400	6	136825262	225436	227291	rs774131564	NC_000006.12:136825261:TTTTT:TTTT
NM_000288.4(PEX7):c.748-5del	PEX7		Peroxisome biogenesis disorder 9B|not specified|none provided|not provided	Benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198711	6	137193321	6	136872183	198711	195872	rs563675060	NC_000006.12:136872182:TTTTTTTTTTT:TTTTTTTTTT
NM_006214.4(PHYH):c.415-11del	PHYH		not provided|Phytanic acid storage disease	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000299254	10	13333923	10	13291923	299254	321262	rs140309981	NC_000010.11:13291922:AAAAAAAAAA:AAAAAAAAA
NM_006214.4(PHYH):c.*189del	PHYH		not provided|Phytanic acid storage disease	Benign(Last reviewed: Aug 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000299239	10	13320112	10	13278112	299239	309744	rs3839912	NC_000010.11:13278111:TTTTTTTTTT:TTTTTTTTT
NM_006214.4(PHYH):c.766_767del (p.Val256fs)	PHYH	V158fs, V258fs, V156fs, V168fs, V256fs	Phytanic acid storage disease	Likely pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000208603	10	13325751 - 13325752	10	13283751 - 13283752	208603	205162	rs797045100	NC_000010.11:13283750:ACA:A
NM_006214.4(PHYH):c.164del (p.Leu55fs)	PHYH	L55fs	Refsum disease, adult, 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000007583	10	13337577	10	13295577	7583	22622	rs730882058	NC_000010.11:13295576:A:
NM_001042702.5(PJVK):c.122del (p.Lys41fs)	PJVK	K41fs, K76fs, K44fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Feb 28, 2007)	no assertion criteria provided	VCV000001303	2	179318257	2	178453530	1303	16342	rs1559366000	NC_000002.12:178453529:AA:A
NM_001042702.5(PJVK):c.988del (p.Val330fs)	PJVK	V171fs, V332fs, V333fs, V330fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001302	2	179325930	2	178461203	1302	16341	rs1559372640	NC_000002.12:178461202:G:
NM_001042702.5(PJVK):c.726del (p.Phe242fs)	PJVK	F83fs, F242fs, F245fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001301	2	179325131	2	178460404	1301	16340	rs1559371613	NC_000002.12:178460403:TTT:TT
NM_181882.3(PRX):c.3198del (p.Phe1066fs)	PLD3|PRX	F1066fs	Charcot-Marie-Tooth disease|Spinocerebellar ataxia 46|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000637402	19	40901061	19	40395154	637402	625417	rs1599651549	NC_000019.10:40395153:AAA:AA
NM_001084.5(PLOD3):c.2071del (p.Cys691fs)	PLOD3	C691fs	Bone fragility with contractures, arterial rupture, and deafness	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000006644	7	100849708	7	101206427	6644	21683	rs786205872	NC_000007.14:101206426:A:
NC_000017.10:g.(?_15162401)_(15162520_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001074661	17	15162401 - 15162520			1074661	1057858		
NC_000017.10:g.(?_15134234)_(15164044_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001074660	17	15134234 - 15164044			1074660	1057856		
NC_000017.10:g.(?_15133097)_(15164054_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV001074659	17	15133097 - 15164054			1074659	1057854		
NM_000304.4(PMP22):c.52_56delinsGCGATCGTG (p.Leu18fs)	PMP22	L18fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000969243	17	15163989 - 15163993	17	15260672 - 15260676	969243	957987		NC_000017.11:15260671:AGCAG:CACGATCGC
NM_000304.4(PMP22):c.335del (p.Ser112fs)	PMP22	S112fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000938786	17	15134382	17	15231065	938786	937726		NC_000017.11:15231064:C:
NC_000017.11:g.(?_15259084)_(15260737_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000831609	17	15162401 - 15164054			831609	820982		
NC_000017.11:g.(?_15229767)_(15239621_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000831399	17	15133084 - 15142938			831399	820981		
NM_000304.4(PMP22):c.*83del	PMP22		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694890	17	15134151	17	15230834	694890	683078	rs1222938795	NC_000017.11:15230833:T:
NC_000017.11:g.(?_15239461)_(15260737_?)del	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000656830	17	15142778 - 15164054	17	15239461 - 15260737	656830	652786		
NM_000304.4(PMP22):c.75_78+2del	PMP22		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637895	17	15163965 - 15163970	17	15260648 - 15260653	637895	625403	rs1597635535	NC_000017.11:15260647:ACGCTGACG:ACG
NM_000304.4(PMP22):c.289del (p.Tyr97fs)	PMP22	Y97fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637846	17	15142818	17	15239501	637846	625384	rs1597607713	NC_000017.11:15239500:AAAA:AAA
NM_000304.4(PMP22):c.174_178+7del	PMP22		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637839	17	15162404 - 15162415	17	15259087 - 15259098	637839	625766	rs1597632803	NC_000017.11:15259086:GCCTCACCGTTTG:G
NM_000304.4(PMP22):c.130_131del (p.Thr44fs)	PMP22	T44fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637838	17	15162458 - 15162459	17	15259141 - 15259142	637838	625400	rs1597632943	NC_000017.11:15259140:GTG:G
NM_000304.4(PMP22):c.367del (p.Glu123fs)	PMP22	E123fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637833	17	15134350	17	15231033	637833	625372	rs1597597710	NC_000017.11:15231032:CC:C
NM_000304.4(PMP22):c.138_139delinsA (p.Ser47fs)	PMP22	S47fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637828	17	15162450 - 15162451	17	15259133 - 15259134	637828	625399	rs1597632913	NC_000017.11:15259132:AG:T
NM_000304.4(PMP22):c.76del (p.Ser26fs)	PMP22	S26fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637827	17	15163969	17	15260652	637827	625404	rs1597635540	NC_000017.11:15260651:T:
NM_000304.4(PMP22):c.318del (p.Gly107fs)	PMP22	E107fs, G107fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637826	17	15142789	17	15239472	637826	625378	rs1597607532	NC_000017.11:15239471:A:
NM_000304.4(PMP22):c.364_365del (p.Pro122fs)	PMP22	P122fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637818	17	15134352 - 15134353	17	15231035 - 15231036	637818	625373	rs1597597725	NC_000017.11:15231034:GGG:G
NM_000304.4(PMP22):c.312del (p.Ala106fs)	PMP22	A106fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637388	17	15142795	17	15239478	637388	625380	rs1597607585	NC_000017.11:15239477:AA:A
NM_000304.4(PMP22):c.11del (p.Leu4fs)	PMP22	L4fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637380	17	15164034	17	15260717	637380	625407	rs1597635843	NC_000017.11:15260716:A:
NM_000304.4(PMP22):c.297del (p.Gly100fs)	PMP22	G100fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637379	17	15142810	17	15239493	637379	625383	rs1597607665	NC_000017.11:15239492:A:
NM_000304.4(PMP22):c.227del (p.Ser76fs)	PMP22	S76fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637372	17	15142880	17	15239563	637372	625391	rs1597608057	NC_000017.11:15239562:C:
NM_000304.4(PMP22):c.433del (p.Leu145fs)	PMP22	L145fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586346	17	15134284	17	15230967	586346	577606	rs1567698872	NC_000017.11:15230966:GGGGG:GGGG
NC_000017.11:g.(?_15239451)_(15239631_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000531713	17	15142768 - 15142948	17	15239451 - 15239631	531713	530827		
NM_000304.3(PMP22):c.-34-?_*1140del	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000237629	17	15133094 - 15164078	17	15229777 - 15260761	237629	242575		
NM_000304.4(PMP22):c.280_281delinsT (p.Gly94fs)	PMP22	G94fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000220861	17	15142826 - 15142827	17	15239509 - 15239510	220861	222558	rs864622678	NC_000017.11:15239508:CC:A
NM_000304.4(PMP22):c.138del (p.Ser47fs)	PMP22	S47fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219616	17	15162451	17	15259134	219616	222559	rs864622180	NC_000017.11:15259133:GG:G
NM_000304.2(PMP22):c.(?_-1)_(*1_?)del	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000218288					218288	214923		
NM_000304.4(PMP22):c.434del (p.Leu145fs)	PMP22	L145fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA|Roussy-Lvy syndrome	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217238	17	15134283	17	15230966	217238	213835	rs863225029	NC_000017.11:15230965:A:
NM_000304.4(PMP22):c.281del (p.Gly94fs)	PMP22	G94fs	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease and deafness|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030158	17	15142826	17	15239509	30158	39114	rs80338763	NC_000017.11:15239508:CCCCCC:CCCCC
NM_000304.4(PMP22):c.344_355del (p.Ala115_Thr118del)	PMP22		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease and deafness	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2003)	no assertion criteria provided	VCV000008441	17	15134362 - 15134373	17	15231045 - 15231056	8441	23480	rs786205111	NC_000017.11:15231044:CCGTGTAGATGGCCG:CCG
NM_000304.4(PMP22):c.19_20del (p.Ser7fs)	PMP22	S7fs	Charcot-Marie-Tooth disease|Hereditary liability to pressure palsies	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000008435	17	15164025 - 15164026	17	15260708 - 15260709	8435	23474	rs587776691	NC_000017.11:15260707:CTC:C
NM_001256007.3(PNPLA8):c.634_637del (p.Asn212fs)	PNPLA8	N112fs, N212fs	Mitochondrial myopathy-lactic acidosis-deafness syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190127	7	108155299 - 108155302	7	108514855 - 108514858	190127	187959	rs786205882	NC_000007.14:108514854:AATTAAT:AAT
NM_033109.5(PNPT1):c.1925_1927del (p.Val642del)	PNPT1	V642del	not provided|Deafness, autosomal recessive 70	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000805221	2	55870540 - 55870542	2	55643405 - 55643407	805221	792982	rs1572796197	NC_000002.12:55643404:CCACC:CC
NM_006941.4(SOX10):c.12_13delinsAT (p.Gln5Ter)	POLR2F|SOX10	Q5*	Waardenburg syndrome type 2E	Pathogenic	criteria provided, single submitter	VCV001220524	22	38379779 - 38379780	22	37983772 - 37983773	1220524	1210500		NC_000022.11:37983771:GC:AT
NM_006941.4(SOX10):c.529_556del (p.Arg177fs)	POLR2F|SOX10	R177fs	Waardenburg syndrome type 2E	Pathogenic	criteria provided, single submitter	VCV001048555	22	38374015 - 38374042	22	37978008 - 37978035	1048555	1036513		NC_000022.11:37978007:CCTGGGCGGCCTTCCCGTTCTTCCGCCGCCTGGGC:CCTGGGC
NM_006941.4(SOX10):c.198_262del (p.Lys67fs)	POLR2F|SOX10	K67fs	Waardenburg syndrome type 2E	Pathogenic	criteria provided, single submitter	VCV001048554	22	38379530 - 38379594	22	37983523 - 37983587	1048554	1036514		
NM_006941.4(SOX10):c.797del (p.Gly266fs)	POLR2F|SOX10	G266fs	Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000007411	22	38370106	22	37974099	7411	22450	rs397515371	NC_000022.11:37974098:CCC:CC
NM_006941.4(SOX10):c.506del (p.Pro169fs)	POLR2F|SOX10	P169fs	Waardenburg syndrome type 2E, without neurologic involvement	Pathogenic(Last reviewed: Aug 15, 2008)	no assertion criteria provided	VCV000007407	22	38374065	22	37978058	7407	22446	rs397515369	NC_000022.11:37978057:GGG:GG
NM_006941.4(SOX10):c.698-740_1085delinsCCT	POLR2F|SOX10		Waardenburg syndrome type 4C	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000007404	22	38369818 - 38370945	22	37973811 - 37974938	7404	22443		
NM_000307.5(POU3F4):c.1086_*3del (p.Ter362TrpextTer?)	POU3F4		Rare genetic deafness	Likely pathogenic(Last reviewed: Dec 27, 2013)	criteria provided, single submitter	VCV000164976	X	82764415 - 82764418	X	83509407 - 83509410	164976	176455	rs727503377	NC_000023.11:83509406:CTGACTG:CTG
NM_000307.5(POU3F4):c.896del (p.Lys299fs)	POU3F4	K299fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000156303	X	82764227	X	83509219	156303	166083	rs267606974	NC_000023.11:83509218:AA:A
NM_000307.5(POU3F4):c.853_854del (p.Ile285fs)	POU3F4	I285fs	Deafness, X-linked 2|Rare genetic deafness	Pathogenic(Last reviewed: Jul 18, 2012)	criteria provided, single submitter	VCV000043352	X	82764185 - 82764186	X	83509177 - 83509178	43352	52522	rs397516336	NC_000023.11:83509176:AT:
NM_000307.5(POU3F4):c.1060del (p.Thr354fs)	POU3F4	T354fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041458	X	82764389	X	83509381	41458	49894	rs398122517	NC_000023.11:83509380:AAAA:AAA
NM_000307.5(POU3F4):c.862_865del (p.Val289fs)	POU3F4	V289fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000011681	X	82764191 - 82764194	X	83509183 - 83509186	11681	26720	rs730882189	NC_000023.11:83509182:GTGAGTG:GTG
NM_000307.5(POU3F4):c.648del (p.Leu217fs)	POU3F4	L217fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011677	X	82763977	X	83508969	11677	26716	rs1555984570	NC_000023.11:83508968:GGGG:GGG
NM_002700.3(POU4F3):c.662_675del (p.Gly221fs)	POU4F3	G221fs	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Jun 4, 2010)	no assertion criteria provided	VCV000101525	5	145719652 - 145719665	5	146340089 - 146340102	101525	107268	rs1064792854	NC_000005.10:146340088:GCTCGCTGAGCCAA:
NM_002700.3(POU4F3):c.882_889del (p.Ile295fs)	POU4F3	I295fs	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000007078	5	145719870 - 145719877	5	146340307 - 146340314	7078	22117	rs398124631	NC_000005.10:146340306:GCTATCCAGC:GC
NM_002764.3(PRPS1):c.-153del	PRPS1		Nonsyndromic Hearing Loss, X-Linked|Charcot-Marie-Tooth, X-linked|Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000367701	X	106871706	X	107628476	367701	351934	rs768856537	NC_000023.11:107628475:G:
NM_181882.3(PRX):c.4335_4336del (p.Ala1447fs)	PRX	A1447fs	Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000917233	19	40899923 - 40899924	19	40394016 - 40394017	917233	905426		NC_000019.10:40394015:CT:
NM_181882.3(PRX):c.832_861del (p.Pro278_Ala287del)	PRX		not provided|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000917232	19	40903398 - 40903427	19	40397491 - 40397520	917232	905480		NC_000019.10:40397490:GGCTGGGGCCTCCACAGCAGGCGGAGCCGGGGCT:GGCT
NM_181882.3(PRX):c.1490_1491delinsTG (p.Pro497Leu)	PRX	P497L	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917169	19	40902768 - 40902769	19	40396861 - 40396862	917169	905473		NC_000019.10:40396860:GG:CA
NM_181882.3(PRX):c.335_340del (p.Val112_Ser113del)	PRX		Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000916916	19	40904568 - 40904573	19	40398661 - 40398666	916916	905484		NC_000019.10:40398660:CAGACAC:C
NM_181882.3(PRX):c.122del (p.Gly41fs)	PRX	G41fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916821	19	40909675	19	40403768	916821	905490		NC_000019.10:40403767:CCC:CC
NM_181882.3(PRX):c.122_124delinsAAGCTGCGCGAGGAAGCTGC (p.Gly41fs)	PRX	G41fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916820	19	40909673 - 40909675	19	40403766 - 40403768	916820	905489		NC_000019.10:40403765:TTC:GCAGCTTCCTCGCGCAGCTT
NM_181882.3(PRX):c.458del (p.Pro153fs)	PRX	P153fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000694922	19	40903801	19	40397894	694922	683105	rs1599656851	NC_000019.10:40397893:GGGG:GGG
NM_181882.3(PRX):c.3772_3773delinsA (p.Gly1258fs)	PRX	G1258fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637848	19	40900486 - 40900487	19	40394579 - 40394580	637848	625416	rs1599650427	NC_000019.10:40394578:CC:T
NM_181882.3(PRX):c.730del (p.Ala244fs)	PRX	A244fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637847	19	40903529	19	40397622	637847	625434	rs1599656243	NC_000019.10:40397621:CCCC:CCC
NM_181882.3(PRX):c.875_906del (p.Val292fs)	PRX	V292fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637491	19	40903353 - 40903384	19	40397446 - 40397477	637491	625432	rs1599655871	NC_000019.10:40397445:TGAGGGCAAGGCAGGCAGCTCCACCTGGGGGA:
NM_181882.3(PRX):c.116_117del (p.Lys39fs)	PRX	K39fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637400	19	40909680 - 40909681	19	40403773 - 40403774	637400	625440	rs1599662861	NC_000019.10:40403772:TTT:T
NM_181882.3(PRX):c.2421del (p.Lys808fs)	PRX	K808fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637396	19	40901838	19	40395931	637396	625421	rs1599652935	NC_000019.10:40395930:GGG:GG
NM_181882.3(PRX):c.3099del (p.Glu1034fs)	PRX	E1034fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637394	19	40901160	19	40395253	637394	625418	rs1599651707	NC_000019.10:40395252:A:
NM_181882.3(PRX):c.1194_1197del (p.Leu400fs)	PRX	L400fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 4F	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2006)	no assertion criteria provided	VCV000637393	19	40903062 - 40903065	19	40397155 - 40397158	637393	625426	rs1599655206	NC_000019.10:40397154:GGAA:
NM_181882.3(PRX):c.1173del (p.Arg392fs)	PRX	R392fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637391	19	40903086	19	40397179	637391	625427	rs757771239	NC_000019.10:40397178:AA:A
NM_181882.3(PRX):c.281_283del (p.Phe94del)	PRX	F94del	not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000575102	19	40904625 - 40904627	19	40398718 - 40398720	575102	570791	rs1424434006	NC_000019.10:40398717:AGAAG:AG
NM_181882.3(PRX):c.3286_3356del (p.Ile1096fs)	PRX		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448139	19	40900903 - 40900973	19	40394996 - 40395066	448139	442226	rs1555800610	
NM_181882.3(PRX):c.2098del (p.Ala700fs)	PRX	A700fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 4F	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000038453	19	40902161	19	40396254	38453	47012	rs281865062	NC_000019.10:40396253:CC:C
NM_022124.6(CDH23):c.*588del	PSAP|CDH23		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Metachromatic leukodystrophy|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000300495	10	73575621	10	71815864	300495	322109	rs148667421	NC_000010.11:71815863:AAA:AA
NM_002834.5(PTPN11):c.*1006del	PTPN11		Noonan syndrome with multiple lentigines|Noonan syndrome|Metachondromatosis	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000307236	12	112944602	12	112506798	307236	323301	rs146940557	NC_000012.12:112506797:G:
NM_002834.5(PTPN11):c.*656del	PTPN11		Noonan syndrome with multiple lentigines|Noonan syndrome|Metachondromatosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000307230	12	112944241	12	112506437	307230	329407	rs886048968	NC_000012.12:112506436:TTTTTTTTTTTT:TTTTTTTTTTT
NM_002834.5(PTPN11):c.*41_*46del	PTPN11		Metachondromatosis|Noonan syndrome with multiple lentigines|not specified|Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	VCV000307227	12	112943635 - 112943640	12	112505831 - 112505836	307227	316045	rs886048967	NC_000012.12:112505830:ACTTTCAC:AC
NM_004637.6(RAB7A):c.331del (p.Ser111fs)	RAB7A	S111fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694965	3	128525365	3	128806522	694965	682983	rs1576303712	NC_000003.12:128806521:A:
NC_000018.9:g.76841645_78077248del1235604	RBFA|SLC66A2|TXNL4A|CTDP1|PARD6G|ADNP2|HSBP1L1|KCNG2|NFATC1|ATP9B		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000242602	18	76841645 - 78077248			242602	188240		
NM_002906.4(RDX):c.-64-1215_12+348del	RDX		Deafness, autosomal recessive 24	Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000983524	11	110150058 - 110151696	11	110279333 - 110280971	983524	971591		
NM_002906.4(RDX):c.-64-6del	RDX		not provided|Nonsyndromic Hearing Loss, Recessive|Deafness, autosomal recessive 24	Benign/Likely benign(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000302354	11	110150487	11	110279762	302354	324240	rs61003001	NC_000011.10:110279761:AAAAAAAAAAAA:AAAAAAAAAAA
NM_002906.4(RDX):c.1308del (p.Lys438fs)	RDX	K438fs, K91fs, K302fs	Rare genetic deafness	Pathogenic(Last reviewed: Sep 7, 2013)	criteria provided, single submitter	VCV000179207	11	110106860	11	110236135	179207	175338	rs727504709	NC_000011.10:110236134:C:
NM_004260.4(RECQL4):c.1573del (p.Cys525fs)	RECQL4		not provided|Rapadilino syndrome|Baller-Gerold syndrome|Rothmund-Thomson syndrome|B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)|High grade surface osteosarcoma|Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2|Rapadilino syndrome|Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: Jul 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006066	8	145740367	8	144514983	6066	21105	rs386833845	NC_000008.11:144514982:A:
NM_001034850.3(RETREG1):c.826del (p.Ser276fs)	RETREG1	S276fs, S135fs	Hereditary sensory and autonomic neuropathy type IIB|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000203444	5	16478190	5	16478081	203444	199857	rs886037748	NC_000005.10:16478080:TTTTTT:TTTTT
NM_001034850.3(RETREG1):c.18_19del (p.Pro7fs)	RETREG1-AS1|RETREG1	P7fs	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000021257	5	16617062 - 16617063	5	16616953 - 16616954	21257	34109		NC_000005.10:16616952:GAG:G
NM_003730.6(RNASET2):c.-183del	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356047	6	167369853	6	166956365	356047	302164	rs886061248	NC_000006.12:166956364:G:
NM_003730.6(RNASET2):c.-77del	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356043	6	167369747	6	166956259	356043	306847	rs886061244	NC_000006.12:166956258:CC:C
NM_003730.6(RNASET2):c.-3_6del (p.Met1_Arg2del)	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356040	6	167369665 - 167369673	6	166956177 - 166956185	356040	306547	rs886061241	NC_000006.12:166956176:GCGCATGGTGC:GC
NM_003730.6(RNASET2):c.50_64del (p.Ala17_Leu21del)	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000416	6	167369607 - 167369621	6	166956119 - 166956133	416	15455	rs1583242286	NC_000006.12:166956118:CCAGGCAAAGCAACGCCAGGCA:CCAGGCA
NM_003730.6(RNASET2):c.332+1del	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000415	6	167356506	6	166943018	415	15454		NC_000006.12:166943017:CC:C
RNASET2, 2.5-KB DEL	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000413					413	15452		
RPGR, 57-BP DEL, NT631	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000009919					9919	24958		
RPGR, 2-BP DEL, 845TG	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000009915					9915	24954		
NM_002968.3(SALL1):c.2801del (p.Ser934fs)	SALL1	S837fs, S934fs	Townes-Brocks syndrome 1	Likely pathogenic(Last reviewed: Aug 13, 2019)	no assertion criteria provided	VCV000829881	16	51173332	16	51139421	829881	818327	rs1597228490	NC_000016.10:51139420:C:
NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs)	SALL1	C1042fs, C1139fs	not provided|Townes syndrome|Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418466	16	51172718 - 51172719	16	51138807 - 51138808	418466	409645	rs1064793257	NC_000016.10:51138806:AT:
NM_002968.3(SALL1):c.*563del	SALL1		Townes-Brocks syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319587	16	51170460	16	51136549	319587	335258	rs886052078	NC_000016.10:51136548:AAAAA:AAAA
NM_002968.3(SALL1):c.*588del	SALL1		Townes-Brocks syndrome 1	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319586	16	51170435	16	51136524	319586	335255	rs35929381	NC_000016.10:51136523:AAAAAAAAA:AAAAAAAA
NM_002968.3(SALL1):c.*705_*706del	SALL1		Townes-Brocks syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319583	16	51170317 - 51170318	16	51136406 - 51136407	319583	343237	rs886052076	NC_000016.10:51136405:TTTTT:TTT
NM_002968.3(SALL1):c.995del (p.Pro332fs)	SALL1	P235fs, P332fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000007436	16	51175138	16	51141227	7436	22475	rs1597230687	NC_000016.10:51141226:GG:G
NM_002968.3(SALL1):c.792_793del (p.Leu264fs)	SALL1	L167fs, L264fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Aug 15, 2001)	no assertion criteria provided	VCV000007433	16	51175340 - 51175341	16	51141429 - 51141430	7433	22472	rs1597230909	NC_000016.10:51141428:GC:
NM_002968.3(SALL1):c.1277_1278del (p.Arg426fs)	SALL1	R426fs, R329fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007430	16	51174855 - 51174856	16	51140944 - 51140945	7430	22469	rs1597230341	NC_000016.10:51140943:TCT:T
NM_002968.3(SALL1):c.1270del (p.Gln424fs)	SALL1	Q327fs, Q424fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007426	16	51174863	16	51140952	7426	22465	rs1597230349	NC_000016.10:51140951:GGG:GG
NM_020436.5(SALL4):c.516_522del (p.Gly174fs)	SALL4	G174fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000916548	20	50408500 - 50408506	20	51791961 - 51791967	916548	904881		NC_000020.11:51791960:GCCTTTGGC:GC
NC_000020.11:g.(?_51802259)_(51802428_?)del	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000642045	20	50418798 - 50418967	20	51802259 - 51802428	642045	653103		
NM_020436.5(SALL4):c.1232del (p.Val411fs)	SALL4	V411fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000580810	20	50407790	20	51791251	580810	571309	rs1568864697	NC_000020.11:51791250:A:
NM_020436.5(SALL4):c.563del (p.Gly188fs)	SALL4	G188fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000463530	20	50408459	20	51791920	463530	470471	rs1555850961	NC_000020.11:51791919:CCCC:CCC
SALL4, DEL	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000003327					3327	18366		
NM_020436.5(SALL4):c.326del (p.Pro109fs)	SALL4	P109fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jun 18, 1994)	no assertion criteria provided	VCV000003324	20	50408696	20	51792157	3324	18363	rs1601171949	NC_000020.11:51792156:GG:G
NM_020436.5(SALL4):c.2425del (p.Ala809fs)	SALL4	A809fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003323	20	50406597	20	51790058	3323	18362	rs1601168015	NC_000020.11:51790057:C:
NM_020436.5(SALL4):c.1904del (p.Phe635fs)	SALL4	F635fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003321	20	50407118	20	51790579	3321	18360	rs1601168967	NC_000020.11:51790578:AA:A
NM_020436.5(SALL4):c.1054del (p.Ala352fs)	SALL4	A352fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jun 10, 2021)	no assertion criteria provided	VCV000003319	20	50407968	20	51791429	3319	18358	rs1601170510	NC_000020.11:51791428:CC:C
NM_001365536.1(SCN9A):c.4026delinsTT (p.Leu1342fs)	SCN9A|SCN1A-AS1	L1331fs, L1342fs	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IID|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2013)	no assertion criteria provided	VCV000157598	2	167085381	2	166228871	157598	167459	rs606231279	NC_000002.12:166228870:C:AA
NC_000007.14:g.(?_83367566)_(83648562_?)del	SEMA3E		CHARGE association	Uncertain significance(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000459534			7	83367566 - 83648562	459534	456159		
NM_001113491.2(SEPTIN9):c.913+62_913+64delinsAGT	SEPTIN9		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694904	17	75478479 - 75478481	17	77482397 - 77482399	694904	683128	rs1598444764	NC_000017.11:77482396:GGC:AGT
NM_001113491.2(SEPTIN9):c.722-6324del	SEPTIN9	L101fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694901	17	75471902	17	77475820	694901	683087	rs1598433427	NC_000017.11:77475819:T:
NM_032861.4(SERAC1):c.1166+8del	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001089951	6	158541449	6	158120417	1089951	1073383		NC_000006.12:158120416:TT:T
NM_032861.4(SERAC1):c.1763del (p.Val588fs)	SERAC1	V588fs	not provided|3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2021)	criteria provided, conflicting interpretations	VCV001031004	6	158534546	6	158113514	1031004	1016686		NC_000006.12:158113513:A:
NM_032861.4(SERAC1):c.308_311del (p.Arg103fs)	SERAC1	R103fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Likely pathogenic	criteria provided, single submitter	VCV000982129	6	158569941 - 158569944	6	158148909 - 158148912	982129	970214		NC_000006.12:158148908:TTTCTT:TT
NM_032861.4(SERAC1):c.438del (p.Thr147fs)	SERAC1	T147fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: May 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000689786	6	158567863	6	158146831	689786	677424	rs1583595091	NC_000006.12:158146830:GG:G
NM_032861.3(SERAC1):c.1167_1170del (p.Gln390Profs)	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Jun 10, 2012)	no assertion criteria provided	VCV000035558	6	158540199 - 158540202	6	158119167 - 158119170	35558	44231	rs772296795	NC_000006.12:158119166:CTGACT:CT
NM_005850.5(SF3B4):c.827del (p.Pro276fs)	SF3B4	P276fs	not provided|Hereditary hearing loss and deafness	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446295	1	149897814	1	149925922	446295	439700	rs797045128	NC_000001.11:149925921:GGGGGG:GGGGG
NM_024577.4(SH3TC2):c.151+15_151+16del	SH3TC2		Charcot-Marie-Tooth disease	Benign	criteria provided, single submitter	VCV000917222	5	148431689 - 148431690	5	149052126 - 149052127	917222	905577		NC_000005.10:149052125:TTT:T
NM_024577.4(SH3TC2):c.53-17del	SH3TC2		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916969	5	148431820	5	149052257	916969	905578		NC_000005.10:149052256:AAAA:AAA
NM_024577.4(SH3TC2):c.1002-8del	SH3TC2		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694976	5	148411258	5	149031695	694976	683114	rs1580903964	NC_000005.10:149031694:GGGG:GGG
NM_024577.4(SH3TC2):c.2015del (p.Val672fs)	SH3TC2	V672fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694973	5	148407280	5	149027717	694973	682991	rs1580900610	NC_000005.10:149027716:A:
NM_024577.4(SH3TC2):c.*858_*862del	SH3TC2		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694967	5	148383412 - 148383416	5	149003849 - 149003853	694967	682985	rs1561755591	NC_000005.10:149003848:CAAAA:
NM_024577.4(SH3TC2):c.1915del (p.Ala639fs)	SH3TC2	A639fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637870	5	148407380	5	149027817	637870	625123	rs1580900732	NC_000005.10:149027816:CC:C
NM_024577.4(SH3TC2):c.253del (p.Asp85fs)	SH3TC2	D85fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637867	5	148427451	5	149047888	637867	625129	rs1580914356	NC_000005.10:149047887:CC:C
NM_024577.4(SH3TC2):c.3305del (p.His1102fs)	SH3TC2	H1102fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637414	5	148389855	5	149010292	637414	625114	rs1580889892	NC_000005.10:149010291:T:
NM_024577.4(SH3TC2):c.1894_1897delinsAAA (p.Glu632fs)	SH3TC2	E632fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637411	5	148407398 - 148407401	5	149027835 - 149027838	637411	625124	rs1580900758	NC_000005.10:149027834:CCTC:TTT
NM_024577.4(SH3TC2):c.2989del (p.Arg997fs)	SH3TC2	R997fs	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000637410	5	148406199	5	149026636	637410	625118	rs1174949678	NC_000005.10:149026635:GG:G
NM_024577.4(SH3TC2):c.688del (p.Val230fs)	SH3TC2	V230fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637409	5	148421022	5	149041459	637409	625127	rs775740308	NC_000005.10:149041458:CC:C
NM_024577.4(SH3TC2):c.2211_2213del (p.Cys737_Pro738delinsTer)	SH3TC2		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637408	5	148407082 - 148407084	5	149027519 - 149027521	637408	625121	rs1580900438	NC_000005.10:149027518:GGG:
NM_024577.4(SH3TC2):c.524del (p.Gln175fs)	SH3TC2	Q175fs	Charcot-Marie-Tooth disease|SH3TC2-Related Disorders	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000631961	5	148422262	5	149042699	631961	620192	rs1561770179	NC_000005.10:149042698:T:
NM_024577.4(SH3TC2):c.3425_3435del (p.Tyr1142fs)	SH3TC2	Y1142fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000543408	5	148388457 - 148388467	5	149008894 - 149008904	543408	520902	rs1222150652	NC_000005.10:149008893:AGCCTTCTCATAGCCTTC:AGCCTTC
NM_024577.4(SH3TC2):c.1194_1195delinsCC (p.Phe399Leu)	SH3TC2	F399L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV000476882	5	148408100 - 148408101	5	149028537 - 149028538	476882	455294	rs1554121791	NC_000005.10:149028536:AA:GG
NM_024577.4(SH3TC2):c.957del (p.Phe320fs)	SH3TC2		not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000448371	5	148417902	5	149038339	448371	440877	rs1554122541	NC_000005.10:149038338:G:
NM_024577.4(SH3TC2):c.3303del (p.Arg1101fs)	SH3TC2	R1101fs	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000220822	5	148389857	5	149010294	220822	221608	rs864622664	NC_000005.10:149010293:CC:C
NM_024577.4(SH3TC2):c.1402_1403delinsTT	SH3TC2	A468F	Charcot-Marie-Tooth disease type 4|Distal spinal muscular atrophy|not provided|Hereditary spastic paraplegia|not specified|Charcot-Marie-Tooth disease|Toe walking	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2021)	criteria provided, conflicting interpretations	VCV000216737	5	148407892 - 148407893	5	149028329 - 149028330	216737	212511	rs863224780	NC_000005.10:149028328:GC:AA
NM_024577.4(SH3TC2):c.28del (p.Glu10fs)	SH3TC2		Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000021697	5	148442558	5	149062995	21697	34549	rs80338918	NC_000005.10:149062994:CCC:CC
NM_024577.4(SH3TC2):c.217_227delinsCCAGTAA (p.Ala73fs)	SH3TC2	A73fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000021692	5	148427477 - 148427487	5	149047914 - 149047924	21692	34544		NC_000005.10:149047913:CTCCGAGCAGC:TTACTGG
NM_005982.4(SIX1):c.397_399del (p.Glu133del)	SIX1	E133del	Branchiootic syndrome 3|Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Aug 27, 2009)	no assertion criteria provided	VCV000008310	14	61115509 - 61115511	14	60648791 - 60648793	8310	23349	rs80356460	NC_000014.9:60648790:CTCCT:CT
NM_001126108.2(SLC12A3):c.20_21del (p.Thr7fs)	SLC12A3	T7fs	Familial hypokalemia-hypomagnesemia|Bartter syndrome|not provided	Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000817609	16	56899166 - 56899167	16	56865254 - 56865255	817609	805888	rs750710315	NC_000016.10:56865253:ACA:A
NM_001365088.1(SLC12A6):c.2436+1del	SLC12A6		Charcot-Marie-Tooth disease|not provided|Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000436730	15	34532861	15	34240660	436730	429644	rs515726215	NC_000015.10:34240659:CC:C
NM_001365088.1(SLC12A6):c.2995_3004del (p.Gln999fs)	SLC12A6	Q984fs, Q940fs, Q948fs, Q999fs, Q990fs	Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2007)	no assertion criteria provided	VCV000005332	15	34528947 - 34528956	15	34236746 - 34236755	5332	20371	rs606231158	NC_000015.10:34236745:GGAGCATCTGGGA:GGA
NM_001365088.1(SLC12A6):c.901del (p.Ile301fs)	SLC12A6	I250fs, I292fs, I286fs, I301fs, I242fs	Charcot-Marie-Tooth disease|Agenesis of the corpus callosum with peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2006)	no assertion criteria provided	VCV000005330	15	34546766	15	34254565	5330	20369	rs606231157	NC_000015.10:34254564:T:
NM_006996.3(SLC19A2):c.64_70del (p.Thr22fs)	SLC19A2	T22fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Mar 16, 2012)	no assertion criteria provided	VCV000599230	1	169454935 - 169454941	1	169485697 - 169485703	599230	590455	rs1557894839	NC_000001.11:169485696:GAGCGGT:
NM_006996.3(SLC19A2):c.584_585del (p.Leu195fs)	SLC19A2	L195fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 22, 2011)	no assertion criteria provided	VCV000599229	1	169446615 - 169446616	1	169477377 - 169477378	599229	590454	rs763099442	NC_000001.11:169477376:AA:
NM_006996.3(SLC19A2):c.*898_*899del	SLC19A2		Thiamine-responsive megaloblastic anemia|Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293514	1	169434188 - 169434189	1	169464950 - 169464951	293514	277101	rs886045525	NC_000001.11:169464949:TTTT:TT
NM_006996.3(SLC19A2):c.429_430del (p.Ile145fs)	SLC19A2	I145fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005962	1	169446770 - 169446771	1	169477532 - 169477533	5962	21001	rs1571537879	NC_000001.11:169477531:AA:
NM_006996.3(SLC19A2):c.885del (p.Leu296fs)	SLC19A2	L95fs, L296fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005959	1	169439347	1	169470109	5959	20998	rs1571532822	NC_000001.11:169470108:AA:A
NM_006996.3(SLC19A2):c.725del (p.Pro242fs)	SLC19A2	P242fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005956	1	169446475	1	169477237	5956	20995	rs1571537544	NC_000001.11:169477236:GGGG:GGG
NM_000441.2(SLC26A4):c.387del (p.Phe130fs)	SLC26A4	F130fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	no assertion criteria provided	VCV001065207	7	107312665	7	107672220	1065207	1053518		NC_000007.14:107672219:C:
NM_000441.2(SLC26A4):c.1922del (p.Asn641fs)	SLC26A4	N641fs	Pendred syndrome	Likely pathogenic	criteria provided, single submitter	VCV000813398	7	107342389	7	107701944	813398	801645	rs1584337134	NC_000007.14:107701943:AA:A
NM_000441.2(SLC26A4):c.1746del (p.Ala584fs)	SLC26A4	A584fs	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV000627476	7	107341584	7	107701139	627476	615803	rs1241745103	NC_000007.14:107701138:G:
NM_000441.2(SLC26A4):c.737del (p.Asn246fs)	SLC26A4	N246fs	Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558078	7	107315522	7	107675077	558078	544006	rs918684449	NC_000007.14:107675076:AAAAA:AAAA
NM_000441.2(SLC26A4):c.1708-27_1708-11del	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446460	7	107341514 - 107341530	7	107701069 - 107701085	446460	439907	rs1554360816	NC_000007.14:107701068:CATTTTAAGTAACTTGACATTT:CATTT
NM_000441.2(SLC26A4):c.1149+1del	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402275	7	107329645	7	107689200	402275	389226	rs1060499807	NC_000007.14:107689199:GG:G
NM_000441.2(SLC26A4):c.*2250_*2251del	SLC26A4		Pendred syndrome|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000358529	7	107358140 - 107358141	7	107717695 - 107717696	358529	301439	rs886061895	NC_000007.14:107717694:GAG:G
NM_000441.2(SLC26A4):c.2224del (p.Ile742fs)	SLC26A4	I742fs	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228397	7	107350633	7	107710188	228397	229546	rs876657723	NC_000007.14:107710187:A:
NM_000441.2(SLC26A4):c.1520del (p.Leu506_Leu507insTer)	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188978	7	107336459	7	107696014	188978	186735	rs786204601	NC_000007.14:107696013:TT:T
NM_000441.2(SLC26A4):c.890del (p.Pro297fs)	SLC26A4	P297fs	Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188977	7	107323769	7	107683324	188977	186732	rs786204600	NC_000007.14:107683323:CCC:CC
NM_000441.2(SLC26A4):c.2127del (p.Phe709fs)	SLC26A4	F709fs	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188869	7	107350534	7	107710089	188869	186742	rs786204523	NC_000007.14:107710088:TTT:TT
NM_000441.2(SLC26A4):c.164+1del	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188838	7	107302250	7	107661805	188838	186724	rs786204504	NC_000007.14:107661804:GG:G
NM_000441.2(SLC26A4):c.279del (p.Ser93fs)	SLC26A4	S93fs	Pendred syndrome|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188715	7	107303855	7	107663410	188715	186728	rs786204421	NC_000007.14:107663409:T:
NM_000441.2(SLC26A4):c.397_398delinsA (p.Ser133fs)	SLC26A4	S133fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 19, 2008)	criteria provided, single submitter	VCV000043556	7	107312675 - 107312676	7	107672230 - 107672231	43556	52725	rs111033400	NC_000007.14:107672229:TC:A
NM_000441.2(SLC26A4):c.294_298del (p.Thr99fs)	SLC26A4	T99fs	Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Nov 8, 2015)	criteria provided, single submitter	VCV000043551	7	107303868 - 107303872	7	107663423 - 107663427	43551	52720	rs111033241	NC_000007.14:107663422:GCCACGC:GC
NM_000441.2(SLC26A4):c.1341+1del	SLC26A4		Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000043505	7	107334925	7	107694480	43505	52675	rs397516417	NC_000007.14:107694479:GG:G
NM_000441.2(SLC26A4):c.1308_1313del (p.Ala437_Leu438del)	SLC26A4		Pendred syndrome|not specified	Uncertain significance(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043503	7	107334890 - 107334895	7	107694445 - 107694450	43503	52673	rs111033207	NC_000007.14:107694444:CTTGCCCT:CT
NM_000441.2(SLC26A4):c.1198del (p.Cys400fs)	SLC26A4	C400fs	Deafness, autosomal recessive|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043494	7	107330616	7	107690171	43494	52664	rs397516413	NC_000007.14:107690170:TT:T
SLC26A4, 1-BP DEL, 1197T	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000004831					4831	19870		
NM_000441.2(SLC26A4):c.917del (p.Val306fs)	SLC26A4	V306fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000004815	7	107323798	7	107683353	4815	19854	rs1584317722	NC_000007.14:107683352:T:
SLC26A4, 1-BP DEL, 1421T	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004814					4814	19853		
SLC26A4, 1-BP DEL, 1565G	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004813					4813	19852		
NM_000441.2(SLC26A4):c.55del (p.Ser19fs)	SLC26A4-AS1|SLC26A4	S19fs	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370620	7	107302141	7	107661696	370620	357526	rs1057516634	NC_000007.14:107661695:A:
NC_000010.10:g.(?_73079047)_(73079087_?)del	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001071023	10	73079047 - 73079087			1071023	1057465		
NM_018344.6(SLC29A3):c.269_275del (p.Thr90fs)	SLC29A3	T12fs, T90fs	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Mar 11, 2018)	criteria provided, single submitter	VCV001069036	10	73082779 - 73082785	10	71323022 - 71323028	1069036	1061942		NC_000010.11:71323021:ACCGGGGA:A
NM_018344.6(SLC29A3):c.713_715del (p.Thr238_Val239delinsIle)	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000999006	10	73115940 - 73115942	10	71356183 - 71356185	999006	993971		NC_000010.11:71356182:CTG:
NM_018344.6(SLC29A3):c.383+7_383+8delinsAG	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000741771	10	73104055 - 73104056	10	71344298 - 71344299	741771	759960	rs1589232669	NC_000010.11:71344297:GA:AG
NM_018344.6(SLC29A3):c.984del (p.Asn329fs)	SLC29A3	N251fs, N329fs	Histiocytosis-lymphadenopathy plus syndrome	Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000664261	10	73121920	10	71362163	664261	639137	rs1415833135	NC_000010.11:71362162:CC:C
NM_018344.6(SLC29A3):c.914_915delinsTC (p.Thr305Ile)	SLC29A3	T227I, T305I	Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000655961	10	73121851 - 73121852	10	71362094 - 71362095	655961	639136	rs1589244189	NC_000010.11:71362093:CG:TC
NM_018344.6(SLC29A3):c.243del (p.Lys81fs)	SLC29A3	K81fs, K3fs	not provided|Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000636986	10	73082752	10	71322995	636986	624410	rs1589220231	NC_000010.11:71322994:AAA:AA
NM_018344.6(SLC29A3):c.300+10del	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000468351	10	73082821	10	71323064	468351	460506	rs770787764	NC_000010.11:71323063:T:
NM_018344.6(SLC29A3):c.308_309del (p.Tyr102_Phe103insTer)	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000030947	10	73103972 - 73103973	10	71344215 - 71344216	30947	39904	rs796052139	NC_000010.11:71344214:TTT:T
NM_018344.6(SLC29A3):c.940del (p.Tyr314fs)	SLC29A3	Y236fs, Y314fs	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Sep 3, 2010)	no assertion criteria provided	VCV000000567	10	73121877	10	71362120	567	15606	rs869025177	NC_000010.11:71362119:T:
NM_018344.6(SLC29A3):c.1045del (p.Leu349fs)	SLC29A3	L349fs, L271fs	not provided|Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000000566	10	73121978	10	71362221	566	15605	rs869025176	NC_000010.11:71362220:CCCCC:CCCC
NM_016180.5(SLC45A2):c.1121del (p.Leu374fs)	SLC45A2	L374fs	Oculocutaneous albinism type 4	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000004506	5	33951694	5	33951589	4506	19545	rs730880271	NC_000005.10:33951588:AA:A
SLC4A11, 32-BP DEL, NT2423	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001318					1318	16357		
NM_001174089.2(SLC4A11):c.1330_1333delinsA (p.Tyr444_Ala445delinsThr)	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001313	20	3211243 - 3211246	20	3230597 - 3230600	1313	16352	rs869320722	NC_000020.11:3230596:CGTA:T
NM_033409.4(SLC52A3):c.85del (p.Leu29fs)	SLC52A3	L29fs	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001074049	20	746334	20	765690	1074049	1064880		NC_000020.11:765689:GGGG:GGG
NC_000020.10:g.(?_745957_749607del	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV001068731					1068731	1058090		
NM_033409.4(SLC52A3):c.1327_1338del (p.Gly443_Leu446del)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000645920	20	741742 - 741753	20	761098 - 761109	645920	648851	rs1462694166	NC_000020.11:761097:GAGCAGCGCTCCGAGCAGCG:GAGCAGCG
NC_000020.11:g.(?_761006)_(765794_?)del	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000640455	20	741650 - 746438	20	761006 - 765794	640455	653115		
NM_033409.4(SLC52A3):c.753del (p.Val252fs)	SLC52A3	V252fs	Brown-Vialetto-Van Laere syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623230	20	744462	20	763818	623230	612166	rs1568721373	NC_000020.11:763817:GG:G
NM_033409.4(SLC52A3):c.-14_-6del	SLC52A3		not specified|not provided|Brown-Vialetto-Van Laere syndrome 1|Progressive bulbar palsy of childhood	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000262228	20	746424 - 746432	20	765780 - 765788	262228	257443	rs11467076	NC_000020.11:765779:TATCTGCCCT:T
NM_033409.4(SLC52A3):c.1325_1326del (p.Leu442fs)	SLC52A3	L442fs	Brown-Vialetto-Van Laere syndrome 1|not provided	Likely pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000000139	20	741754 - 741755	20	761110 - 761111	139	15178	rs794728004	NC_000020.11:761109:GAG:G
NM_021815.5(SLC5A7):c.1497del (p.Lys499fs)	SLC5A7	K252fs, K394fs, K499fs	Neuronopathy, distal hereditary motor, type viia|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039495	2	108627071	2	108010615	39495	48094	rs1558872865	NC_000002.12:108010614:G:
NC_000023.11:g.153696346_153701690del	SLC6A8|BCAP31		Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068445	X	152961800 - 152967144	X	153696345 - 153701689	68445	79336		
NM_003047.5(SLC9A1):c.862del (p.Ile288fs)	SLC9A1	I288fs	Lichtenstein-knorr syndrome	Pathogenic(Last reviewed: Sep 18, 2020)	no assertion criteria provided	VCV000978078	1	27436220	1	27109729	978078	966204		NC_000001.11:27109728:T:
NM_014332.3(SMPX):c.29del (p.Asn10fs)	SMPX	N10fs	Deafness, X-linked 4	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000975949	X	21772380	X	21754262	975949	964595		NC_000023.11:21754261:TT:T
NM_014332.3(SMPX):c.99del (p.Arg34fs)	SMPX	R34fs	Deafness, X-linked 4	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040063	X	21761901	X	21743783	40063	48574	rs398122930	NC_000023.11:21743782:GGGGGG:GGGGG
NM_014332.3(SMPX):c.130del (p.Glu44fs)	SMPX	E44fs	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029948	X	21761870	X	21743752	29948	38903	rs398122848	NC_000023.11:21743751:CC:C
NM_006941.3(SOX10):c.(?_698)_(1401_?)del	SOX10|POLR2F		Rare genetic deafness	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000228398	22	38369502 - 38370205	22	37973495 - 37974198	228398	231133		
NM_001124758.2(SPNS2):c.c.1066_1067delinsT (p.Pro356Cysfs)	SPNS2	P356fs	Deafness, autosomal recessive 115|Inborn genetic diseases	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000521864	17	4436402 - 4436403	17	4533107 - 4533108	521864	512292	rs1555537637	NC_000017.11:4533106:CC:T
NM_020971.3(SPTBN4):c.7453del (p.Ala2485fs)	SPTBN4	A2485fs	Inborn genetic diseases|Myopathy, congenital, with neuropathy and deafness	Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000559549	19	41078057	19	40572151	559549	550272	rs1555721549	NC_000019.10:40572150:GG:G
NM_006415.4(SPTLC1):c.1254+8del	SPTLC1		Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 1	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000917301	9	94800522	9	92038240	917301	905627		NC_000009.12:92038239:A:
NM_153700.2(STRC):c.461del (p.Pro154fs)	STRC	P154fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV001120087	15	43910158	15	43617960	1120087	1108917		NC_000015.10:43617959:GGGGGG:GGGGG
NM_153700.2(STRC):c.2356del (p.Leu786fs)	STRC	L786fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV001120086	15	43906209	15	43614011	1120086	1108916		NC_000015.10:43614010:GGG:GG
NM_153700.2(STRC):c.4251del (p.Leu1417_Leu1418insTer)	STRC		not provided|Deafness, autosomal recessive 16	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817586	15	43896318	15	43604120	817586	805825	rs1366021609	NC_000015.10:43604119:AA:A
15q15.3 deletion	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 24, 2019)	no assertion criteria provided	VCV000813830					813830	802083		
NM_153700.2(STRC):c.3499_4701+1del	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000692158	15	43893593 - 43901532	15	43601395 - 43609334	692158	679904		
NM_153700.2(STRC):c.3128_3138+5del	STRC		Rare genetic deafness	Likely pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000505025	15	43903692 - 43903707	15	43611494 - 43611509	505025	497680	rs1555447538	NC_000015.10:43611493:CTCACATCGTGCCTAG:
15q15.3 deletion	STRC		Deafness, autosomal dominant 16	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236065					236065	237629		
NM_153700.2(STRC):c.(?_4443)_(4845_?)-68del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV000228400	15	43892948 - 43895542	15	43600750 - 43603344	228400	230552		
NM_153700.2(STRC):c.(?_4376)-190_(4845_?)-68del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Nov 28, 2014)	criteria provided, single submitter	VCV000180122	15	43892948 - 43895799	15	43600750 - 43603601	180122	175771		
NM_153700.2(STRC):c.3484del (p.Trp1162fs)	STRC	W1162fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	VCV000179717	15	43902524	15	43610326	179717	175972	rs727505074	NC_000015.10:43610325:A:
NM_153700.2(STRC):c.4796_4800del (p.Cys1599fs)	STRC	C1599fs	Rare genetic deafness	Pathogenic(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	VCV000165302	15	43893114 - 43893118	15	43600916 - 43600920	165302	175964	rs727503442	NC_000015.10:43600915:TCCAC:
NM_153700.2(STRC):c.4917_4918delinsCT (p.Leu1640Phe)	STRC		Deafness, autosomal recessive 16|not provided|not specified	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000165301	15	43892807 - 43892808	15	43600609 - 43600610	165301	176105	rs727503441	NC_000015.10:43600608:GT:AG
NM_153700.2(STRC):c.(?_3795)_(4993_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	VCV000165297	15	43892732 - 43897597	15	43600534 - 43605399	165297	176096		
NM_153700.2(STRC):c.(?_4702)_(4993_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000165296	15	43892732 - 43893212	15	43600534 - 43601014	165296	175911		
NM_153700.2(STRC):c.(?_1)_(5328_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000165295	15	43891870 - 43910920	15	43599672 - 43618722	165295	175952		
NC_000015.10:g.(?_43599438)_(43608225_43613711)del	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004345			15	43599438 - 43613711	4345	19384		
NM_153700.2(STRC):c.2171_2174del (p.Val724fs)	STRC	V724fs	Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004344	15	43906634 - 43906637	15	43614436 - 43614439	4344	19383	rs786200883	NC_000015.10:43614435:CAAACA:CA
NC_000019.10:g.(?_36003337)_(36008681_?)del	SYNE4		Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000228292	19	36494239 - 36499583	19	36003337 - 36008681	228292	230977		
NM_001039876.3(SYNE4):c.228_229del (p.Trp77fs)	SYNE4	W77fs	Deafness, autosomal recessive 76	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000088870	19	36499169 - 36499170	19	36008267 - 36008268	88870	94439	rs587777072	NC_000019.10:36008266:AT:
NM_001199107.2(TBC1D24):c.715del (p.Val239fs)	TBC1D24	V239fs	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001072207	16	2546863	16	2496862	1072207	1063617		NC_000016.10:2496861:GG:G
NM_001199107.2(TBC1D24):c.642_793del (p.Trp215fs)	TBC1D24	W215fs	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001071941	16	2546786 - 2546937	16	2496785 - 2496936	1071941	1063616		
NM_001199107.2(TBC1D24):c.820_822del (p.Arg274del)	TBC1D24	R274del	Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001060035	16	2546969 - 2546971	16	2496968 - 2496970	1060035	1049541		NC_000016.10:2496967:AGA:
NM_001199107.2(TBC1D24):c.76_77delinsTT (p.Glu26Leu)	TBC1D24	E26L	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001026209	16	2546225 - 2546226	16	2496224 - 2496225	1026209	1012056		NC_000016.10:2496223:GA:TT
NM_001199107.2(TBC1D24):c.172del (p.Arg57_Leu58insTer)	TBC1D24		Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000541316	16	2546320	16	2496319	541316	530198	rs1555501140	NC_000016.10:2496318:CC:C
NC_000016.10:g.(?_2496129)_(2500978_?)del	TBC1D24		Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000474299	16	2546130 - 2550979	16	2496129 - 2500978	474299	465533		
NM_001199107.2(TBC1D24):c.554_559del (p.Asp185_Leu186del)	TBC1D24		Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|not provided	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448645	16	2546701 - 2546706	16	2496700 - 2496705	448645	441891	rs1215641557	NC_000016.10:2496699:GGACCTGG:GG
NM_001199107.2(TBC1D24):c.557del (p.Leu186fs)	TBC1D24	L186fs	not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430018	16	2546706	16	2496705	430018	422085	rs1131691737	NC_000016.10:2496704:T:
NM_001199107.2(TBC1D24):c.*2850_*2851del	TBC1D24		Myoclonic epilepsy, familial infantile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318673	16	2553803 - 2553804	16	2503802 - 2503803	318673	342572	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCC
NM_001199107.2(TBC1D24):c.*2851del	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318672	16	2553803	16	2503802	318672	341045	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCCC
NM_001199107.2(TBC1D24):c.*2540del	TBC1D24		Myoclonic epilepsy, familial infantile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318661	16	2553487	16	2503486	318661	341038	rs58172016	NC_000016.10:2503485:AAAAAAAAAAAAA:AAAAAAAAAAAA
NM_001199107.2(TBC1D24):c.475del (p.Leu159fs)	TBC1D24	L159fs	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207507	16	2546623	16	2496622	207507	203229	rs796053403	NC_000016.10:2496621:CC:C
NM_001199107.2(TBC1D24):c.1008del (p.His336fs)	TBC1D24	H330fs, H336fs	DOORS syndrome|not provided|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000091398	16	2548263	16	2498262	91398	96874	rs398122967	NC_000016.10:2498261:T:
NM_005422.4(TECTA):c.5235del (p.Ile1746fs)	TBCEL-TECTA|TECTA	I1746fs, I2060fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000667390	11	121033040	11	121162331	667390	654645	rs1229070290	NC_000011.10:121162330:GGG:GG
NM_005422.4(TECTA):c.1247_1248del (p.Gly416fs)	TBCEL-TECTA|TECTA	G416fs, G735fs	Deafness, autosomal recessive|Deafness, autosomal recessive 21	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619173	11	120996052 - 120996053	11	121125343 - 121125344	619173	610568	rs773573968	NC_000011.10:121125342:GGGG:GG
NM_005422.4(TECTA):c.5754_5755del (p.Val1918_Ile1919insTer)	TBCEL-TECTA|TECTA		Rare genetic deafness	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000505042	11	121039389 - 121039390	11	121168680 - 121168681	505042	497174	rs1555129231	NC_000011.10:121168679:AA:
NM_005422.4(TECTA):c.6037del (p.Glu2013fs)	TBCEL-TECTA|TECTA	E2013fs, E2327fs	Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000007019	11	121058577	11	121187868	7019	22058	rs1281790755	NC_000011.10:121187867:GG:G
NM_207037.2(TCF12):c.1646del (p.Lys549fs)	TCF12	K355fs, K467fs, K537fs, K289fs, K330fs, K379fs, K491fs, K525fs, K548fs, K549fs	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055914	15	57555370	15	57263172	55914	70556	rs886037638	NC_000015.10:57263171:AAAA:AAA
THRB, 1-BP DEL, CODON 438, C	THRB		Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000012570					12570	27609		
NC_000023.11:g.(?_101346475)_(101348757_?)del	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000929951	X	100601463 - 100603745			929951	918496		
NM_004085.4(TIMM8A):c.127del (p.Cys43fs)	TIMM8A	C43fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 15, 2006)	no assertion criteria provided	VCV000011326	X	100603526	X	101348538	11326	26365	rs869320667	NC_000023.11:101348537:AAA:AA
TIMM8A, DEL	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Mar 23, 2004)	no assertion criteria provided	VCV000011323					11323	26362		
NM_004085.4(TIMM8A):c.73del (p.Glu24_Val25insTer)	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000011322	X	100603580	X	101348592	11322	26361	rs869320665	NC_000023.11:101348591:CC:C
NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)	TIMM8A	K50fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000011319	X	100601624 - 100601633	X	101346636 - 101346645	11319	26358	rs869320733	NC_000023.11:101346635:GCCCAGGCTTG:G
NM_004085.4(TIMM8A):c.116del (p.Met39fs)	TIMM8A	M39fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000011318	X	100603537	X	101348549	11318	26357	rs869320664	NC_000023.11:101348548:A:
NM_138691.2:c.(?_-52-7)_(16+6_?)del	TMC1		Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000666999	9	75263506 - 75263586			666999	654978		
NM_138691.3(TMC1):c.2130-1del	TMC1		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000503746	9	75445366	9	72830450	503746	495429	rs1554731002	NC_000009.12:72830449:G:
NM_138691.3(TMC1):c.229del (p.Arg77fs)	TMC1	R77fs	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236042	9	75309623	9	72694707	236042	237605	rs878853230	NC_000009.12:72694706:A:
NM_138691.3(TMC1):c.1236del (p.Met413fs)	TMC1	M413fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228405	9	75406812	9	72791896	228405	229703	rs876657727	NC_000009.12:72791895:TT:T
NM_138691.3(TMC1):c.22del (p.Ile8fs)	TMC1	I8fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	VCV000178942	9	75303628	9	72688712	178942	174844	rs727504554	NC_000009.12:72688711:AAA:AA
NM_147196.3(TMIE):c.94-2_98delinsC	TMIE		Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003393	3	46747278 - 46747284	3	46705788 - 46705794	3393	18432	rs876657371	NC_000003.12:46705787:AGCCCAG:C
NM_147196.3(TMIE):c.122_125del (p.Pro41fs)	TMIE	P41fs	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003389	3	46747307 - 46747310	3	46705817 - 46705820	3389	18428	rs876661301	NC_000003.12:46705816:CCGCC:C
NM_001256317.3(TMPRSS3):c.208del (p.His70fs)	TMPRSS3	H70fs	not provided|Inborn genetic diseases|Deafness, autosomal recessive 8|Rare genetic deafness|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000165492	21	43809152	21	42389043	165492	176368	rs727503493	NC_000021.9:42389042:GG:G
TMPRSS3, 1-BP DEL, 207C	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000030492					30492	39449		
TMPRSS3, 8-BP DEL, SATELLITE REPEAT INS	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004942					4942	19981		
TNFRSF11B, 3-BP DEL AND 2-BP INS	TNFRSF11B		Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006972					6972	22011		
NM_001128228.3(TPRN):c.1530del (p.Thr511fs)	TPRN	T511fs	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000138	9	140093634	9	137199182	138	15177	rs387906222	NC_000009.12:137199181:CCC:CC
NM_001128228.3(TPRN):c.1427del (p.Pro476fs)	TPRN	P476fs	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000135	9	140093737	9	137199285	135	15174	rs387906219	NC_000009.12:137199284:GGG:GG
NM_001039141.3(TRIOBP):c.3634_3646del (p.Leu1212fs)	TRIOBP	L1212fs	Deafness, autosomal recessive|Deafness, autosomal recessive 28	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562075	22	38122196 - 38122208	22	37726189 - 37726201	562075	553273	rs1569042782	NC_000022.11:37726188:GCTGATCCCCCAAG:G
NM_001039141.3(TRIOBP):c.1193_1195del (p.Gln398del)	TRIOBP	Q398del	not specified|Deafness, autosomal recessive 28|not provided	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198447	22	38119755 - 38119757	22	37723748 - 37723750	198447	195608	rs55745992	NC_000022.11:37723747:CAAC:C
NM_001039141.3(TRIOBP):c.3202_3203del (p.Asp1069fs)	TRIOBP	D1069fs	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001496	22	38121765 - 38121766	22	37725758 - 37725759	1496	16535	rs1601632909	NC_000022.11:37725757:CG:
NM_021625.5(TRPV4):c.1782_1783del (p.Gly595fs)	TRPV4	G488fs, G535fs, G548fs, G561fs, G595fs	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917067	12	110230498 - 110230499	12	109792693 - 109792694	917067	905349		NC_000012.12:109792692:CAC:C
NM_021625.5(TRPV4):c.1656del (p.Tyr553fs)	TRPV4	Y493fs, Y506fs, Y553fs, Y446fs, Y519fs	Charcot-Marie-Tooth disease axonal type 2C|not provided|Charcot-Marie-Tooth disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2021)	criteria provided, conflicting interpretations	VCV000241385	12	110231334	12	109793529	241385	241228	rs541606391	NC_000012.12:109793528:G:
NM_144991.3(TSPEAR):c.1728del (p.Lys577fs)	TSPEAR-AS1|TSPEAR	K577fs, K509fs	Deafness, autosomal recessive 98|ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH HYPOHIDROSIS	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037311	21	45929108	21	44509225	37311	45886	rs782540538	NC_000021.9:44509224:G:
NM_000371.4(TTR):c.*3_*11del	TTR		Charcot-Marie-Tooth disease|not provided|Cardiomyopathy|Cardiovascular phenotype|not specified	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043452	18	29178641 - 29178649	18	31598678 - 31598686	43452	52622	rs143948820	NC_000018.10:31598677:GACTTCTCC:
NM_006701.2:c.Exon 3 deletion	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253189					253189	247602		
NM_006701.5(TXNL4A):c.154-959_257+638del	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253188	18	77736960 - 77738660	18	79976960 - 79978660	253188	247600		
NC_000018.9(TXNL4A):g.77748604_77748637del34	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000190413	18	77748604 - 77748637	18	79988604 - 79988637	190413	188238	rs786205699	NC_000018.10:79988603:GCGCGCGCTAGCGCCGTGCGTGCTGACGGCATGTGCG:GCG
NM_001305563.1(TXNL4A):c.-60-10914_-60-10880del	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162208	18	77748581 - 77748636	18	79988581 - 79988636	162208	171916		
NM_006701.4(TXNL4A):c.258_429del172 (p.Asn87Alafs)	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162207	18	77733685 - 77737597	18	79973685 - 79977597	162207	171915		
NC_000018.9:g.77748262delA	TXNL4A	V44fs	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162206	18	77748262	18	79988262	162206	171914	rs727502795	NC_000018.10:79988261:A:
NC_000018.9:g.77748581_77748614del34	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162203	18	77748581 - 77748614	18	79988581 - 79988614	162203	171911	rs535089924	NC_000018.10:79988580:CGCCGTGCGTGCTGACGGCATGCGCGCGCGCTAGCGCCGTGCGTGCTGACGGCATG:CGCCGTGCGTGCTGACGGCATG
NM_153676.4(USH1C):c.1211-1175del	USH1C	G388fs, G407fs	Retinitis pigmentosa|not provided|Usher syndrome, type 1C|Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555064	11	17539012	11	17517465	555064	546384	rs1207247951	NC_000011.10:17517464:CCC:CC
NM_153676.4(USH1C):c.1139del (p.Gly379_Ser380insTer)	USH1C		Deafness, autosomal recessive 18|Usher syndrome, type 1C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553726	11	17542488	11	17520941	553726	546388	rs1554960390	NC_000011.10:17520940:G:
NM_153676.4(USH1C):c.748_759+5del	USH1C		not provided|Usher syndrome, type 1C|Deafness, autosomal recessive 18|Usher syndrome	Likely pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437936	11	17545993 - 17546009	11	17524446 - 17524462	437936	431752	rs1355262412	NC_000011.10:17524445:CTCACCTCCAATCCCACCTCA:CTCA
NM_153676.4(USH1C):c.841_848del (p.Ser281fs)	USH1C	S281fs	Deafness, autosomal recessive 18|Usher syndrome, type 1C|not provided|Usher syndrome type 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000424972	11	17544786 - 17544793	11	17523239 - 17523246	424972	413306	rs1064797153	NC_000011.10:17523238:CTGCGGCT:
NM_153676.4(USH1C):c.497-2del	USH1C		Usher syndrome, type 1C|not provided|Usher syndrome type 1	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV000005140	11	17548589	11	17527042	5140	20179	rs1480243085	NC_000011.10:17527041:T:
NM_173477.5(USH1G):c.*371=	USH1G		Retinitis pigmentosa-deafness syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000325047	17	72913796	17	74917702	325047	336966	rs1555522334	NC_000017.11:74917701:C:C
NM_173477.5(USH1G):c.832_851del (p.Ser278fs)	USH1G	S175fs, S278fs	Usher syndrome type 1|Usher syndrome, type 1G	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000002916	17	72916080 - 72916099	17	74919985 - 74920004	2916	17955	rs397515345	NC_000017.11:74919984:GAGACGCTGTCCTCGTCCGAGAG:GAG
NC_000001.10:g.(?_216260061)_(216270555_?)del	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Aug 1, 2013)	criteria provided, single submitter	VCV000989467	1	216260061 - 216270555			989467	977405		
NM_206933.2(USH2A):c.(?_5299)_(5572_?)del (p.(?))	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	VCV000989466	1	216251431 - 216251704			989466	977404		
NM_206933.4(USH2A):c.14649del (p.Ile4883fs)	USH2A	I4883fs	Usher syndrome, type 2A|Retinal dystrophy	Likely pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000866663	1	215821006	1	215647664	866663	855909		NC_000001.11:215647663:T:
NM_206933.4(USH2A):c.15200del (p.Ile5067fs)	USH2A	I5067fs	Retinal dystrophy|not provided|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556916	1	215807898	1	215634556	556916	540830	rs1295968274	NC_000001.11:215634555:A:
NM_206933.4(USH2A):c.7524del (p.Arg2509fs)	USH2A	R2509fs	Rare genetic deafness|Retinal dystrophy|Usher syndrome, type 2A|Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa 39|not provided	Pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000517494	1	216073487	1	215900145	517494	508746	rs751176116	NC_000001.11:215900144:AAA:AA
NM_206933.2(USH2A):c.9335_9371+8063del	USH2A		Rare genetic deafness	Likely pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000505591	1	216003269 - 216011368	1	215829927 - 215838026	505591	496184		
NM_206933.4(USH2A):c.3317-14del	USH2A|USH2A-AS1		Retinitis Pigmentosa, Recessive|Retinitis pigmentosa-deafness syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000295434	1	216373477	1	216200135	295434	278958	rs376363548	NC_000001.11:216200134:AAAAAAAAAAAA:AAAAAAAAAAA
NM_206933.4(USH2A):c.4627+1205_4627+1208del	USH2A		Retinitis Pigmentosa, Recessive|Retinitis pigmentosa-deafness syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295404	1	216347386 - 216347389	1	216174044 - 216174047	295404	280397	rs751661540	NC_000001.11:216174043:TAGTTA:TA
NM_206933.4(USH2A):c.9685del (p.Glu3229fs)	USH2A	E3229fs	Usher syndrome, type 2A|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000236049	1	215987132	1	215813790	236049	237597	rs878853233	NC_000001.11:215813789:CC:C
NM_206933.4(USH2A):c.6639del (p.Lys2213fs)	USH2A	K2213fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000228415	1	216172247	1	215998905	228415	228328	rs876657732	NC_000001.11:215998904:TTT:TT
NC_000001.11:g.(?_215888426)_(215900905_?)del	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	VCV000228410	1	216061768 - 216074247	1	215888426 - 215900905	228410	228251		
NM_206933.4(USH2A):c.5877del (p.Ser1961fs)	USH2A	S1961fs	not provided|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome type 2|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000180092	1	216243615	1	216070273	180092	172522	rs727505343	NC_000001.11:216070272:A:
NM_206933.2(USH2A):c.(?_8682)_(8845_?)del (p.(?))	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	VCV000179512	1	216040349 - 216040512	1	215867007 - 215867170	179512	172463		
NM_206933.2(USH2A):c.(?_1645)_(1840_?)del (p.(?))	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 9, 2012)	criteria provided, single submitter	VCV000178657	1	216465517 - 216465712	1	216292175 - 216292370	178657	172881		
NC_000001.11:g.(?_216292175)_(216327654_?)del	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 2, 2012)	criteria provided, single submitter	VCV000178656	1	216465517 - 216500996	1	216292175 - 216327654	178656	172741		
NM_206933.3(USH2A):c.12295-?_14133+?del	USH2A		not provided|Usher syndrome|Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000177859	1	215844314 - 215848958	1	215670972 - 215675616	177859	172740		
NM_206933.4(USH2A):c.6795_6797del (p.Glu2265_Tyr2266delinsAsp)	USH2A		Rare genetic deafness|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166478	1	216166370 - 216166372	1	215993028 - 215993030	166478	172765	rs727503723	NC_000001.11:215993027:TATT:T
NM_206933.4(USH2A):c.13374del (p.Glu4458fs)	USH2A	E4458fs	Retinitis pigmentosa 39|Rare genetic deafness|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166428	1	215847879	1	215674537	166428	172517	rs727503715	NC_000001.11:215674536:TT:T
NM_206933.4(USH2A):c.6289_6302del (p.Leu2096_Ile2097insTer)	USH2A		not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048558	1	216219796 - 216219809	1	216046454 - 216046467	48558	57720	rs111033268	NC_000001.11:216046453:CTGCCTGAATAGATC:C
NM_206933.4(USH2A):c.3558del (p.Cys1186fs)	USH2A|USH2A-AS1	C1186fs	Retinal dystrophy|Retinitis pigmentosa 39|not provided|Rare genetic deafness|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048504	1	216373222	1	216199880	48504	57666	rs397518014	NC_000001.11:216199879:A:
NM_206933.4(USH2A):c.3435del (p.Val1147fs)	USH2A|USH2A-AS1	V1147fs	Rare genetic deafness|Usher syndrome, type 2A	Pathogenic(Last reviewed: Aug 19, 2010)	criteria provided, single submitter	VCV000048502	1	216373345	1	216200003	48502	57664	rs397518012	NC_000001.11:216200002:T:
NM_206933.4(USH2A):c.11411del (p.Pro3804fs)	USH2A	P3804fs	not provided|Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048375	1	215916656	1	215743314	48375	57537	rs397517973	NC_000001.11:215743313:GG:G
NM_206933.4(USH2A):c.10190_10191del (p.Lys3397fs)	USH2A	K3397fs	Rare genetic deafness|not provided|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000048343	1	215960208 - 215960209	1	215786866 - 215786867	48343	57505	rs397517964	NC_000001.11:215786865:TTT:T
NM_206933.4(USH2A):c.2898del (p.Thr967fs)	USH2A|USH2A-AS1	T967fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002352	1	216405390	1	216232048	2352	17391	rs397518008	NC_000001.11:216232047:C:
NM_206933.4(USH2A):c.2299del (p.Glu767fs)	USH2A	E767fs	not specified|not provided|Cone-rod dystrophy|Distal arthrogryposis|Abnormality of upper limb joint|Chronic pain|High palate|Short stature|Abnormal morphology of bones of the upper limbs|Multiple joint contractures|Cognitive impairment|Brisk reflexes|Anxiety|Dislocated radial head|Abnormality of the upper limb|Dysautonomia|USH2A-Related Disorders|Congenital stationary night blindness|Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome|Retinitis pigmentosa|Rare genetic deafness|Usher syndrome|Macular dystrophy|Inborn genetic diseases|Retinal dystrophy	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002351	1	216420437	1	216247095	2351	17390	rs80338903	NC_000001.11:216247094:C:
NM_152564.5(VPS13B):c.5148del (p.Gln1717fs)	VPS13B	Q1717fs, Q1742fs	Cohen syndrome	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001217352	8	100589789	8	99577561	1217352	1207336		NC_000008.11:99577560:T:
NM_152564.5(VPS13B):c.4633+22del	VPS13B		Cohen syndrome	Benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001167609	8	100523755	8	99511527	1167609	1156015		NC_000008.11:99511526:TTTTTTTT:TTTTTTT
NM_152564.5(VPS13B):c.2013+9del	VPS13B		Cohen syndrome	Benign(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001167047	8	100160244	8	99148016	1167047	1156013		NC_000008.11:99148015:TTTT:TTT
NM_152564.5(VPS13B):c.2208+9del	VPS13B		Cohen syndrome	Benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001165247	8	100168977	8	99156749	1165247	1156014		NC_000008.11:99156748:AAAA:AAA
NM_152564.5(VPS13B):c.8446-10_8446-6del	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001135443	8	100830927 - 100830931	8	99818699 - 99818703	1135443	1118938		NC_000008.11:99818698:TTTTATTTT:TTTT
NM_152564.5(VPS13B):c.2334-16_2334-11del	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001132111	8	100205085 - 100205090	8	99192857 - 99192862	1132111	1118867		NC_000008.11:99192856:TTTCTGTTT:TTT
NM_152564.5(VPS13B):c.11495+10_11495+11delinsAC	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001095807	8	100883125 - 100883126	8	99870897 - 99870898	1095807	1075740		NC_000008.11:99870896:TT:AC
NM_152564.5(VPS13B):c.1652-7del	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001093969	8	100155195	8	99142967	1093969	1075631		NC_000008.11:99142966:C:
NC_000008.10:g.(?_100533117)_(100568891_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001076763	8	100533117 - 100568891			1076763	1057327		
NC_000008.10:g.(?_100479622)_(100533258_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001076762	8	100479622 - 100533258			1076762	1057325		
NC_000008.10:g.(?_100479632)_(100494040_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001076761	8	100479632 - 100494040			1076761	1057326		
NC_000008.10:g.(?_100454619)_(100533248_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001076760	8	100454619 - 100533248			1076760	1057324		
NC_000008.10:g.(?_100443745)_(100589881_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001076759	8	100443745 - 100589881			1076759	1057323		
NC_000008.10:g.(?_100182257)_(100182401_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV001076626	8	100182257 - 100182401			1076626	1057316		
NM_152564.5(VPS13B):c.5539_5540del (p.Lys1847fs)	VPS13B	K1847fs, K1872fs	Cohen syndrome	Pathogenic(Last reviewed: May 10, 2020)	criteria provided, single submitter	VCV001075529	8	100654357 - 100654358	8	99642129 - 99642130	1075529	1061467		NC_000008.11:99642128:AA:
NM_152564.5(VPS13B):c.3194_3198del (p.Lys1065fs)	VPS13B	K1065fs	Cohen syndrome	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001075459	8	100443876 - 100443880	8	99431648 - 99431652	1075459	1061464		NC_000008.11:99431647:AGCAT:
NM_152564.5(VPS13B):c.6201_6210del (p.Lys2067fs)	VPS13B	K2067fs, K2092fs	Cohen syndrome	Pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001075025	8	100711907 - 100711916	8	99699679 - 99699688	1075025	1061469		NC_000008.11:99699678:GGATGATCTT:
NC_000008.10:g.(?_99346108_100589843del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV001074934					1074934	1057363		
NC_000008.10:g.(?_100146850)_(100287492_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001074933	8	100146850 - 100287492			1074933	1057314		
NC_000008.10:g.(?_100182257)_(100221906_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV001074676	8	100182257 - 100221906			1074676	1057317		
NC_000008.10:g.(?_100147223)_(100155413_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001074675	8	100147223 - 100155413			1074675	1057315		
NC_000008.10:g.(?_100133395)_(100134000_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001074674	8	100133395 - 100134000			1074674	1057313		
NC_000008.10:g.(?_100123316)_(100123517_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 9, 2020)	criteria provided, single submitter	VCV001074673	8	100123316 - 100123517			1074673	1057311		
NC_000008.10:g.(?_100778992)_(100779208_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001074672	8	100778992 - 100779208			1074672	1057332		
NC_000008.10:g.(?_100654029)_(100654736_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001074671	8	100654029 - 100654736			1074671	1057330		
NC_000008.10:g.(?_100568668)_(100568891_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001074670	8	100568668 - 100568891			1074670	1057328		
NM_152564.5(VPS13B):c.3068del (p.Thr1023fs)	VPS13B	T1023fs	Cohen syndrome	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001073915	8	100403918	8	99391690	1073915	1061463		NC_000008.11:99391689:C:
NM_152564.5(VPS13B):c.11252del (p.Asn3751fs)	VPS13B	N3751fs, N3776fs	Cohen syndrome	Pathogenic(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001073212	8	100880552	8	99868324	1073212	1061484		NC_000008.11:99868323:AA:A
NM_152564.5(VPS13B):c.1366del (p.Cys456fs)	VPS13B	C456fs	Cohen syndrome	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001070957	8	100147306	8	99135078	1070957	1061454		NC_000008.11:99135077:T:
NM_152564.5(VPS13B):c.10982del (p.Pro3661fs)	VPS13B	P3661fs, P3686fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001070923	8	100871644	8	99859416	1070923	1061483		NC_000008.11:99859415:CCC:CC
NM_152564.5(VPS13B):c.1527del (p.Arg510fs)	VPS13B	R510fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001070881	8	100147925	8	99135697	1070881	1061455		NC_000008.11:99135696:T:
NC_000008.10:g.(?_100127918)_(100221906_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001070871	8	100127918 - 100221906			1070871	1057312		
NC_000008.10:g.(?_100108530)_(100287492_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 13, 2020)	criteria provided, single submitter	VCV001070870	8	100108530 - 100287492			1070870	1057310		
NC_000008.10:g.(?_100396426)_(100523750_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001070733	8	100396426 - 100523750			1070733	1057322		
NC_000008.10:g.(?_100396426)_(100403942_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001070732	8	100396426 - 100403942			1070732	1057321		
NC_000008.10:g.(?_100286406)_(100874194_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001070731	8	100286406 - 100874194			1070731	1057320		
NC_000008.10:g.(?_100221800)_(100589881_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001070730	8	100221800 - 100589881			1070730	1057319		
NC_000008.10:g.(?_100182257)_(100479872_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001070729	8	100182257 - 100479872			1070729	1057318		
NM_152564.5(VPS13B):c.10975del (p.Arg3659fs)	VPS13B	R3659fs, R3684fs	Cohen syndrome	Pathogenic(Last reviewed: Aug 28, 2020)	criteria provided, single submitter	VCV001069655	8	100871637	8	99859409	1069655	1061482		NC_000008.11:99859408:CCC:CC
NM_152564.5(VPS13B):c.8494_8495del (p.Ile2832fs)	VPS13B	I2832fs, I2857fs	Cohen syndrome	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001069292	8	100830989 - 100830990	8	99818761 - 99818762	1069292	1061478		NC_000008.11:99818760:AT:
NC_000008.10:g.(?_100654029)_(100712170_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001068729	8	100654029 - 100712170			1068729	1057331		
NC_000008.10:g.(?_100654019)_(100673739_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001068728	8	100654019 - 100673739			1068728	1057329		
NM_152564.5(VPS13B):c.8430del (p.Val2811fs)	VPS13B	V2811fs, V2836fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001068499	8	100830746	8	99818518	1068499	1061475		NC_000008.11:99818517:AA:A
NC_000008.10:g.(?_100515082_100589871del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001067843					1067843	1054438		
NC_000008.10:g.(?_100821603)_(100821758_?)del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV001067842	8	100821603 - 100821758			1067842	1054440		
NC_000008.10:g.(?_100781239_100789156del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV001066500					1066500	1054439		
NC_000008.10:g.(?_100479254_100479653del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV001066499					1066499	1054437		
NC_000008.10:g.(?_100162579_100168929del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Jul 14, 2019)	criteria provided, single submitter	VCV001066498					1066498	1054434		
NM_152564.5(VPS13B):c.2178_2200del (p.His727fs)	VPS13B	H727fs	Cohen syndrome	Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, single submitter	VCV001065824	8	100168936 - 100168958	8	99156708 - 99156730	1065824	1054087		NC_000008.11:99156707:CTGCTTCATTATTGTTATGTACACTGCT:CTGCT
NC_000008.10:g.100246250_100460500del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV001048632	8	100246250 - 100460500			1048632	1036719		
NC_000008.10:g.(?_100519978)_(100533258_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001023708	8	100519978 - 100533258			1023708	1001573		
NM_152564.5(VPS13B):c.6747_6752del (p.Gln2250_Val2251del)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV001016639	8	100732658 - 100732663	8	99720430 - 99720435	1016639	1008219		NC_000008.11:99720429:AAGTACAAGT:AAGT
NC_000008.10:g.(?_100155202)_(100221801_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001011638	8	100155202 - 100221801			1011638	986371		
NM_152564.5(VPS13B):c.6962_6963delinsCG (p.Val2321Ala)	VPS13B	V2321A, V2346A	Cohen syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001009562	8	100733187 - 100733188	8	99720959 - 99720960	1009562	992997		NC_000008.11:99720958:TA:CG
NM_152564.5(VPS13B):c.7365del (p.Cys2455fs)	VPS13B	C2455fs, C2480fs	Cohen syndrome	Likely pathogenic	criteria provided, single submitter	VCV000974865	8	100789120	8	99776892	974865	963151		NC_000008.11:99776891:C:
NM_152564.5(VPS13B):c.2441_2450delinsTGTCAGC (p.Ser814_His817delinsMetSerAla)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000971728	8	100205211 - 100205220	8	99192983 - 99192992	971728	955548		NC_000008.11:99192982:GTTGGTCTCA:TGTCAGC
NM_152564.5(VPS13B):c.2778del (p.Phe927fs)	VPS13B	F927fs	Cohen syndrome	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000970409	8	100287435	8	99275207	970409	955549		NC_000008.11:99275206:CC:C
NM_152564.5(VPS13B):c.4946_4947delinsAA (p.Ser1649Lys)	VPS13B	S1649K, S1674K	Cohen syndrome	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000963380	8	100568878 - 100568879	8	99556650 - 99556651	963380	946260		NC_000008.11:99556649:GC:AA
NM_152564.5(VPS13B):c.10327del (p.Val3443fs)	VPS13B	V3443fs, V3468fs	Cohen syndrome	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000961803	8	100865944	8	99853716	961803	946273		NC_000008.11:99853715:G:
NM_152564.5(VPS13B):c.7247+2043_7403del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000960681	8	100781239 - 100789156	8	99769011 - 99776928	960681	959872		
NM_152564.5(VPS13B):c.3701del (p.Asn1234fs)	VPS13B	N1234fs	Cohen syndrome	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000957915	8	100493860	8	99481632	957915	946250		NC_000008.11:99481631:AA:A
NM_152564.5(VPS13B):c.4959del (p.His1654fs)	VPS13B	H1654fs, H1679fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV000953655	8	100587894	8	99575666	953655	946261		NC_000008.11:99575665:GG:G
NM_152564.5(VPS13B):c.1604del (p.Ala535fs)	VPS13B	A535fs	Cohen syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000952123	8	100148933	8	99136705	952123	925282		NC_000008.11:99136704:C:
NM_152564.5(VPS13B):c.2013+2341_2166del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000951757	8	100162579 - 100168929	8	99150351 - 99156701	951757	940890		
NM_152564.5(VPS13B):c.7191_7192del (p.Ser2398fs)	VPS13B	S2398fs, S2423fs	Cohen syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000944827	8	100779142 - 100779143	8	99766914 - 99766915	944827	925293		NC_000008.11:99766913:TT:
NM_152564.5(VPS13B):c.4050_4053del (p.Cys1350fs)	VPS13B	C1350fs	Cohen syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000939125	8	100515069 - 100515072	8	99502841 - 99502844	939125	934463		NC_000008.11:99502840:TGTATG:TG
NM_152564.5(VPS13B):c.11364del (p.Ala3789fs)	VPS13B	A3814fs, A3789fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000864213	8	100880665	8	99868437	864213	835273		NC_000008.11:99868436:T:
NM_152564.5(VPS13B):c.2347_2348del (p.Gln783fs)	VPS13B	Q783fs	Cohen syndrome	Pathogenic(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV000862275	8	100205117 - 100205118	8	99192889 - 99192890	862275	835193		NC_000008.11:99192888:CA:
NM_152564.5(VPS13B):c.5354_5375del (p.Gln1785fs)	VPS13B	Q1810fs, Q1785fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000858359	8	100654172 - 100654193	8	99641944 - 99641965	858359	835222		NC_000008.11:99641943:AGCACAGTGGTGCCAGTCAGCA:
NM_152564.5(VPS13B):c.7828del (p.Cys2610fs)	VPS13B	C2635fs, C2610fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000854662	8	100796591	8	99784363	854662	835247		NC_000008.11:99784362:T:
NM_152564.5(VPS13B):c.6731del (p.Glu2244fs)	VPS13B	E2244fs, E2269fs	Cohen syndrome	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000846904	8	100732646	8	99720418	846904	835231		NC_000008.11:99720417:A:
NC_000008.11:g.(?_99661344)_(99784486_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000833514	8	100673572 - 100796714			833514	820027		
NC_000008.11:g.(?_99121167)_(99721057_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000833226	8	100133395 - 100733285			833226	820011		
NC_000008.11:g.(?_99102933)_(99103140_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000833102	8	100115161 - 100115368			833102	820008		
NC_000008.11:g.(?_99142974)_(99143165_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000833096	8	100155202 - 100155393			833096	820015		
NC_000008.11:g.(?_99135015)_(99143165_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000832881	8	100147243 - 100155393			832881	820014		
NC_000008.11:g.(?_99096302)_(99136762_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000832379	8	100108530 - 100148990			832379	820005		
NC_000008.11:g.(?_99209582)_(99275264_?)del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000832260	8	100221810 - 100287492			832260	820018		
NC_000008.11:g.(?_99467404)_(99521020_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000832188	8	100479632 - 100533248			832188	820021		
NC_000008.11:g.(?_99481579)_(99721067_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832137	8	100493807 - 100733295			832137	820022		
NC_000008.11:g.(?_99501677)_(99502960_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000832133	8	100513905 - 100515188			832133	820023		
NC_000008.11:g.(?_99013769)_(99209688_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000832081	8	100025997 - 100221916			832081	820003		
NC_000008.11:g.(?_99467404)_(99467644_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000832002	8	100479632 - 100479872			832002	820020		
NC_000008.11:g.(?_99111088)_(99170173_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000831638	8	100123316 - 100182401			831638	820010		
NC_000008.11:g.(?_99135005)_(99143175_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831519	8	100147233 - 100155403			831519	820013		
NC_000008.11:g.(?_99391557)_(99556653_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000831437	8	100403785 - 100568881			831437	820019		
NC_000008.11:g.(?_99096312)_(99148010_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000831436	8	100108540 - 100160238			831436	820007		
NC_000008.11:g.(?_99170039)_(99170163_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000831433	8	100182267 - 100182391			831433	820016		
NC_000008.11:g.(?_99520889)_(99521020_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000831307	8	100533117 - 100533248			831307	820024		
NC_000008.11:g.(?_99575648)_(99577643_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000831249	8	100587876 - 100589871			831249	820026		
NC_000008.11:g.(?_99102953)_(99170163_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000831045	8	100115181 - 100182391			831045	820009		
NC_000008.11:g.(?_99520899)_(99584089_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000830905	8	100533127 - 100596317			830905	820025		
NC_000008.11:g.(?_99699505)_(99721067_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000830743	8	100711733 - 100733295			830743	820028		
NC_000008.11:g.(?_99096302)_(99556663_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000830631	8	100108530 - 100568891			830631	820006		
GRCh37/hg19 8q22.2(chr8:100123326-100182391)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000813330	8	100123326 - 100182391			813330	801577		
NM_152564.5(VPS13B):c.468_471del (p.Asn157fs)	VPS13B	N157fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812108	8	100115236 - 100115239	8	99103008 - 99103011	812108	800357	rs1588038825	NC_000008.11:99103007:TAAT:
NM_152564.5(VPS13B):c.7683del (p.Lys2561fs)	VPS13B	K2561fs, K2586fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812106	8	100791163	8	99778935	812106	800358	rs771308343	NC_000008.11:99778934:G:
NM_152564.5(VPS13B):c.1844-8_1844-4del	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000794043	8	100160058 - 100160062	8	99147830 - 99147834	794043	787500	rs745701200	NC_000008.11:99147829:TTTAATTT:TTT
NM_152564.5(VPS13B):c.147+8_147+15del	VPS13B		not provided|Cohen syndrome	Likely benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000752068	8	100026167 - 100026174	8	99013939 - 99013946	752068	775437	rs1587912564	NC_000008.11:99013938:AGCTATTTAGCT:AGCT
NM_152564.5(VPS13B):c.11495+7_11495+8del	VPS13B		not provided|Cohen syndrome	Likely benign(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000746167	8	100883122 - 100883123	8	99870894 - 99870895	746167	759679	rs1588810879	NC_000008.11:99870893:TT:
NM_152564.5(VPS13B):c.8793-6del	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV000737712	8	100832142	8	99819914	737712	759721	rs756641209	NC_000008.11:99819913:GG:G
NC_000008.11:g.(?_99102933)_(99209688_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000665053	8	100115161 - 100221916	8	99102933 - 99209688	665053	651727		
NC_000008.11:g.(?_99274188)_(99275264_?)del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000664444	8	100286416 - 100287492	8	99274188 - 99275264	664444	651827		
NC_000008.11:g.(?_99384188)_(99511532_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660699	8	100396416 - 100523760	8	99384188 - 99511532	660699	651830		
NM_152564.5(VPS13B):c.8421del (p.Asn2808fs)	VPS13B	N2833fs, N2808fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000658663	8	100830736	8	99818508	658663	637535	rs1588743576	NC_000008.11:99818507:CCC:CC
NM_152564.5(VPS13B):c.5171del (p.Gln1723_Leu1724insTer)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000653338	8	100589811	8	99577583	653338	637521	rs1434257397	NC_000008.11:99577582:TT:T
NC_000008.11:g.(?_99661334)_(99661511_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000651830	8	100673562 - 100673739	8	99661334 - 99661511	651830	651833		
NC_000008.11:g.(?_99391537)_(99521030_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000650184	8	100403765 - 100533258	8	99391537 - 99521030	650184	651730		
NM_152564.5(VPS13B):c.572del (p.Asp191fs)	VPS13B	D191fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000642885	8	100115340	8	99103112	642885	637497	rs1588038976	NC_000008.11:99103111:A:
NC_000008.11:g.(?_99556430)_(99577653_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000640450	8	100568658 - 100589881	8	99556430 - 99577653	640450	651831		
NM_152564.5(VPS13B):c.3446-382_3463del	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000639619	8	100479254 - 100479653	8	99467026 - 99467425	639619	652013	rs1588410519	
NM_152564.5(VPS13B):c.2889del (p.Trp963fs)	VPS13B	W963fs	Cohen syndrome	Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000623221	8	100396499	8	99384271	623221	612149	rs1563700124	NC_000008.11:99384270:GG:G
NC_000008.11:g.(?_99556430)_(99642518_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000584011	8	100568658 - 100654746	8	99556430 - 99642518	584011	567309		
NC_000008.11:g.(?_99096292)_(99156763_?)del	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000583868	8	100108520 - 100168991	8	99096292 - 99156763	583868	567308		
NC_000008.11:g.(?_99134612)_(99136772_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000583567	8	100146840 - 100149000	8	99134612 - 99136772	583567	562333		
NC_000008.11:g.(?_99096292)_(99193077_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000583528	8	100108520 - 100205305	8	99096292 - 99193077	583528	564559		
NC_000008.11:g.(?_99115680)_(99193077_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000583454	8	100127908 - 100205305	8	99115680 - 99193077	583454	564566		
NM_152564.5(VPS13B):c.1334_1335delinsTT (p.Cys445Phe)	VPS13B	C445F	Cohen syndrome	Uncertain significance(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000571025	8	100147274 - 100147275	8	99135046 - 99135047	571025	565283	rs1563560499	NC_000008.11:99135045:GC:TT
NM_152564.5(VPS13B):c.10440_10441del (p.Cys3481fs)	VPS13B	C3481fs, C3506fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000559918	8	100866056 - 100866057	8	99853828 - 99853829	559918	550613	rs1554581504	NC_000008.11:99853827:TTT:T
NM_152564.5(VPS13B):c.11501del (p.Met3834fs)	VPS13B	M3834fs, M3859fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557762	8	100883681	8	99871453	557762	544901	rs1394681818	NC_000008.11:99871452:T:
NM_152564.5(VPS13B):c.4971_4973del (p.Arg1658del)	VPS13B	R1658del, R1683del	Cohen syndrome	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555177	8	100587905 - 100587907	8	99575677 - 99575679	555177	544866	rs770497996	NC_000008.11:99575676:AGGAG:AG
NM_152564.5(VPS13B):c.9300_9303del (p.Val3102fs)	VPS13B	V3102fs, V3127fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552844	8	100836174 - 100836177	8	99823946 - 99823949	552844	544885	rs773945333	NC_000008.11:99823945:CTATCT:CT
NM_152564.5(VPS13B):c.10166_10167del (p.Leu3389fs)	VPS13B	L3389fs, L3414fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552135	8	100865782 - 100865783	8	99853554 - 99853555	552135	544888	rs1554581267	NC_000008.11:99853553:CTC:C
NM_152564.5(VPS13B):c.11236del (p.Asp3746fs)	VPS13B	D3746fs, D3771fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550889	8	100880537	8	99868309	550889	544583	rs1347701279	NC_000008.11:99868308:G:
NM_152564.5(VPS13B):c.5154delinsCC (p.Gln1719fs)	VPS13B	Q1719fs, Q1744fs	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550106	8	100589795	8	99577567	550106	545013	rs1554853667	NC_000008.11:99577566:T:CC
NC_000008.11:g.(?_99209572)_(99391724_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000528872	8	100221800 - 100403952	8	99209572 - 99391724	528872	523181		
NM_152564.5(VPS13B):c.11702_11705del (p.Leu3901fs)	VPS13B	L3901fs, L3926fs	not provided|Cohen syndrome	Likely pathogenic(Last reviewed: May 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000524122	8	100883880 - 100883883	8	99871652 - 99871655	524122	514581	rs1161589003	NC_000008.11:99871651:ACTCAC:AC
NM_152564.5(VPS13B):c.8042_8043del (p.Gly2681fs)	VPS13B	G2681fs, G2706fs	Cohen syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000459250	8	100821703 - 100821704	8	99809475 - 99809476	459250	458110	rs1554560735	NC_000008.11:99809474:GT:
NM_152564.5(VPS13B):c.6299_6308del (p.Trp2100fs)	VPS13B	W2125fs, W2100fs	Cohen syndrome	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000459247	8	100712002 - 100712011	8	99699774 - 99699783	459247	458643	rs1554911731	NC_000008.11:99699773:TGTGGAGAGCTGT:TGT
NC_000008.11:g.(?_99121157)_(99193077_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000459244			8	99121157 - 99193077	459244	457745		
NM_152564.5(VPS13B):c.7099del (p.Ala2367fs)	VPS13B	A2367fs, A2392fs	Cohen syndrome	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000437259	8	100779050	8	99766822	437259	428876	rs1554948192	NC_000008.11:99766821:G:
NM_152564.5(VPS13B):c.6009del (p.Phe2003fs)	VPS13B	F2003fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000437257	8	100673680	8	99661452	437257	428874	rs1357171752	NC_000008.11:99661451:TTT:TT
NM_152564.5(VPS13B):c.5438_5452del (p.Asp1813_Thr1817del)	VPS13B		not provided|Cohen syndrome	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374644	8	100654254 - 100654268	8	99642026 - 99642040	374644	361530	rs1057519183	NC_000008.11:99642025:TGACATATTTATTACTG:TG
NM_152564.5(VPS13B):c.5334del (p.Arg1779fs)	VPS13B	R1779fs, R1804fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371494	8	100654152	8	99641924	371494	357704	rs763909903	NC_000008.11:99641923:C:
NM_152564.5(VPS13B):c.8559del (p.Gln2854fs)	VPS13B	Q2879fs, Q2854fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371300	8	100831052	8	99818824	371300	357724	rs765302278	NC_000008.11:99818823:GGG:GG
NM_152564.5(VPS13B):c.11520del (p.Arg3840fs)	VPS13B	R3840fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371090	8	100883700	8	99871472	371090	357751	rs747217399	NC_000008.11:99871471:A:
NM_152564.5(VPS13B):c.3240del (p.Pro1081fs)	VPS13B	P1081fs	Cohen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2018)	criteria provided, conflicting interpretations	VCV000370978	8	100454657	8	99442429	370978	357698	rs764544747	NC_000008.11:99442428:TT:T
NM_152564.5(VPS13B):c.901_904del (p.Thr301fs)	VPS13B	T301fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370733	8	100128063 - 100128066	8	99115835 - 99115838	370733	357681	rs759536357	NC_000008.11:99115834:CTTACTT:CTT
NM_152564.5(VPS13B):c.5678_5679del (p.Leu1893fs)	VPS13B	L1918fs, L1893fs	not provided|Cohen syndrome	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000280368	8	100654496 - 100654497	8	99642268 - 99642269	280368	264375	rs886041586	NC_000008.11:99642267:TT:
NM_152564.5(VPS13B):c.7217del (p.Asn2406fs)	VPS13B	N2406fs, N2431fs	Cohen syndrome|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279781	8	100779167	8	99766939	279781	264296	rs886041184	NC_000008.11:99766938:AA:A
NM_152564.5(VPS13B):c.5927del (p.Pro1976fs)	VPS13B	P1976fs, P2001fs	Cohen syndrome|not provided	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279779	8	100673599	8	99661371	279779	264404	rs755125969	NC_000008.11:99661370:CC:C
NM_017890.4(VPS13B):c.6370_6371delAT	VPS13B	M2099fs, M2124fs	not provided|Abnormality of the eye|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242548	8	100712001 - 100712002	8	99699773 - 99699774	242548	205460	rs748404277	NC_000008.11:99699772:AT:
NM_152564.5(VPS13B):c.11705_11709delinsAGAA (p.Thr3902fs)	VPS13B	T3902fs, T3927fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189182	8	100883885 - 100883889	8	99871657 - 99871661	189182	186773	rs386834067	NC_000008.11:99871656:CAGTG:AGAA
NM_152564.5(VPS13B):c.11831_11841delinsG (p.Pro3944fs)	VPS13B	P3944fs, P3969fs	not provided|Cohen syndrome	Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188770	8	100887731 - 100887741	8	99875503 - 99875513	188770	186774	rs786204456	NC_000008.11:99875502:CCAGCTGTTCT:G
NM_152564.5(VPS13B):c.5734_5735del (p.Ile1912fs)	VPS13B	I1912fs, I1937fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056678	8	100654551 - 100654552	8	99642323 - 99642324	56678	71317	rs386834098	NC_000008.11:99642322:TAT:T
NM_152564.5(VPS13B):c.5140_5157del (p.Ser1714_Gln1719del)	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056671	8	100589780 - 100589797	8	99577552 - 99577569	56671	71310	rs180177362	NC_000008.11:99577551:AAGTGTGGCTCAAGTTCAA:A
NM_152564.5(VPS13B):c.2934+1_2934+2del	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056657	8	100396546 - 100396547	8	99384318 - 99384319	56657	71296	rs180177358	NC_000008.11:99384317:GT:
NM_152564.5(VPS13B):c.11831_11840del (p.Pro3944fs)	VPS13B	P3969fs, P3944fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056643	8	100887730 - 100887739	8	99875502 - 99875511	56643	71282	rs386834069	NC_000008.11:99875501:CCCAGCTGTTC:C
NM_152564.5(VPS13B):c.11620_11623del (p.Ser3876fs)	VPS13B	S3901fs, S3876fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056640	8	100883797 - 100883800	8	99871569 - 99871572	56640	71279	rs386834066	NC_000008.11:99871568:GTGAGTG:GTG
NM_152564.5(VPS13B):c.11050del (p.Leu3684fs)	VPS13B	L3709fs, L3684fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000056632	8	100874007	8	99861779	56632	71271	rs386834058	NC_000008.11:99861778:CCC:CC
VPS13B, EX46-50DEL	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002830					2830	17869		
VPS13B, 1-BP DEL, 11564A	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002829					2829	17868		
VPS13B, EX6-16DEL	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002828					2828	17867		
NM_006005.3(WFS1):c.1949_1950del (p.Tyr650fs)	WFS1	Y650fs	Wolfram syndrome 1	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000929946	4	6303470 - 6303471	4	6301743 - 6301744	929946	918251		NC_000004.12:6301742:TAT:T
NM_006005.3(WFS1):c.2638_2643del (p.Asp880_Phe881del)	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000807720	4	6304156 - 6304161	4	6302429 - 6302434	807720	798546	rs1272826809	NC_000004.12:6302428:CTTCGACTTC:CTTC
NM_006005.3(WFS1):c.439del (p.Arg147fs)	WFS1	R147fs	Wolfram syndrome 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000620589	4	6290836	4	6289109	620589	611975	rs1560408865	NC_000004.12:6289108:CC:C
NM_006005.3(WFS1):c.2643_2646del (p.Phe882fs)	WFS1	F882fs	Wolfram syndrome 1|not provided	Likely pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, single submitter	VCV000562467	4	6304163 - 6304166	4	6302436 - 6302439	562467	553651	rs1560422383	NC_000004.12:6302435:TTCTTT:TT
NM_006005.3(WFS1):c.1060_1062del (p.Phe354del)	WFS1	F354del	Monogenic diabetes|not provided|Rare genetic deafness	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	VCV000228420	4	6302581 - 6302583	4	6300854 - 6300856	228420	229188	rs876657735	NC_000004.12:6300853:CTTC:C
NM_006005.3(WFS1):c.2643_2644del (p.Phe883fs)	WFS1	F883fs	not provided|Wolfram syndrome 1	Pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000215409	4	6304164 - 6304165	4	6302437 - 6302438	215409	211087	rs863224268	NC_000004.12:6302436:TCT:T
NM_006005.3(WFS1):c.1243_1245del (p.Val415del)	WFS1	V415del	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215406	4	6302763 - 6302765	4	6301036 - 6301038	215406	211050	rs863224265	NC_000004.12:6301035:TCGTC:TC
NM_001145853.1(WFS1):c.2648_2651del (p.Phe883fs)	WFS1	F883fs	Wolfram syndrome 1|Type 2 diabetes mellitus|Wolfram-like syndrome, autosomal dominant|Cataract 41|Autosomal dominant nonsyndromic deafness 6|Wolfram syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000209207	4	6304168 - 6304171	4	6302441 - 6302444	209207	205740	rs797045076	NC_000004.12:6302440:TTTCTT:TT
WFS1, 4-BP DEL, 1387CTCT	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000030558					30558	39515		
V415del	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030557					30557	39514		
WFS1, 8-BP DEL, NT2106	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Dec 15, 2008)	no assertion criteria provided	VCV000030553					30553	39510		
WFS1, 16-BP DEL, NT1362	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000004525					4525	19564		
NM_006005.3(WFS1):c.1385_1393del (p.Glu462_Thr464del)	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000004514	4	6302902 - 6302910	4	6301175 - 6301183	4514	19553	rs1578609780	NC_000004.12:6301174:CACCGAGGTCACCG:CACCG
WFS1, 15-BP DEL, NT1685	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000004508					4508	19547		
WFS1, 2-BP DEL, 2812TC	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000004507					4507	19546		
NM_015404.4(WHRN):c.-608_-601del	WHRN		not provided|Nonsyndromic Hearing Loss, Recessive|Retinitis pigmentosa-deafness syndrome	Benign/Likely benign(Last reviewed: Jul 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000364711	9	117267682 - 117267689	9	114505402 - 114505409	364711	316153	rs150944893	NC_000009.12:114505401:GCCTCCGCGCCTC:GCCTC
NM_015404.4(WHRN):c.2423del (p.Gly808fs)	WHRN	G808fs, G807fs, G425fs, G457fs	Deafness, autosomal recessive 31	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000208207	9	117165615	9	114403335	208207	204465	rs869320674	NC_000009.12:114403334:CC:C
NM_015404.4(WHRN):c.643del (p.Val215fs)	WHRN	V215fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 5, 2012)	criteria provided, single submitter	VCV000045679	9	117241027	9	114478747	45679	54844	rs397517258	NC_000009.12:114478746:CC:C
NM_018979.4(WNK1):c.640del (p.Met214fs)	WNK1	M214fs	Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IIA	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2020)	no assertion criteria provided	VCV000637917	12	863370	12	754204	637917	625281	rs1591543044	NC_000012.12:754203:AA:A
NM_018979.4(WNK1):c.1065_1066del (p.Phe356fs)	WNK1	F356fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637896	12	936339 - 936340	12	827173 - 827174	637896	625283	rs1591884457	NC_000012.12:827172:TCT:T
NM_003680.4(YARS1):c.1276del (p.Asn425_Leu426insTer)	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001045888	1	33245744	1	32780143	1045888	1023210		NC_000001.11:32780142:GG:G
NM_003680.4(YARS1):c.1005del (p.Lys335fs)	YARS1	K335fs	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001022511	1	33248042	1	32782441	1022511	1002736		NC_000001.11:32782440:TTTTTT:TTTTT
NM_003680.4(YARS1):c.1383_1392del (p.Ala462fs)	YARS1	A462fs	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001014489	1	33245067 - 33245076	1	32779466 - 32779475	1014489	1002733		NC_000001.11:32779465:ACCAGGAGCA:
NM_003680.4(YARS1):c.112del (p.Ile38fs)	YARS1	I38fs	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000952197	1	33276604	1	32811003	952197	921994		NC_000001.11:32811002:TTTT:TTT
NC_000001.11:g.(?_32810581)_(32811067_?)del	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000831669	1	33276182 - 33276668			831669	818964		
NM_003680.4(YARS1):c.1405del (p.Phe468_Val469insTer)	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000644353	1	33245054	1	32779453	644353	627756	rs777156625	NC_000001.11:32779452:C:
NM_003680.4(YARS1):c.1094del (p.Pro365fs)	YARS1	P365fs	not provided|Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000581271	1	33246695	1	32781094	581271	558477	rs1413975578	NC_000001.11:32781093:GGG:GG
NM_003680.4(YARS1):c.739_740delinsGC (p.Lys247Ala)	YARS1	K247A	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000464879	1	33252621 - 33252622	1	32787020 - 32787021	464879	447801	rs1553123307	NC_000001.11:32787019:TT:GC
NC_000001.11:g.(?_32810591)_(32811057_?)del	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000417512	1	33276192 - 33276658	1	32810591 - 32811057	417512	390748		
NM_003680.4(YARS1):c.241_242delinsAT (p.Asp81Ile)	YARS1	D81I	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187863	1	33276330 - 33276331	1	32810729 - 32810730	187863	185755	rs786204003	NC_000001.11:32810728:TC:AT
NM_003680.4(YARS1):c.458_469del (p.Val153_Val156del)	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000006190	1	33272124 - 33272135	1	32806523 - 32806534	6190	21229	rs786200893	NC_000001.11:32806522:CCACCTGCTTTACCACCT:CCACCT
NM_001109809.5(ZFP57):c.898_905del (p.Gly299_Thr300insTer)	ZFP57		Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000721	6	29640983 - 29640990	6	29673206 - 29673213	721	15760	rs606231123	NC_000006.12:29673205:GCCTGGGTGCCTGG:GCCTGG
NM_001109809.5(ZFP57):c.1383del (p.Tyr462fs)	ZFP57	Y390fs, Y462fs	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000717	6	29640505	6	29672728	717	15756	rs606231122	NC_000006.12:29672727:G:
